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Despite decades of awareness and research, cancer continues to grow as a threat 
to public health. This prevalence indicates the continued importance of attending to how 
cancer is covered and constructed in public health campaigns (“official” discourses) and 
mainstream news coverage (“common” discourses), particularly since the latter 
frequently shapes public perceptions about the disease and the former educates 
populations about the disease. In this dissertation, I assess and evaluate the differences 
and similarities between official and common discourses of health, paying particular 
attention to the existence, location, and mobilization of fissures between these discourses, 
especially as these fissures could indicate the pervasive discourses around particular 
cancers that patients are likely to have encountered and that may influence their 
perceptions of the disease, their experiences, and appropriate treatment. I am guided by 
four questions: (a) What are the differences, if any, between official and common health 
discourses of, respectively, breast, bladder, and skin cancers? (b) How are health 
providers, patients, and specific cancers rhetorically characterized, respectively, within 
and across official and common discourses? (c) How are individual and structural 
responsibility (or unaccountability) rhetorically mobilized across these different health 
conditions? (d) What are the implications of these findings for health information, 
education, promotion, and intervention efforts? 
I answer these questions through a critical rhetorical analysis of two distinct sets
 iv 
of texts for each cancer type under examination here: official/institutional discourses 
broadly disseminated to the public about these cancers and mainstream news coverage. 
Analysis of these texts suggest that, in each case, official discourses characterize cancer, 
patients, and the medical establishment in ways that are distinct from common 
discourses. In doing so, this study contributes to extant health communication literature 
by continuing to parse established knowledge about assumptions of patient responsibility 
and the role of structural entities in the fight against cancer. This study also complicates 
the official/common binary in order to apprehend a potential middle ground discourse 
between official and vernacular discourses, thus resurfacing and redefining the notion of 
the “common” in order to account for the continued blurring of the line between media 



















To Mom—my first and best teacher 
 
  
TABLE OF CONTENTS 
 
ABSTRACT ....................................................................................................................... iii 
 




I INTRODUCTION ............................................................................................................ 1 
 
Communicating Health ................................................................................................... 4 
Theoretical Framework ................................................................................................... 9 
Method .......................................................................................................................... 26 
Preview .......................................................................................................................... 31 
Contribution .................................................................................................................. 41 
 
II BLOODIED AND BOWED: PATIENT AGENCY AS CASUALTY OF WAR (ON 
BREAST CANCER) ......................................................................................................... 44 
 
Official Discourses ........................................................................................................ 45 
Common Discourses ..................................................................................................... 55 
Summary ....................................................................................................................... 78 
 
III TO INVISIBILITY AND BEYOND: THE NEBULOUS DISCURSIVE NATURE OF 
BLADDER CANCER ...................................................................................................... 79 
 
Official Discourses ........................................................................................................ 80 
Common Discourses ..................................................................................................... 92 
Summary ..................................................................................................................... 102 
 
IV SUSPICIOUS MINDS, SHAMED BODIES: MORALITIES AND 
RESPONSIBILITIES IN SKIN CANCER DISCOURSE ............................................. 104 
 
Official Discourses ...................................................................................................... 105 
Common Discourses ................................................................................................... 114 
Summary ..................................................................................................................... 127 
 
V PROGNOSIS: CONTRIBUTIONS AND IMPLICATIONS OF DISCURSIVE 
CANCER PRACTICES .................................................................................................. 129
 vii 
Rhetorical Motifs ......................................................................................................... 131 
Contributions ............................................................................................................... 140 
Implications ................................................................................................................. 144 
Limitations and Future Directions ............................................................................... 147 
 









This dissertation is the result of my determination to finish in 4 years and my 
advisor’s dedication to helping me make that happen. As such, endless thanks are owed 
to my advisor, Dr. Helene Shugart, for teaching, guiding, defending, and encouraging me. 
I will be forever grateful that she agreed to advise me and continued to advise me despite 
the many challenges involved in doing so. Thank you for being majestic, Helga.  
I am also grateful for the opportunities I had to learn from Dr. Mary Strine. Many 
teachers have changed my life and my perspective as a scholar, but Dr. Strine changed 
me as a person and I thank her for that. And also for affirming me; I will never forget 
where I was when she called my analyses “excellent.” Finally, many thanks to my 
committee members for their constructive critiques over the years. 
The people who kept me alive and in this program will, sadly, never receive the 
level of recognition they deserve for their kindness and selflessness. While becoming a 
doctor is undoubtedly awesome, the phenomenal group of people I got to meet in the 
process is the indisputable win here. Below are the meager thanks I can offer for the 
immeasurable gifts these lovely people have bestowed upon me. 
Stephanie Gomez: Thank you for being my academic partner in all things and the 
other half of this great platonic love story. No one else understands me like you do. 
Thank you for keeping me alive during comps, understanding my feral ways, formatting 
my dissertation, helping me woo Helga, being alone together, storing my food
  
ix 
in your fridge during the blackout, and the innumerable other things that you have done 
that were game changers. You truly are the best.  
Amanda Friz: Thank you for being my soulmate and for giving me the courage to 
keep going when things felt impossible. You have been there for me through all the 
things. Thank you for all the advice, listening, love, empathy, frosting shots, cuddles, and 
sweaters of color. I love you.  
Kris May: Thank you for being there for me, believing in me, letting me cry in 
your car, listening to me, abstaining from judgment when I probably should have been 
judged, and funding more Moscato and concerts than I can ever repay. I adore you. 
Diana Zulli: Thank you for always listening to me complain, encouraging me 
when I needed it, driving me to barre during comps, and understanding my fussiness. 
You are wonderful. 
Ian Summers: Thank you for being there for me from day one and for always 
making inappropriate jokes at inopportune times and for making my life better by being 
in the cubicle next door and for making me believe that everything would be fiiiiine. You 
made all the difference.  
Ashley and Jason Elrick: Thank you for understanding my love for fast food, for 
supporting and funding my Diet Coke addiction, and for remaining friends with me even 
when I am (frequently) not my best self. Supper Club is my favorite.  
I am very grateful for the rest of the brilliant people in my cohort who totally 
intimidated me in seminars, but who were also the best people to learn from and 
experience this program with. Jeremy Weaver: Thank you for all the breakfasts and hours 
of talking/listening. Angel Maldonado: Thank you for being my friend against all 
  
x 
odds…XOXO. Jason Jordan: Thank you for empathizing and not judging my cynicism.  
Finally, I am immensely grateful for the wonderful people who helped me adjust 
to Utah and become confident(ish) as a PhD student. Erin Potts: Thank you for bringing 
me into your life, inviting me to camp, listening to me cry on the phone, and making my 
life better. Brian Cozen: Thank you for being there for me during good and bad times; 
you are delightful.  
I would not have managed to start—let alone finish—this program without the 
support of my family. You all cheered me on when I was down, celebrated every victory 
(both big and small), and showered me with love, grace, encouragement, and pick-me-up 
gifts. I could not have carried on without you all. I love you with all my heart. 
Mama: Thank you for being my biggest fan and fiercest supporter. You inspire 
me to keep going. Without you, there would be no things. You are my favorite in the 
history of ever. 
Stephanie and Klayton: Thank you for always being there for me and for being 
proud of me. You have no idea how much that has meant to me, especially during times 
when I felt like I was drowning. And thank you for introducing me to the Warriors.  
Ally: Thank you for loving me like no one else does (or could), and for being 
majestic in all ways. You complete a part of my soul, my dear girl.  
Nate and Katie: Thank you for bringing a joyful noise to my life and for making 













 With the emergence and subsequent privileging of the biomedical approach to 
health and illness in the U.S. healthcare system, the body has become a normalized site of 
tensions over which regulatory actions—if any—should be imposed upon it in order to 
maintain institutional notions of well-being (Lupton, 2012). This approach to health care 
is contextualized by and situated within a larger political economic system that is heavily 
informed by neoliberal sensibilities and locates the responsibility for individual health 
squarely on the patient (Crawford, 1980; Willis, 1991). Thus, how patients understand, 
discuss, and mobilize issues pertaining to their health is informed by and reflective of 
these sensibilities and imperatives that are disseminated, in various ways, in public 
discourses about health.  
 Although complex and varied, specific understandings of health often emerge 
from—and are informed by—official discourses promoted by the medical establishment 
to inform patients of optimal health practices and persuade alignment with these 
practices. Official discourses are generally understood to be those that are widely 
available and are afforded the cultural authority—by dint, for example, of institutional or 
structural power—to shape history and how citizens are allowed to exist within spaces 
constructed by dominant ideologies (Ono & Sloop, 1995). The processes of navigating 




within and represent a specific group’s orientation toward the world. Whereas official 
discourses frequently function as directives that are shaped by and conform to 
governmental and/or institutional doctrine about health, vernacular discourses arise from 
the everyday lives and interactions of communities that are operating in material and 
cultural contexts that frequently are not accounted for in official discourses (Ono & 
Sloop, 1995). The dramatic rise in participation from and interaction between producers 
and consumers fostered by dramatic cultural and technological shifts since these concepts 
were introduced and theorized suggests that the original binary of “official” and 
“vernacular” may no longer adequately or neatly capture discursive cultural dynamics 
and contestations over meaning. That is, this emphasis on sharing, responding to, and 
engaging with mainstream media content in vernacular spaces—for example, blogs and 
social media posts—challenges the notion that broader public discourses cannot 
constitute the vernacular because the former and the latter seemingly draw on one another 
to produce, negotiate, and circulate ideas (Howard, 2008). Howard (2008) puts forward 
the notion of “common vernacular” discourse in acknowledgment of these shifts in 
relation to contemporary mainstream media venues. While he finds the concept 
problematic—effectively hegemonic in its state as a hybrid of vernacular and institutional 
discourses that confounds attempts to draw clear distinctions between the two—I would 
like to revisit and explore that concept and assert, essentially, that “common” discourse is 
more complex and amorphous in its interrelationships with official and, especially, 
vernacular discourses than Howard (2008) posited (or at least was representative at the 
time of his writing). Due to dramatic cultural and technological shifts and the widespread 




communities, mainstream news media in the United States—as privately owned 
entities—must resonate with highly interactive lay audiences in order to remain popular. 
As such, mainstream news discourse, I argue, qualifies as a common discourse per the 
heavy reliance on and responsiveness to audiences given their input into mass mediated 
articulations that, I assert, is more nuanced and more reflective of cultural imperatives 
and sensibilities that are—if not more closely aligned with and reflective of vernacular 
communities than with official discourses—then at least not so far removed from them as 
Howard (2008) speculated at the time of his writing.  
 Accordingly, a broader theoretical aim of my project is to explore and assess 
whether differences in official and common discourses do in fact inhere, thereby 
justifying at least a conditional expansion of Ono and Sloop’s originary considerations of 
discourse as informed by a critical rhetorical perspective. In particular, my interest is in 
assessing intersections and, especially, points of convergence and divergence between 
conventionally “official” and “common,” mainstream cultural articulations or 
narratives—discourses—of health. This provides a valuable opportunity to examine how 
health discourses are generated and proliferated by those who have a vested interest in the 
processes inherent to receiving and understanding care (i.e., patients) and 
providing/communicating about care (i.e., health providers).  The significant impact of 
cancer across the United States—resulting in approximately 1.6 million new diagnoses in 
2015, with a similar number projected for 2016 (American Cancer Society, 2016b)—
provides a key opportunity to examine the potential differences and disparities between 
official and common health discourses, especially in an historical moment when the 




details the necessity of studying cancer-specific discourses—particularly as they pertain 
to breast, bladder, and skin cancers—in order to identify the points of convergence and 
divergence between official and what I aver are common discourses on cancer, and to 
establish the implications of these findings for health promotion, education, and 
interventions.    
 
Communicating Health 
 Consistent concerns for health communication scholars since the inception of the  
discipline have centered on how patients learn about, understand, mobilize, and act on 
general ideas about health and comply with prescriptive guides from providers (O’Keefe 
& Jensen, 2007). This emphasis on patient knowledge and understanding frequently 
extends to how patients talk about their health in both formal encounters with medical 
professionals and informal engagement in health discourses with family, friends, and 
extended online networks (Himelboim & Han, 2014). The vast advancement and 
proliferation of online discourses about health enable new and enhanced methods for 
relaying and receiving information in discussions about health, illness, and medicine. As 
such, interrogating how the public at large understands and takes up ideas about health 
and illness must extend to the media through which these notions are mobilized, as well 
as the kinds of official dictums against which these ideas are drawn.   
 These configurations of health discourses participated in and/or created by 
governmental or health-based institutions and popular media platforms provide key 
opportunities to elaborate on existing health and identity scholarship. Specifically, all 
understandings about cancer (and arguably any experience) inevitably intersect and 




identity markers as gender, age, race, and class. Because contemporary “common” 
discourses acknowledge particular cultures, communities, and materialities typically not 
accounted for by the broader aims and leveling assumptions of official discourses, the 
intersections between these identity markers in common and official discourses suggest 
the importance of assessing these varied discourses in relation to each other because they 
can furnish valuable insight into how and why people understand and practice health and 
illness in the ways that they do, as well as why some campaigns and initiatives may be 
more or less effective (e.g., see Dubriwny, 2008; Oduro, Connor, Litwin, & Maliski, 
2012; Pudrovska, 2010). For example, diagnoses of and discourses about each of the 
cancer types proposed for analysis here frequently associate certain cancer types with 
various combinations of these identity markers, resulting in the potential for rhetorical 
motifs that reflect and refract culturally inscribed notions of identity in regard to cancer 
diagnoses, treatments, and preventive measures. Common and official discourses, then, 
must be considered to illuminate how they are informed by cultural notions surrounding 
these identity markers in different ways. Vernacular discourses, of course, have relevance 
to and for these matters, in general and in relation to health. However, my project here is 
to assess and compare official and common health discourses as primary resources for 
individuals and communities—in particular, patients—in order to assess if common 
discourses, which, I aver, are more reflective today of broader exigent cultural 
imperatives and sensibilities than official discourses, diverge in significant ways from 
official discourses. I want to do this in order to potentially inform optimal health 
communication practices, as well as assert that we need to reevaluate the significance and 




In order to mobilize this interest and operationalize the rhetorical construction of cancer 
and identity in these separate—yet related—discourses, breast, bladder, and skin cancers 
will serve as impetuses for mediated negotiations and discussions about these diseases, as 
well as the potential identities that are impacted and/or developed in relation to them.  
 Communication about science has become a common and encouraged phenomena 
in public discourse and the U.S. mass media since approximately the mid-1990s (Davies, 
2008; Powell & Colin, 2008). A key part of the influx of attempts by science to 
communicate itself to publics is the dissemination of information about advances in 
health and medicine (Smith, Niederdeppe, Blake, & Cappella, 2013; Taylor et al., 2015). 
With research funding and support from the National Cancer Institute and other federal 
initiatives, cancer has become the most covered disease in health-focused news coverage 
and achieved a permanent position on the public agenda (Smith et al., 2013). Some health 
care providers and health promotion and education advocates laud the proliferation of 
information regarding cancer science in the public discourse for its ability to 
inform/empower the populace (Smith, Singer, & Kromm, 2010). Many cancer experts, 
however,  prefer citizens to know primarily about prevention and early detection rather 
than all relevant cancer information that could be acquired or made available (Diviani & 
Schulz, 2011; K. C. Smith et al., 2010). Relatedly, whereas conflicting cancer-related 
information in the news has been found to help some viewers grasp the complexity of the 
disease and associated screening and treatment procedures (Dixon, Scully, Wakefield, & 
Murphy, 2008), this optimistic allusion to health literacy is not universally shared. 
Others—especially those conducting clinical and medical cancer research—have 




complex scientific information in mainstream formats and venues may in fact hinder 
research and/or treatment protocols (Smith, Singer, & Kromm, 2010).  
 Furthermore, public comprehension of cancer-related information in mass media 
has been found to be lacking, with consumers frequently overgeneralizing and confusing 
details specific to prevention and screening, thus leading to concerns that patient agency 
and cancer risk may be both over or underestimated by consumers (Mazor et al., 2010). 
Concerns about the accuracy and utility of health information in news coverage 
frequently center on the over/underrepresentation of health issues relative to their actual 
rates of occurrence, including cancer and related health scares, such that viewers gain 
skewed perceptions of cancer risk and prevalence (Ackerson & Viswanath, 2010; 
Bomlitz & Brezis, 2008; Jensen et al., 2014). Relatedly, concerns about the accuracy and 
focus of medical information in the news, including those stories based in part or in 
whole on press releases about health-related research, raise questions about the 
presentation and reception of cancer-related information, especially regarding the 
emphasis on disconcerting and attention-grabbing statistics (Taylor et al., 2015). Finally, 
segmented cancer messages in media—that is, those that are targeted toward specific or 
mainstream audiences—also vary in their content, suggesting that not all groups are 
receiving commensurate and adequate cancer information (Fishman, Ten Have, & 
Casarett, 2012).  
  In illuminating what “on the ground” understandings of respective cancers are, 
this study can inform researchers and health practitioners whether, in the first place, any 
disconnect between the science and public beliefs about cancer can be laid at the feet of 




occur. Perhaps most compellingly, this study can inform praxis regarding what 
information ought to be put out there. In other words, debate around the public discourse 
of science has typically revolved around very specific “official” messages, and 
sometimes interpretation thereof. This study comes at the issue from the other side: the 
mobilization of broader cultural, or “common,” understandings of cancer, regardless of 
where that information came from, which stands to inform health communicators how 
best to intersect with those everyday understandings. 
 
Research Questions 
 In order to assess and evaluate the differences and similarities between official 
and common discourses of health, attention must be paid to the existence, location, and 
mobilization of fissures between these discourses, especially as these fissures could 
indicate the pervasive discourses around particular cancers that patients are likely to have 
encountered and that may influence their perceptions of the disease, their experiences, 
and appropriate treatment. As such, this study will address and be guided by the 
following research questions: 
RQ1: What are the differences, if any, between official and common health 
discourses of, respectively, breast, bladder, and skin cancers? 
RQ2: How are health providers, patients, and specific cancers rhetorically 
characterized, respectively, within and across official and common discourses?  
RQ3: How are individual and structural responsibility (or unaccountability) 
rhetorically mobilized across these different health conditions? 
RQ4: What are the implications of these findings for health information, 





 The theoretical framework for this project is undergirded by scholarship in 
contemporary rhetorical theory, health communication, and media studies. Specifically, 
the interrogation of official and common discourses about cancer requires understanding 
about rhetoric as the mobilization of discourses, as well as critical approaches to 
rhetorical inquiry and health discourses.  
 
Rhetoric 
 While rhetoric is frequently (and understandably) conflated with the available 
means of persuasion, per Aristotle, or viewed as the handmaiden of the arts, the 
mobilization of the term has evolved beyond persuasion, politics, puffery, and prose. 
Lucaites and Condit (1999) note that current conceptualizations of rhetoric are often 
influenced and informed by the classical tradition’s focus, which assumes rhetoric to be 
“the public, persuasive, and contextual characteristics of human discourse in situations 
governed by the problems of contingency” (p. 2, original emphasis). This emphasis on 
context and contingency is necessary for understanding rhetoric as “the human use of 
symbols to communicate” (Foss, 2009, p. 3). That is, context and contingency account for 
the fluid and dynamic nature of signs and symbols across cultures, thus allowing for 
increased inclusion of what counts as rhetoric. With the understanding that 
communication is inherently rhetorical (Brockriede, 1974), the following inclusive 
definition from Deluca and Demo (2000) is particularly salient and the one on which this 
study is based: rhetoric is “the mobilization of signs for the articulation of identities, 
ideologies, consciousnesses, communities, publics, and cultures” (p. 253). This attention 




through communication and that inquiry into these processes must examine the impact 
and long-term significance of rhetorical acts and their underlying symbolic processes 
(Campbell, 1974).  
 Foci for rhetorical inquiry—historically and currently—have frequently included 
public address (e.g., Palmer & Lucas, 2008), communication systems (e.g., Keränen, 
2001; Mechling & Mechling, 1983), and mass communication processes (including 
production, distribution, and audience reception) (Condit, 1989; Condit et al., 2002) in 
order to examine how realities are articulated by and through these phenomena. Of 
particular importance for the current project is rhetoric’s attention to health imperatives 
and how cultural meanings of health, medicine, and illness are discursively and socially 
constructed through—among other “texts”—health policies, patient-provider interactions, 
news coverage, and international events (e.g., kairotic accounts of disorders emerging 
from and associated with specific conflicts and events, such as the association between 
active duty and Posttraumatic Stress Disorder) (Segal, 2008; Solomon, 1985). 
Furthermore, how meanings about cancer are rhetorically mobilized and negotiated 
bespeaks the importance of interrogating tensions between dominant discourses and 
patient perspectives on the disease, especially as these tensions and discourses have the 
potential to impact health policy, news coverage, and common knowledge about cancer 
detection, prevention, and treatment (Keränen, 2010; Pezzullo, 2003; Trendowski, 2014). 
 Inquiry into the rhetorical dimensions of health communication encompasses 
assessment of the everyday disclosures and information-seeking endeavors of patients 
(Segal, 2008; Zoller & Kline, 2008), especially as these disclosures and mobilizations of 




primary example (Harter, Japp, & Beck, 2005; Sharf, 2009). How issues of health are 
negotiated by patients and providers through storytelling is often informed and impacted 
by the narratives and structures of the medical establishment (Carmack, 2010; Harter et 
al., 2005). Narrative medicine—the privileging of patients and their processes of 
narrativizing their orientations toward health—serves as a way to eliminate barriers 
between patients and providers, as well as approaches the medical encounter as a 
performance for all involved in health contexts (Charon, 2006; Langellier, 2009). 
Furthermore, how patients construct narratives about their health practices connects to 
sensemaking about health (Bute & Jensen, 2011). Relatedly, narrative as a medium for 
patient understanding about health information is not limited to just those stories that are 
shared within the medical context. Rhetorical scholars also attend to how mediated 
narratives inform patients about illness and disease (Zoller & Worrell, 2006) and the 
forms and functions of the medical establishment (Harter & Japp, 2001), as well as serve 
as “edutainment”—the embedding of health education in fictionalized narratives 
(Piotrow, Rimon, Payne Merritt, & Saffitz, 2003)—for audiences of popular culture texts 
like television series (Dutta, 2007; Gray, 2007). 
 
Critical Rhetoric 
 Critical rhetoric attends to the circulation of signs and symbols and the 
negotiation(s) of their meanings in a culture, but with increased awareness of and 
attention to the fluidity of power and the positionality of the critic. This orientation—
which collapses the distinction between theory and method—seeks to demystify power 
and complicate rigid notions of ideology that fail to account for and negotiate the 




1989). Comprised of two primary and complementary perspectives—the critique of 
domination and the critique of freedom—that each necessitate the understanding of 
power as both creative and repressive (Ono & Sloop, 1992), this orientation eschews the 
idea of power as a relatively stable and distributed entity that falls into the oppositional 
have/have-not binary, and engages in the negotiations of power in everyday practices and 
performances (as opposed to the excavation of ideology and the chipping away at power). 
Critical rhetoric, then, attends to how dominant discourses function as normalized and 
normalizing structures that hinge on notions of authority and order social relations so as 
to maintain their privileged positions in political, social, and cultural milieus and that, 
moreover, are in constant dynamic, fluid, and symbiotic relation with resistance and 
alterity to that end (McKerrow, 1989; Ono & Sloop, 1992).  
 In critiquing these structures, the critic creates a text representative of the cultural 
phenomenon under study by combining ideologically based fragments of culture that are 
inherently informed by—and often collapsed into—their historical context (Hasian, 2001; 
McGee, 1990). Examining this context requires critic collaboration rather than 
ideological exhumation. That is, critical rhetoric attempts to resituate the critic as a 
collaborator and seeks to remove the undertones of elitism inherent to the practice of 
declaring (and often romanticizing) the composition and material constraints of certain 
groups deemed to be oppressed (Charland, 1991). By necessitating that critics take the 
agentic audience and their own subject positions into account, critical rhetoric absolves 
the critic of being a definitively authoritative or objective voice on any given subject. 
Indeed, Ono and Sloop (1992) assert that “critics must highlight their contingency, not 




and contextualize their perspectives and positionality, as well as account for the  
fact that they are part of the ideological system they are critiquing (McGee, 1990). 
 Critical rhetoric and health.  With its attention to the circulation of signs and 
symbols and the negotiation of their meanings in culture, this orientation illuminates how 
discourses about health are negotiated in and across communities, as well as across media 
(Lupton, 2012; McKerrow, 1989). A rhetorical approach to the study and critique of 
health discourses is useful for examining how “common knowledge is produced and 
circulated in the varied discourses that underlie our cultural practice of health and 
medicine” (Leach & Dysart-Gale, 2011, p. 1), especially as they occur in the public and 
professional domains of mass media (Segal, 2005). By interrogating axes of power and 
reconfiguring how health is understood, critical rhetoricians privilege the voices of their 
participants and encourage them to speak for themselves, as well as critique how the 
social and political power of discourses surrounding health have the potential to privilege 
some perspectives over others (Lupton, 1994; Segal, 2005; Zoller & Worrell, 2006). The 
tensions involved in discussions about health and cancer are integral to illuminating how 
individuals take up ideas about their health; this understanding is imperative for 
effectively conveying accurate health information (Babrow & Mattson, 2003). This 
orientation is also useful for examining how cultural notions of identity take hold in and 
inform discourses about cancer, especially as these notions are demonstrated in 
vernacular discourses that are rhetorically drawn against official campaigns and 
initiatives about cancer. These varied discourses provide the opportunity to examine how 
rhetorical motifs potentially shape a form of reality that constructs or constrains how 




 Critical approaches—and specifically critical rhetoric—have been effectively 
mobilized in the interrogation of discursive constructions of health and illness, and how 
power is imbued within societal structures that promote and perpetuate disparities in care 
(Lupton, 1994). Drawing on notions of power and ideology to critique the structures that 
often subjugate and/or discipline the body into acceptance, conformity, and/or silence 
(Zoller & Dutta, 2008), critical scholars target the neoliberal constraint of health as an 
individual responsibility (Dutta, 2010) and attend to how standards of health are 
subjectively defined and utilized to police bodies (Jordan, 2004; Zoller, 2003). Lupton 
(1994) explains that bodies are inscribed by dominant discourses and relations of power 
are exercised through commonplace health and medical practices. Specifically, these 
constraining systems, standards, and practices alienate patients from their bodies and 
render them intelligible only though medical intervention, thus privileging the expertise 
of providers and medical technologies (Harter & Japp, 2001; Kroløkke, 2010). This is in 
keeping with Dutta’s (2010) lobbying for the critical cultural turn in health 
communication which attends to the need for interrogating the exigencies that inform 
knowledge claims. 
 These practices that inform notions of health and medicine necessitate the 
understanding of culture as inherently fragmented and the practice of selecting fragments 
as texts for analysis (McGee, 1990). For example, Shugart (2011) assesses the 
rhetorically constructed narrative about obesity as demonstrated in cultural fragments in 
popular culture, and Brouwer (1998) utilizes a small number of interviews with gay men 
to illuminate the experiences of these men and their decisions to get HIV-positive tattoos. 




depression in national news discourse pathologizes female bodies as uniquely susceptible 
to depression and in need of a disciplinary mechanism because they are defective, 
passive, and sites of danger. Finally, by examining how news discourse constructed 
breast cancer and the expectations for the performance of breast cancer patient, Dubriwny 
(2008) attempts to find the balance between discursivity and materiality (a task which has 
proven difficult for critical rhetoricians who often deliberately avoid declaring and 
romanticizing certain groups as oppressed and impacted by rhetorically negotiated 
meanings of power). These tensions surrounding prevalent and varied understandings of 
health generally and cancer specifically are best examined in potentially competing, 
complementary, and circumvented discourses about health, medicine, and disease (Ono 
& Sloop, 1995; Segal, 2008). 
 Cancer, as the second leading cause of death in the United States, necessitates the 
examination and interrogation of how the disease is both experienced and discursively 
constructed by those traditionally involved with a patient’s diagnosis, including patients, 
health providers, loved ones, caregivers (Centers for Disease Control and Prevention, 
2016). Research into the interpersonal dynamics of communicating about cancer heavily 
emphasizes the patient-provider relationship and the impact of this relationship on patient 
adherence, satisfaction, and health outcomes (Brown, Stewart, & Ryan, 2003), especially 
as it pertains to improving patient-centered care (McCormack et al., 2011; Parker, 
Davison, Tishelman, Brundage, & The SCRN Communication Team, 2005), reducing 
disparities in cancer care (Dilworth, Higgins, Parker, Kelly, & Turner, 2014), and aiding 
in shared decision-making between patients and physicians (Shabason, Mao, Frankel, & 




patients’ stories about their embodied experiences with the disease (Ott Anderson & 
Geist Martin, 2003), while rhetorical approaches frequently assess the language used to 
discuss and define cancer and the implications thereof for those dealing with the disease, 
especially in regard to sense-making metaphors (Cobb & Starr, 2012), health education 
(Kline, 2007), and identity construction (Dubriwny, 2008). Relatedly, critical approaches 
interrogate the disease through the understanding that its diagnosis, treatment, and 
awareness are often stratified and experienced differently based on intersections of race, 
gender, age, socioeconomic status, and geographic location ( Holt, Wynn, Southward, et 
al., 2009; Pezzullo, 2003; Pudrovska, 2010). Significant to the current project is the 
contribution it seeks to make to this literature base. While much critical health 
communication scholarship has established and confirmed the neoliberal and individual 
responsibility power dynamic in health communication—especially of the 
official/mainstream variety—I want to contribute by refining that work and examining 
precisely how individual responsibility is deployed, in potentially quite variable ways. 
 
Discourse Production and Power 
 Grounded in the critical rhetorical tradition and built on the tenets of interrogating 
the dynamic nature of power and ideology, Ono and Sloop’s (1995) theorizing about the 
vernacular provides a nuancing of how we understand discourse from a critical rhetorical 
perspective to both differentiate and assert relations between official and vernacular 
discourse. Official discourse, as they allude, comprises those texts that construct history, 
delimit public space, and control understanding about dominant ideologies (Ono & 
Sloop, 1995). Vernacular discourse extends the orientation towards critiques of 




communities that are often oppressed and/or consigned to the margins (McKerrow, 1989; 
Ono & Sloop, 1995). With their emphasis on speech and resulting texts specific to these 
groups, Ono and Sloop (1995) privilege those discourses that reside within specific 
communities and frequently occur outside the mainstream media. While carefully 
avoiding the conflation of vernacular critique with liberatory practice, Ono and Sloop 
(1995) provide a useful framework through which to examine how culturally specific 
discourses circulate among communities that historically have been or currently are 
systematically ignored by dominant discourses and perspectives. Furthermore, examining 
these discourses “reveals how material conditions shape and motivate collective 
understandings of ourselves and the way we think things ought to be,” thus enhancing 
understanding about how marginalized communities convey meaning and demonstrate 
discontent with the status quo (Triece, 2011, p. 435).  
 The importance of vernacular discourses in the construction and enactment of 
identities and subject positions in marginalized groups is exemplified by Ono and Sloop’s 
(1995) theorizing about cultural syncretism and pastiche as a function of this practice. 
Oppressed groups practice the former by subtly protesting against dominant groups and 
ideologies by generating culturally specific discourses that affirm the subjectivities of the 
group; this practice is furthered by the borrowing or absorbing of fragments of popular 
culture into localized discourses, resulting in embodied practices that affirm the group 
while challenging dominant discourse (Ono & Sloop, 1995). Furthermore, definitions of 
what constitutes marginalization and which groups can reasonably be categorized as such 
have been expanded by research into online platforms and media technologies. Whereas 




ethnicity (especially as these identity markers intersect with cultural norms and 
discourses of gender), Hess (2009) argues that stigmatization operates as a form of 
marginalization and that social media and online users meet the criterion of resistance, 
rather than oppression. Thus, groups that take to the Internet to challenge official 
discourses and (re)form their cultural identities can productively be studied through 
increased “understanding of the discursivity of everyday resistance” rather than 
oppression and acknowledgement of divergence from the status quo (Hess, 2009, p. 415). 
 These critiques and extensions of vernacularity suggest the need for further 
critical inquiry that accounts for the changing media landscape. While mainstream news 
used to be appropriately understood as official or dominant, the changing nature of news 
media—including technological advancements in interactivity and engagement between 
producers and consumers—indicates the prominence and likelihood of consumer 
influence on content. Additionally, the increasing demand for and credence given to 
infotainment as a legitimate news source suggests that mainstream voices are diverging 
from the sole agenda-setting function of days past and instead engaging with cultural and 
social discourses desired by the public (Piotrow et al., 2003). As such, these mainstream 
discourses have the potential to serve as a good barometer of vernacularity in this 
historical moment, functioning not only primarily or exclusively as agenda setters (and 
thus official discourses) but as reflective of and resonant with prevailing cultural 
understandings and sensibilities.  
 The current project: official and common health discourses.  This study is 
predicated on two primary needs: first, for continued and enhanced understanding about 




enhanced applicability of common discourse in the context of a dynamic media 
landscape. To begin, the necessity of illuminating how individuals learn about and 
discuss their health in relation to cancer, as well as related medical treatments and 
preventative measures, is undergirded by the imperative to improve the construction, 
implementation, and (hopefully) reception of public health campaigns. Furthermore, how 
medical information—including that which pertains to illness and disease—is understood 
and acted on by patients and generally discussed in their day-to-day lives are key 
components to the successful navigation of patient-provider interactions (Lupton, 2012). 
As such, illuminating how various discourses about cancer intersect and perhaps even 
contradict each other has the potential to indicate mediated and interpersonal methods for 
physician intervention and participation in the coconstruction of knowledge about cancer. 
Thus, by attending to the cultural practices that discursively produce meanings of health 
and cancer, I take up Segal’s (2005) assertion that rhetoric is useful for examining the 
functions of language, especially as they occur in the public and professional domains of 
mass media.  
 Regarding the production and dissemination of discourse as conceptualized from 
a critical rhetorical standpoint, I want to assert and develop the contemporary relevance 
of “common” discourse in relation to the foundational concepts of official and vernacular 
discourses. Although Ono & Sloop (1995) highlight nondominant discourses as giving 
voice to and making space for alternative perspectives—and thus merit theoretical 
attention—this approach relies on simplistic binaries of dominant/nondominant 
discourses, and mainstream/alternative media. As critical scholars frequently note (Ono 




distribution of power as a zero-sum game (Foucault, 2000). That is, power’s productive 
nature gives rise to resistive practices and tensions that hinge on the negotiation of status, 
access, and control, resulting in a process of exchange rather than a simple determination 
of “haves and have-nots.” This approach to power, then, negates any understanding of 
certain discourses being vernacular solely because they are relegated to certain 
communities, as well as raises questions about what constitutes localized communities, 
what constitutes marginalization in the globalized mediascape, and what constitutes 
dominance in the context of fluid power. Conceptualizations of dominant discourses, 
then, need to account for those relatively narrow and stable discourses that dictate 
meanings for—but do not draw from—cultural and social sensibilities in order to 
conceive of those vernacular discourses that do. Regarding health communication, 
official discourses are primarily prescriptive and dictate proper courses of action, so 
greater understanding about how vernacular discourses address similar messages is 
warranted.  
  Furthermore, the official/alternative binary fails to account for the complex means 
of content production and distribution, especially in the contemporary mediascape. That 
is, lay voices and localized communities are frequently (re)presented or incorporated in 
media that cannot be labeled alternative, oppositional, or resistive. For example, one does 
not need to read zines to learn how the public understands a governmental policy (though 
that would certainly be an option); one could simply read an Op-Ed essay in The New 
York Times and the attendant comments section to ascertain how official dictums are 
being filtered through and to the public. And, with ease of access to online content—and 




vernacular content becomes complicated by the complexities of Web 2.0 and the fluid 
boundaries between public/private that are endemic to the prevalence of new media 
technologies. That is, lay perspectives have access to an unprecedented amount of 
platforms and cannot be easily confined to spaces shared solely by members of those 
unique communities.  In light of these developments and pressing importance of the 
intersection between health and media/technology, this project is situated at the tensions, 
fissures, and negotiations between official and vernacular discourses about cancer across 
traditional and digital media.  
 Other scholars have noted these tensions inherent to the vernacular/official binary, 
and have worked to trouble and/or refine Ono and Sloop’s (1995) original 
conceptualizations of discourses as official and vernacular. A primary critique centers on 
the simplicity and defined nature of the official/vernacular binary. As Howard (2008) 
notes, the changing mediascape—facilitated by the Internet and web-based technologies, 
as well as an increasing emphasis on participatory engagement from/with consumers—
renders a clear distinction between vernacular and official/institutional discourses 
ambiguous. Additionally, much of Ono and Sloop’s (1995) distinction relies on an 
oppressed/dominant binary that establishes the vernacular as originated by groups that are 
historically oppressed. However, this binary, too, has been challenged by scholars who 
posit that a better metric of “vernacular” is an emphasis on resistance or challenging of 
dominant discourses (Hess, 2009; Howard, 2005). 
 Relatedly, the notion of what constitutes “official” discourse has been similarly 
challenged, particularly in light of the ascension of participatory media. As previously 




rooted in the understanding that institutional discourses lack definitive boundaries in the 
age of online interaction and the interrelationship between media producers and 
consumers. Bruns (2006) takes up this notion when theorizing about “produsage,” or “the 
collaborative, iterative, and user-led production of content by participants in a hybrid 
user-producer, or produser role” (p. 275). Theorizing about produsage is grounded in the 
assumption that the boundary between producers and consumers—that is, official and 
vernacular voices—has been broken down in the age of Web 2.0 and participatory media 
(Bruns, 2008). Other scholars have similarly attended to the enhanced role that audiences 
play in the production and dissemination of media content. Tandoc (2014) notes that web 
analytics have altered the ways in which journalists conceive of the audience and 
integrate their feedback in the process of constructing the news, resulting in enhanced 
attention to audience preferences and behaviors. Likewise, Lee, Lewis, and Powers 
(2014) assert that news editors are increasingly taking audiences into consideration in 
their gatekeeping processes. This emergent trend of increased reciprocal interaction 
between journalists/editors and consumers indicates a normalizing function such that 
desires and interests expressed by the latter will likely be taken up by the former (Lewis, 
Holton, & Coddington, 2014). 
 The news industry—often considered the conventional conduit for official 
discourses—has likewise experienced a breaking down of expertise and distinction 
between journalists and consumers. The aura of expertise that formerly surrounded the 
journalism field has been tarnished in recent years due to a variety of changes in 
journalistic practice, largely in response to a changing media field and financial 




for journalists has been reduced in recent years (Finberg, 2014). There has been a 
concomitant rise in citizen journalism, resulting in altered perceptions of journalism, 
journalists, and the rules that guide both in the context of citizen-driven journalism 
(Holton, Coddington, & Gil de Zúñiga, 2013). Particularly relevant to the current project 
is the changing dynamic and norms surrounding health and science journalism, primarily 
the absence of specialized training for health and science journalists that used to be 
standard practice and the cuts to funding for health and science journalists, often resulting 
in an increase in unspecialized freelance journalists (Schwitzer, 2009).  
 These broad changes and subtle shifts in our current dynamic mediascape 
demands a need for new ways to think about the official/vernacular and producer/user 
binaries by seeking a middle ground discourse that complicates these distinctions. 
Particularly in light of the media changes detailed above, this middle ground discourse 
best reflects Howard’s (2008) conceptualizations of “common” discourse, or “the view of 
the vernacular [that] identifies its alterity as alternate to institutionally empowered 
speaking situations” (p. 494). Howard’s (2008) conceptualization of the “common,” 
however, is ultimately suspicious of mainstream news media and explicitly rejects it, 
largely on the grounds that it does not adequately attend to power imbalances inherent to 
media production. A dismissal of the “common,” however, does a disservice for those 
wanting to attend to the fluidity of power and changing views on expertise that are 
prevalent in this historical moment. As such, I want to revive and revisit “common” and 
venture a reconceptualization of it as more amorphous and fluid—not quite the hybrid 
that Howard (2008) asserts is prevalent in the vernacular Web, but not quite a “lite” 




deployment of official). All of the reasons noted above suggest that mainstream news, 
especially, challenges original conceptualization of the official/vernacular binary, and 
thus must be attended to in light of the unsustainable nature of this binary (despite 
original thinking that notes the symbiosis of these opposing perspectives/voices).  
 Although not the basis of my project, attending to classically vernacular 
discourses—online/audience/lay driven texts—compared to official discourses would 
indeed be a worthwhile endeavor were my project specifically to assess how lay 
audiences—while not interchangeable with vernacularity, more closely aligned with it 
per Ono and Sloop’s originary binary—understand health matters. However, while I am 
interested in assessing marked differences between institutional and broader cultural 
understandings of health for the improvement of practical health care and dispensation, I 
also want to explore my hypothesis regarding “common” discourses as qualitatively 
distinct from official ones, as well as how and where those differences inhere. 
 
Critical Health Discourses 
 Although Ono and Sloop’s (1995) framework is rarely taken up in inquiry about 
the rhetorics of health and medicine, the interconnections between official/institutional 
and vernacular discourses about health are nonetheless necessary to consider. As Keränen 
(2007) explains, it is often important to examine these interconnections because the 
combination of perspectives “can yield productive critical insights into rhetorical 
practice,” especially as they pertain to medical discourse (p. 181). In keeping with this 
idea is Keränen’s (2005, 2010) examination of how issues of trust, persona, and character 
were rhetorically mobilized in news discourse about the lumpectomy controversy in the 




about it, as well as delimited roles for the breast cancer patients to adopt in the wake of 
the controversy. As such, the power and inevitability of these varied discourses to 
intersect and interact in productive ways suggests the need for further inquiry into the 
tensions between official and vernacular health discourses about cancer.  
 Taking up Keränen’s (2007) argument that the interconnections between official 
and vernacular discourses have the potential to provide insights unique to their combined 
study, the current project seeks to engage these matters via the concept of “common” 
discourse, or mainstream public discourse broadly reflective of cultural imperatives and 
sensibilities that are not necessarily or arguably as likely to be apparent in official—
institutional, state, or establishment—discourse. Messages and narratives about health 
have overwhelmingly been constructed and disseminated from health promotion and 
education campaigns. With the valuable and laudable goal of informing the public about 
productive health practices, these campaigns are generally oriented by and from the 
creators (and authority figures) who work in fields related to public health, health care, 
and promotion. Although some efforts have been made to design these campaigns to 
reflect the values and beliefs of the targeted communities, they generally are not of and 
by the communities themselves (e.g., see Holt et al., 2009). Rather, the culturally oriented 
and specific messages are still funneled through the formal channels and official 
discourses of governmental agencies, health promotion initiatives and organizations, and 
academic studies. The current project, predicated on the assertion that it is feasible to 
draw a distinction between official and common discourses, attends to how mainstream 
press outlets filter, mobilize, and make sense of information about various types of 




importantly—by changes to mainstream news media that have altered due to sweeping 
cultural and technological changes, ranging from shifting priorities and commitments to 




  A rhetorical approach is necessary for examining potential patterns of privilege, 
culture, and identity that are articulated in discourses about bladder, breast, and skin 
cancers across media, and specifically a critical rhetorical approach is the most 
advantageous way of examining how these patterns are demonstrated in and against 
official and common discourses. Blurring the line between theory and method, critical 
rhetoric allows for the interrogation of texts and contexts through careful attention to the 
material relevance of rhetoric on bodies (McKerrow, 1989). Utilizing this approach 
requires the consolidation of fragments of culture—in this case, public health 
information, health campaign materials, and online news content—in a process that 
creates rhetoric at the same time the rhetoric is assessed. Furthermore, these fragmented 
texts are created by/within their contexts and informed by factors both internal and 
external to their production, including, for example, popular culture, politics, and social 
media user interfaces (Hasian, 2001; McGee, 1990). As a critic, then, I am a collaborator 
in the creation of these texts and thus must be self-reflexive about the assumptions that 
result from my subject position(s) as a scholar and that inform my text selection, 
methodological choices, and analytical approach (Louis & Barton, 2002). Indeed, Ono 
and Sloop (1992) assert that “critics must highlight their contingency, not simply footnote 




contextualize their perspectives and positionality, as well as account for the fact that they 
are part of the ideological system they are critiquing and that one’s critiques are 
complicated by other possible interpretations (McGee, 1990). 
 The texts proposed here for analysis provide insight into how governmental 
entities and health organizations discursively construct various cancer types, as well as 
how mainstream news media discuss these diseases. Specifically, public health 
campaigns, awareness programs, and education resources about breast, bladder, and skin 
cancers will constitute the official discourses under examination (and will be gathered 
exclusively through the websites of the entities in question). News discourses from 
national newspapers and newsmagazines—all available and gathered online—as well as 
articles from popular online news sources—for example, The Huffington Post—will 
comprise the common discourses that circulate around and reflect the experiences with 
and perspectives on cancer that resonate with the public. As mainstream, accessible 
engageable texts—which feature, for instance, comments sections and “like” and 
“dislike” features—these texts are ideal for this project insofar as permeability and 
participation (specifically as relevant to audiences) are integral to their public presence, 
and thus poised to be responsive or reflective to audiences and, more precisely, their 
cultural articulations in relation to phenomena at hand.   
 Assessing the data sets for this project through a critical rhetorical lens requires 
systematic and repeated viewing and reading of the texts in order to identify patterns. 
Interest in each cancer type under examination here is mobilized through two distinct 
data sets specific to each disease, with those data sets encompassing official and common 




discourses construct cancer types necessitates systematic reading in order to illuminate 
patterns, repetitions, and emphases regarding the nature of each cancer, especially as the 
discourses about it reflect and intersect with cultural notions of identity and neoliberal 
emphases on responsibility. As such, care must be taken to highlight how specific 
perspectives of and positions in relation to cancer are represented, included, silenced, or 
even absent in the data sets, and what these presences and absences suggest about 
configurations of how health are discussed in and across media, and furthermore appear 
to be taken up in cultural contexts and communities. 
 Distinguishing between official and common discourses requires attention not 
only to the origins of texts, but also the design of the messages and means of distribution. 
Official discourses—public health campaigns, health foundation websites, and 
governmental resources, among others—are designed as intervention- and education-
based information resources that privilege the outcome of improved informed decision 
making for consumers (Holt, Wynn, & Litaker, et al., 2009). As authoritative voices that 
wield the power of science and medical technologies to substantiate their claims, these 
discourses function as the official version (or the master narrative) about cancer that all 
other media outlets must repackage for their readers or must be made sense of by the 
general public. If vernacular discourses are associated with localized speech (Ono & 
Sloop, 1995), texts that are drawn against and have the task of digesting and reformatting 
these official discourses and that invite and incorporate, in a contemporary mediascape, 
audience engagement and response, comprise a common discourse that reflects culturally 
received understanding and articulations, as well. 
 Written at an approximately 11
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fulfilled their role to package and present information to readers in language that reflects 
the preferences of the audience and renders the content as accessible as possible (in order 
to benefit commercially, of course; Conboy, 2010). Relatedly, magazines—both news 
and popular—are expected to be produced under the same banner of accessibility and 
readability, and thus represent the general tastes, cultural sensibilities, language, and 
information preferences of the general population. Finally, the accessibility of news 
stories in online formats has proliferated such that the availability of this information is 
no longer reserved for those who can afford subscriptions or newsstand prices.  
 The decision to categorize these texts as common is grounded partly in the 
popularity and prevalence of edutainment and infotainment in a for-profit media industry 
context (Piotrow et al., 2003) and partly in the characteristics of cultural syncretism and 
pastiche (Ono & Sloop, 1995). The practices and products of edutainment assist—often 
through careful scripting—health practitioners in their quest to promote and proliferate 
accurate health information to those who may otherwise not be exposed to such 
information, and do so through the inclusion of health-based information in entertainment 
and informative contexts (e.g., see Dutta, 2007). Cultural syncretism and pastiche as a 
function of it allow both for representation of counterhegemonic perspectives and subtle 
incorporation of dominant ideas and discourses to aid in constructing and communicating 
about identities and subject positions unique to specific communities (Ono & Sloop, 
1995). Pastiche, then, allows for the appropriation of elements from dominant discourses 
and other cultural fragments to render new subjectivities and ways of knowing and 
talking about phenomena (in this case, cancer). 




materials published by the public health campaigns and health resources (all of which 
constituted the official discourses under examination here). Collecting my “common” 
discourse data necessitated a reliance on several primary research databases purchased by 
the University of Utah’s Marriott Library: Newspaper Source Plus, ProQuest, 
EBSCOhost, and New York Times Historical Newspaper. These databases were used due 
to their extensive publications index, as well as the fact that many news publications 
websites require subscriptions in order to access more than a handful of articles per 
month (The New York Times is a primary example of this type of proprietary website). 
For each respective data set, I searched the aforementioned databases for the following 
terms: “breast cancer,” “bladder cancer,” and “skin cancer,” and I limited my search to 
the specific date range of January 1, 2013 to December 31, 2015 (in order to gather 
sufficient data for my bladder cancer chapter, I extended the date range from January 1, 
2012 to December 31, 2016). In order to productively limit my data set to only those 
articles that directly discussed these cancer types, I eliminated all articles that only briefly 
referenced these respective cancers, as well as all obituaries and duplicate articles. My 
search for “breast cancer” yielded 247 articles total; when transferred to a Word 
document, this data resulted in 645 single-spaced pages (once all front matter was 
removed from each article). My search for “bladder cancer” yielded 330 articles; when 
transferred to a Word document, this data resulted in 443 single-spaced pages (once all 
front matter was removed from each article). My search for “skin cancer” yielded 130 
articles total; when transferred to a Word document, this data resulted in 307 single-space 
pages of data (once all front matter was removed from each article). Analyzing this data 




characterized and discussed therein. Themes emerged that were refined and revised in 
order to capture the primary characterizations and understandings of these cancers.  
 
Preview 
 The following sections build on this methodological foundation to address the 
importance of studying discourses about breast, bladder, and skin cancers, as well as the 
specific data that will be collected and analyzed via close and repeated reading. Studying 
cancer discourses necessitates a productively narrow focus that allows for the 
examination of the potential intersection of notions about gender, age, race, and class as 
they possibly manifest in official and localized discourses, as well as how imperatives of 
individual responsibility are potentially mobilized. The prevalence and severity of breast, 
bladder, and skin cancers render these diseases and their attendant discourses particularly 
relevant for study at this historical moment as each of them holds a unique position in the 
national narratives about the fight against cancer (Keränen, 2010). As such, each section 
below explains and justifies the selected texts that represent official and common 
discourses about each cancer type, as well as why these discourses are important to 
examine across different media types. 
 
Breast Cancer 
 As the most prevalent cancer amongst women in the United States (Centers for 
Disease Control and Prevention, 2015)—resulting in approximately 230,000 new 
diagnoses every year—breast cancer has been on the public agenda since Betty Ford’s 
radical mastectomy made headlines in the 1970s (Dubriwny, 2008). It is the most covered 




reproductive cancer) (Jensen, Moriarty, Hurley, & Stryker, 2010) and public perception 
of its prevalence is commensurate with the actual rates of annual diagnoses (Jensen et al., 
2014).The continual visibility of breast cancer—reaffirmed every year in October by the 
proliferation of pink products in honor of Breast Cancer Awareness Month—has been 
heightened by the recent spate of news coverage focused on the BRCA1 and BRCA 2 
gene mutations and the Supreme Court’s ruling that Myriad Genetics’ patents on the 
mutations were unconstitutional (Pollack, 2013). Further garnering attention for the 
disease has been the high-profile diagnoses and treatments (including prophylactic) 
undergone by such public figures as actor and activist Angelina Jolie and actor Christina 
Applegate in 2013 and 2008, respectively (Board, 2013).   
 Due to its prevalence and consistent national attention, breast cancer posed the 
challenge of productively narrowing the texts collected and combined for study. In order 
to attend to how breast cancer is rhetorically constructed by the professional (i.e., official) 
and public (i.e., common) sectors of cancer information in the United States, these 
discourses were examined across print news and public health campaigns and initiatives. 
Specifically, the official discourses about breast cancer analyzed here included programs 
funded by the National Breast Cancer Foundation and campaigns funded by the Centers 
for Disease Control and Prevention. Texts featuring common discourses were those that 
privilege and facilitate lay discussion about the disease via national news coverage and 
via texts that can potentially fall under the rubric of education-entertainment (or 
“edutainment;” e.g., entertainment news; Piotrow et al., 2003). 
 First, the National Breast Cancer Foundation provides a variety of educational 




breast cancer diagnoses from early detection through the process of managing treatment 
costs. Founded in 1991, the Foundation features the Beyond the Shock program which is 
a free interactive application that patients download on their smartphones, tablets, or 
laptops in order to receive educational resources and support throughout all stages of 
diagnosis, treatment, and recovery. The application-based program also serves as an 
educational resource for family and friends of breast cancer patients and for physicians to 
be involved with the dissemination of information (National Breast Cancer Foundation, 
2015).  
 Second, the Centers for Disease Control and Prevention—as the government 
agency that wields the expertise and resources of scientists and disease detectives to 
maintain national health (and ostensibly security)—provides two campaigns centered on 
raising awareness about breast cancer. First, the Right to Know campaign targets 
specifically women with disabilities and promotes screenings for this frequently 
underserved community; in doing so, the campaign addresses common barriers to 
knowledge about the disease and provides printed and electronic materials that correct for 
misperceptions and erroneous information about diagnosis rates, likelihood, screening 
procedures, and treatment (Right to Know, 2014). Finally, the Bring Your Brave 
campaign targets women under 45 years of age in order to educate this group—who is 
diagnosed with less frequency—about the importance of family history and the 
exploration of risk factors that can contribute to diagnoses in young women (Bring Your 
Brave, 2016).  
 In contrast to these official governmental and organizational discourses that frame 




discourses are prevalent in popular culture and national news media. As the past 5 years 
have been marked by heightened interest in breast cancer prevention and treatments (for 
example, Angelina Jolie’s Op-Ed essay in 2013 and SCOTUS revoking the patents on the 
BRCA 1 and BRCA 2 gene mutations), popular press and mainstream discourses about 
the disease provide important sites through which consumers learn about health and 
illness (Lupton, 2012). Inclusive of mainstream media, the following texts all include lay 
perspectives of breast cancer that are drawn against the official discourses distributed by 
governmental, nonprofit, and health organizations, thus allowing for the examination of 
possible fissures in how different media potentially facilitate differing discourses about 
the disease. Specifically, print news coverage published between 2013 and 2015 will be 
selected to reflect a variety of genres, target audiences, and ideological positions, 
including The New York Times, USA Today, Time, and People. Although these texts 
encompass distinctive genres—including more or less “legitimate” news sources and 
celebrity-based fare, for example—they can indeed be apprehended as common because 
they interpret official discourses of health and illness for public audiences in ways that 
also draw on resonant imperatives of culture and identity, especially insofar as these texts 
seek to relate to their audiences for continued circulation and profits.  
 
Bladder Cancer 
 Unlike breast cancer and its firmly embedded position on the public health 
agenda, bladder cancer is a largely ignored disease in the United States, earning the 
unfortunate designation as “the invisible cancer” because of the historical lack of private, 
public, and governmental funding and attention given to it (Johns Hopkins University, 




(Jensen et al., 2014) and primarily affecting older white men, bladder cancer poses a 
unique fiscal challenge to patients and providers: it is the most expensive type to treat per 
patient due to high recurrence rates and the constant monitoring and treatments that are 
required for the duration of the patients’ lives (American Cancer Society, 2014; Bladder 
Cancer Advocacy Network, 2014; Lotan et al., 2009). Despite its prevalence as the sixth 
most common cancer type (Jensen et al., 2014) and the annual diagnosis of 75,000 new 
cases (American Cancer Society, 2014), bladder cancer is perceived to be the least 
common type by the public (Jensen et al, 2014) and is one of the most underrepresented 
cancer types in the news (Jensen et al., 2010).  
 Despite the prevalence and severity of this disease, no current public health 
campaign exists in the United States.
1
 As such, the official resources available for bladder 
cancer patients—and which constitute the official discourses under study here—include 
the Websites of health foundations and networks, including the American Bladder Cancer 
Society, the Bladder Cancer Advocacy Network, and the American Cancer Society’s 
online resources about the disease. Drawn against these texts are those that privilege and 
result from the voices of bladder cancer patients, although common (not to mention 
vernacular) discourses about the disease are as conspicuously minimal as official 
discourses. Specifically, national news coverage of the disease will be assessed for its 
construction of the disease and related processes for prevention, diagnosis, and treatment.  
 Founded in 2007, the American Bladder Cancer Society (whose slogan is, 
tellingly, “Forget Us Not”) is a nonprofit organization with the mission of helping 
patients “form questions in order to have more informative conversations with your  




 North American attention to bladder cancer is present in Canada’s public health 




medical team” (American Bladder Cancer Society, 2016g). Organized and operated by 
bladder cancer survivors, the Society’s website offers visitors information based on both 
personal history with the disease and resources for enhancing the patient-provider 
encounter. Based on this aim, the website provides a series of educational resources for 
patients who need assistance in finding treatment centers, support communities, and 
information about the various kinds of diagnoses, as well as resources for caregivers and 
those interested in volunteering and raising awareness. Even though this is a patient-
generated effort, it nonetheless functions as official because of how it positions itself as a 
resource for patients, particularly an instructive resource that guides patients in talking 
with their medical providers about their diagnosis and health—in other words, it serves as 
an authorial source that organizes patients and providers into formalized social relations. 
 Relatedly, the Bladder Cancer Action Network (BCAN) has advocated for the 
advancement of research and support for patients since its creation in 2005. With their 
aim of an eventual cure, the BCAN supports a wide range of awareness efforts and 
research initiatives, as well as features a variety of educational resources to aid patients in 
understanding their diagnoses and possible treatments. A unique feature of the website is 
its attention to women and diagnoses common to them. Because it most frequently occurs 
in older (white) men, bladder cancer is generally associated with this specific 
demographic group. As such, BCAN’s attention to the experiences unique to women is 
noteworthy and useful for inclusion in order to interrogate how notions of gender play out 
in cancer discourses.  
 The final official channel of information is the bladder cancer section of the 




comprehensive cancer care information, the ACS website features extensive tools and 
resources tailored to specific cancer types, as well as educational forums in which to 
learn more about the research being done to cure variations of the disease. The American 
Cancer Society is the most recognizable and oldest of the official channels of information 
included here, and as such, the resources and information provided therein reflect original 
research that is likely to be reiterated in the other aforementioned official discourses 
about the disease.   
 Aligning with my previous discussion of common discourses about breast cancer, 
the discourses about bladder cancer are similarly mainstream in order to assess how the 
limited official ideas available about the disease potentially feature in and/or get 
negotiated by a wide variety of national news sources. Although collected from the same 
3-year span of time as news coverage of breast cancer, broader inclusion of types of news 
sources were taken into account here due to bladder cancer’s traditional absence from the 
public imaginary. As such, the texts selected for analysis included both those assessed for 
breast cancer—The New York Times and USA Today—as well as additional newspapers, 
newsmagazines, and new amalgamator sites—specifically, USA Today Magazine, Los 
Angeles Times, Wall Street Journal, Huffington Post, Rolling Stone, Chicago Tribune, 
The Washington Post, Reuters, and Boston Globe. These publications provided the 
opportunity to assess how different identities were constructed in relation to the disease 
and its related processes, particularly in light of how limited public discourse and 






Skin Cancer  
 With annual diagnoses occurring at similar rates as bladder cancer, melanoma of 
the skin impacts approximately 74,000 new patients every year, is one of the most 
common cancer types in the United States, and causes the most deaths among types of 
skin cancer (National Cancer Institute, n.d.; Skin Cancer Statistics, 2015). Unlike bladder 
cancer, however, skin cancer is perceived to be slightly more common than it actually is 
(Jensen et al., 2014) and featured in more news stories than other types that occur with 
greater frequency (Jensen et al., 2010). The prevalence of skin cancer news coverage, 
however, is understandable when considering that the less severe and mostly curable 
nonmelanoma skin cancers—basal cell and squamous cell carcinomas—occur with such 
great frequency that they are not tracked by central cancer registries (Skin Cancer 
Statistics, 2015). As such, the breadth and depth of severity posed by all three kinds of 
skin cancer render the disease to be of utmost relevance for study.   
 Frequently the center of media attention at rates more closely resembling that of 
breast cancer than bladder cancer, skin cancer features a variety of official initiatives to 
prevent and detect the development of the disease. Comprised of three types that render it 
the most common cancer type—and one of the most deadly in the case of melanoma— 
skin cancer and its widespread impact yield extensive lay discourses about safe sun 
practices and related activities, as well as cancer diagnoses and treatment. As such, the 
potential data for this section—though relatively plentiful—are narrowed to campaigns 
and social media posts. The official discourses under examination here and detailed 
below all target specific aspects of skin cancer: teaching self-detection practices for 




Melanoma Research Foundation; encouraging abstention from self-tanning via the Go 
With Your Own Glow campaign from The Skin Cancer Foundation; and instructing in 
sun safety awareness behaviors via the annual Don’t Fry Day from The National Council 
on Skin Cancer Prevention. Compared to these discourses are those published in 
mainstream news sources in order to assess how ideas about the disease are filtered to the 
public through news and entertainment news outlets.    
 The Melanoma Research Foundation (MRF) features two related public 
awareness campaigns designed to encourage self-detection practices. The #GetNaked 
campaign utilizes social media parlance in the marketing of their materials about 
performing self-exams to detect skin abnormalities. Although the campaign website 
reaffirms that melanoma does not discriminate based on age, the emphasis on and use of 
social media engagement to share and encourage the practice of self-exams—and thus 
“getting naked”—seems to target younger audiences. Social media users are encouraged 
to use the eponymous hashtag, #melanoma, and include the MRF’s Twitter handle in 
tweets about performing self-exams, using and sharing MRF resources, and changing 
one’s profile picture to the ad for the campaign. Relatedly, the Check Me Out! campaign 
emphasizes patient participation in the cancer detection process (rather than relying on 
physicians) and provides charts and a video encouraging people to regularly check and 
monitor their moles for changes and abnormalities.  
 Founded in 1979, The Skin Cancer Foundation has pioneered many awareness 
and education initiatives to assist the public and the medical profession in understanding 
the disease, modifying cancer-causing behaviors, and engaging in early detection 




prompted by the understanding that this disease is primarily caused by lifestyle choices 
and can reasonably be prevented by related choices. A relevant campaign that reflects this 
perspective is the Go With Your Own Glow campaign. Ostensibly attempting to harness 
the norms of femininity in the United States to discourage tanning, the Go With Your 
Own Glow campaign targets women with the message that natural skin hue is preferable 
and fashionable. The extensive campaign website features fashion magazine-style ads 
used in print and digital platforms, sun safe beauty tips, antiaging tutorials, and news 
resources for female consumers interested in learning more about the harmful effects of 
indoor and outdoor tanning.  
 The National Council on Skin Cancer Prevention has declared the Friday before 
Memorial Day to be Don’t Fry Day and provides an extensive range of awareness and 
educational materials to promote sun safety and skin protection. The campaign targets all 
ages at a time that is generally considered to be the beginning of peak sun exposure 
months in the United States and promotes behavior modification through antitanning ads, 
incorporation of the American Cancer Society’s awareness campaign for healthy sun 
exposure practices (“Slip! Slop! Slap! and Wrap”), and a library of sun safety fact sheets 
and URLs to aid in decision making. Similar to the #GetNaked campaign, Don’t Fry Day 
encourages a social media presence for the campaign and even provides sample tweets—
all of which contain #DontFryDay, of course—for people to post in support of sun and 
skin safety behaviors.  
 Contrasting with these official dictums for how to deal with sun safety and skin 
cancer is mainstream news coverage. This common collective discourse, even as it might 




audiences understand and respond to skin cancers, and as such serve as the filter through 
which many official ideas about skin cancer get filtered to the public. Similar to common 
discourses about breast and bladder cancers, skin cancer coverage was assessed via 3 
years’ worth of news coverage from The New York Times, USA Today, Time, People, 
Health, and Men’s Health in order to illuminate which ideas about sun safety, skin 
care/damage, and cancer get taken up and promoted to the public via both “legitimate” 
and “edutainment” publications.  
 
Contribution 
 Predicated on the assumption that how common discourses rhetorically construct 
cancer is different from official discourses about the disease, this study will seek to 
contribute to current understanding about health, rhetoric, and media studies in three 
primary ways. First, this study seeks to contribute to critical rhetorical studies. By 
examining the potential distinctions between official and common discourses in health 
contexts, this study will attend to the ways in which these potential distinctions indicate 
the possibility for mainstream media content to be reconceived of as common, 
particularly in light of how mainstream news is beholden to—and ostensibly impacted by 
the online capabilities of engagement with—consumers. In this way, official discourses 
will be those that define the status quo, while common discourses are expected to work 
with and against the ideas outlined by governmental and institutional structures in the 
process of (re)articulating these ideas for lay audiences. In particular, this study seeks to 
assert and refine a “third way” or a middle ground: a “common” discourse, originally 
articulated by Howard (2008). Although at the time of his writing he found it suspect and 




significance as a notable discourse that incorporates both conventionally vernacular and 
official discourses to evince a distinctive discourse redolent of broad cultural sensibilities 
and imperatives that cannot, in this historical moment, be so easily dismissed, especially 
if and as venues of common discourse—mainstream news outlets, for instance—continue 
to serve as a resource for cultural and practical knowledge. 
 Second, this study will contribute to the health communication literature that 
pertains to the rhetorical construction of patients. Specifically, it will examine how 
discourses about cancer potentially construct patients as responsible for their diagnoses 
and treatments, as well as construct them in relation to medical providers (who are 
assumed likewise to be rhetorically constructed in specific ways) and the disease 
generally and specifically. It is useful to interrogate the established observation that 
individual patient responsibility lies at the heart of discourse around health broadly in the 
United States and attend not only to not what this means, but how it is mobilized in each 
of these discursive articulations of these common cancers. Additionally, the types of 
cancer included here for study—breast, bladder, and skin—are all situated within 
tensions that highlight the material impacts of these diseases on certain bodies (e.g., 
bladder cancer affecting predominantly older white males and the influence of hegemonic 
masculinity on gender norms and expectations in the U.S. imaginary), as well as on 
interactions with medical providers.  
 Finally, this study will contribute to extant literature on public health campaigns, 
in particular as articulated via contemporary technologies. By illuminating how 
mainstream public ideas about cancer detection and prevention are negotiated and drawn 




study has implications for how future public health campaigns are constructed and 
promoted to target audiences, especially in regard to how ideas about patients, 
physicians, and the medical establishment are constructed in potentially divergent ways. 
Understanding broad popular conceptions and mobilizations of these cancers, as well as 
providers and patients in relation to it, can inform appropriate and productive engagement 
with and treatment of patients with these cancers, particularly engaging them in terms of 






BLOODIED AND BOWED: PATIENT AGENCY AS CASUALTY 
 OF WAR (ON BREAST CANCER 
 
 In the 4 decades since President Richard Nixon declared war on cancer in 1971 
and First Lady Betty Ford’s subsequent well-publicized radical mastectomy in 1974, 
breast cancer has become—and remained—a highly visible and enduring battlefield on 
which the war is waged (Dubriwny, 2008). As one of the most common cancers among 
women in the United States—as well as the most covered cancer in the news—breast 
cancer and attendant discourses about it necessitate critical inquiry into how both 
authorities and mainstream news understand and engage the condition, particularly as 
they impact providers and patients (Centers for Disease Control and Prevention, 2015; 
Jensen et al., 2010). While discourses about breast cancer are indeed common owing to 
the disease’s seemingly permanent position on the public agenda, they are particularly 
relevant to study now in the wake of high profile news events about breast cancer, 
including the Supreme Court’s overturning patents on the BRCA 1 and BRCA 2 gene 
mutations and actor/philanthropist Angelina Jolie’s New York Times essay about her 
prophylactic mastectomy. In this context of continued—and arguably recently 
heightened—attention on breast cancer, critical interrogation of public discourses about 
the disease is necessary in order to understand how public representations and 




against one another; this type of  interrogation ensures that health services/practitioners 
have awareness of and appreciation for how patients may understand and engage breast 
cancer in order to ensure effective treatment.  
 In this chapter, then, I analyze how breast cancer, patients, and providers— as 
well as prevention, diagnosis, and treatment—are rhetorically characterized in public 
health campaigns, as well as how these ideas are mobilized in mainstream news 
discourses about breast cancer, in order to apprehend how these articulations about breast 
cancer potentially overlap, mingle, and/or diverge. The importance of this inquiry is 
located within its potential to illuminate how the predominant voices in public discourses 
about breast cancer are constructing the disease and how these findings may impact the 
everyday treatment of patients, as well as the future construction of subsequent public 
health campaigns.  
 
Official Discourses 
 Official public health campaigns and initiatives are most often crafted to address a 
health issue or condition that is perceived as relevant in either its prevalence or danger (or 
both). Generally informational, these official discourses tend to instruct consumers about 
prevention, detection, treatment, and the like. This information is inevitably rhetorical, 
and thus engages cultural perspectives and discourses regarding how we perceive the 
condition in question, the people affected by it, and the cause and redress of the 
condition. Thus, we often tend to understand health issues based on how they are 
constructed by public health campaigns (e.g., obesity as an epidemic that targets children 
per the prominent the Let’s Move campaign, which further identifies parents as the 




 As one of the most prevalent, visible, and funded cancers, breast cancer naturally 
is at the center of a multitude of initiatives and public health campaigns, and thus the 
selected discourses included here for critical interrogation were selected for their unique 
perspective on the disease. First, the Beyond the Shock program—funded by the National 
Breast Cancer Foundation—offers a free interactive application with education resources 
for breast cancer patients, supporters, and medical providers, thus offering triangulated 
content and perspectives; this program is studied primarily through the educational 
videos offered on the website that explain the disease in lay terminology. Second, the 
Right to Know campaign—funded by the Centers for the Disease Control (CDC)—is the 
first breast cancer campaign designed to target women with disabilities in order to 
improve the quality of screenings and care women with disabilities receive. Finally, the 
Bring Your Brave campaign—also funded by the CDC—is likewise unique in that it 
targets young women (those under 45 years of age) in order to educate them about their 
potential risk factors for getting the disease at a young age (while rare, diagnoses in 
young women are a growing problem).  
 These health-based based programs and campaigns are important to study due to 
their authorial status and credibility, as well as their uniqueness and prevalence; the 
former program is one of—if not the—first free comprehensive and interactive online 
guides for dealing with a breast cancer diagnosis, and the latter campaigns are two of the 
CDC’s most prominent initiatives (and ostensibly some of the most visible and 
accessible, as well). When analyzed together, these official discourses position breast 
cancer, and how to understand it, as an individual issue that hinges largely on the 




to deal with the disease, regardless of its severity, thus reifying the understanding that 
patients are ultimately in control of their emotions and outcomes (if not necessarily their 
bodies).  
 
Mobilization of Agency 
 Perhaps not surprisingly, public health campaigns about breast cancer primarily 
focus on constructing plans of action for patients, resulting in an emphasis on those 
aspects of disease detection, prevention, and treatment that can be gauged and impacted 
by the decision-making processes of patients. These campaigns, then, render individual 
agency as natural and to be expected, and thus articulate how agency can—and should—
be mobilized by patients. Enacting control over one’s health—and possible disease—
hinges on the abilities of patients to monitor their risk for cancer and their bodies as 
potential sites of disease and to manage their emotional care. These enactments of agency 
construct the image of a breast cancer patient as ultimately in control of her diagnosis and 
emotions, if not necessarily her body.
2
  
 Monitoring bodies.  As the primary imperatives of most public health campaigns 
are to raise awareness and aid in prevention, the emphasis placed on monitoring the body 
as a potential site for disease and unease is indeed common for the breast cancer 
campaigns analyzed here. How the body is to be monitored, per these campaigns, 
reinforces the idea that the female body is always already at risk, and thus women must 
be vigilant agents in the prevention and detection of cancer. The process of monitoring 
                                                 
 
 2 While men can get breast cancer, less than one percent of all diagnoses are in 
men, and thus the disease overwhelmingly affects women, so public discourses about it, 





bodies at risk is articulated as an individual effort that is accomplished both alone and in 
conjunction with the medical establishment, with both paths underwriting the primary 
role individual women must play in the fight against potential and actual breast cancer. 
Additionally, by apprehending women in this role, these discourses objectify the female 
body by necessitating constant inspection and interrogation of it by both the patient and 
the overseeing medical expert who is automatically granted this authority over the female 
body. This objectification operates to accentuate the risks inherent to a female body and 
renders it suspect, and thus naturally in need of vigilant oversight.  
 A key element in the process of monitoring bodies at risk is the initiative to do so 
without prompting from medical providers and in service to others, suggesting that health 
maintenance and disease prevention are inherent practices that should be innate to women 
as the nurturing epicenters of familial and social circles. The cultural presumption that 
women are vanguards of health—both their own and others’—underscores that this 
propensity towards health maintenance is necessary because the female body is a suspect 
object, and thus must be monitored closely for any possible unruly changes that might 
negatively impact others (for example, family members). In a poster for the Right to 
Know campaign, a breast cancer survivor is featured and credited with centering the 
locus of responsibility internally: 
Helen credits screening and early detection with still being alive today, and 
reminds us to take care of ourselves first if we want to be there for our loved ones. 
(Right to Know, 2016b) 
 
In this case, monitoring a body at risk necessitates not only agency in the form of 
personal initiative (for example, screening at home and/or at a doctor’s office), but also 




remain healthy so as to care for others). Thus, personal responsibility becomes 
synonymous with empowerment in that women are assumed to be in control of 
suspecting and inspecting their bodies, as well as preserving their utility for others. 
Concomitantly, this purported empowerment reifies the understanding that the female 
body is suspicious and likely to become unruly if control is not seized by the female 
patient. Although implied here, the involvement of the medical establishment is mostly 
obfuscated, suggesting that it serves more as a supplement to the directives of patients, 
rather than a governing body. This notion of medical expertise operating silently in the 
background is reinforced in the Bring Your Brave campaign:  
To manage her risk for developing breast cancer, Amy gets regular screenings. 
She considers knowing her breast cancer risk a “head start” in staying vigilant 
with regard to  prevention—truly empowered by learning her risk. 
(CDCBreastCancer, 2016a)  
 
In discussing both regular screenings (ostensibly performed by medical providers) as 
opposed to at-home surveillance and learning about risk as a form of prevention, this 
campaign reflects the Right to Know campaign in both the obscured position of medical 
providers in this woman’s care, but also the need for women to take control of their 
futures (for their families, feelings of empowerment, etc.). 
 These campaigns also frequently attend to the increased risk inherent to women 
with BRCA 1 and BRCA 2 gene mutations, and thus further center the disease as an 
individualized problem due to the genetic makeup and/or genealogical history of the 
patient. By locating the need for monitoring within the genetic composition of women—
and in the process underwriting the notion that many women’s bodies are sites of known 
and unknown threats—these campaigns reinforce the understanding that breast cancer is 




campaign highlights the personal steps taken to monitor and reduce the possible dangers 
that could result from genetic mutations: 
To manage her breast and ovarian cancer risk, Marleah currently undergoes 
surveillance and makes healthy lifestyle choices like maintaining a healthy 
weight, exercising, and limiting her alcohol intake. Because BRCA2 gene 
mutations are associated with a higher risk for melanoma, the deadliest kind of 
skin cancer, Marleah also visits a dermatologist every year for a skin exam. She 
enjoys outdoor activities while protecting her skin. (CDCBreastCancer, 2016d)  
 
Through the assistance of medical intervention in the form of genetic testing, this 
potential breast cancer patient (or “previvor,” in BRCA1 and BRCA 2 parlance) 
highlights the role of personal initiative in combatting her risk for developing cancer. The 
knowledge provided by medical intervention—that is, genetic testing and counseling, and 
also full body surveillance—undergirds the understanding that medical care operates as 
an optional supplement to the required actions taken by patients. Similarly, the emphasis 
on the importance of family history further solidifies the understanding of breast cancer 
as an individualized disease (regardless of genetic composition), particularly when 
discussing women who do not have BRCA 1 and BRCA 2 gene mutations. For example, 
the Bring Your Brave campaign features the following biography: 
Although Lisa’s genetic testing did not find a BRCA gene mutation, her family 
health  history still puts her at a higher risk of getting breast and ovarian cancer at 
a young age. This is because the negative test result only shows that a BRCA gene 
mutation is not the cause of the increased prevalence of cancer within her family. 
It does not explain what is causing the increased breast and ovarian cancer risk in 
her family, such as a different type of genetic mutation. To address this risk, Lisa 
continues to take her doctor’s advice about breast cancer screenings and exercises 
regularly. (CDCBreastCancer, 2016c) 
 
As with the previous examples about the importance of monitoring a body at risk, this 
excerpt serves to underscore both the notion of the female body as a site for unknown and 




discovered or tested for), as well as the understanding that medical expertise bolsters the 
personal initiative that women must take in managing their cancer risk(s).  
 This dual focus that positions women as both self-advocates (ostensibly working 
against flaws with their providers or care) and as patients working under the expertise of 
medical providers ultimately functions to assert the primacy of patient agency by 
reinforcing the understanding that the medical establishment operates at the behest of 
patients.  This attention on monitoring the body promotes agentic action while 
undermining the notion of the body as operating independently of modern medicine. This 
seemingly contradictory expectation placed on women is demonstrated by another Right 
to Know campaign poster which features a breast cancer survivor and her advice to other 
patients:  
[June] tells us to ask for an accessible screening and not let the system decide 
what’s  best. Finding her cancer early allowed June to go on with her life. 
Screening allowed her to take control. (Right to Know, 2016a) 
 
By emphasizing the shortcomings of the medical establishment (in this case, screenings 
for women with disabilities are often difficult or unsuccessful due to accessibility 
problems) while simultaneously instructing women to adapt to these shortcomings, this 
poster reassures women that they are always already in control, and thus should be 
unconcerned by these failings. Requiring women to identify and compensate for 
problems in the system, then, reinforces the understanding that women can take control 
of their situations and manage their bodies and/or disease through individual agency.  
 Emotional care.  The rhetorical motif of the objectification of the self, as well as 
the responsibility for oneself (and to others), is carried over to emotional and 




underscore the expectation that women be autonomous in their health monitoring and 
management. The role of the medical establishment in emotional care is nearly 
nonexistent—rather than secondary or reactive—and operates to reinforce individual 
responsibility and agency by promoting self-initiative and resourcefulness as the primary 
resources for women. By defining optimal strategies for breast cancer patients to manage 
their disease, these campaigns construct the ideal ways for women to mobilize individual 
agency in these realms that are seemingly distinct from—yet inherently tied to—the 
body. As such, themes of resourcefulness and optimism are mobilized as integral 
components of self-care, particularly as they operate to bespeak the importance of  
women taking the literal and metaphorical lead regarding their health.  
 Successfully managing one’s cancer diagnosis, per these campaigns, often 
requires adherence to, yet also control over, the dictums established by oncologists and 
related medical personnel. The role of medical intention, however, is overshadowed by 
the psychological fortitude that a patient must have in order to manage the physical 
impact of cancer treatment on the body, and thus, the importance of individual 
responsibility is normalized. For example, the following excerpt from an educational 
video about breast cancer treatments produced by the Beyond the Shock program 
addresses the strain placed on the body by certain treatments: 
You need to be aware that more intense treatment methods will tax your body. 
During radiation therapy, it is essential to take care of yourself by getting extra 
rest and making good nutrition a priority. (Beyond the Shock, 2011b) 
 
In addition to the actual directive for patients—rest and healthful eating—this excerpt 
demonstrates the fundamental, yet secondary, role that modern medicine plays in the 




a given, the management of that treatment and its side effects are entirely attributed to 
personal initiative and resourcefulness. By positioning individual agency as the natural—
and singular—way to deal with the collateral damage inherent to most cancer treatments 
(in this case, fatigue), this campaign suggests resourcefulness on the part of patients is 
largely necessary as a response to, and accommodation of, medical intervention.  
 Maintaining a sense of resourcefulness—that is, successfully monitoring and 
managing one’s body, risk, and disease—in the face of a potential cancer diagnosis also 
undergirds one’s ability to create and/or sustain a positive outlook on both the diagnosis 
and the future (with or without cancer). Resourcefulness, then, is presented as 
empowering for patients by suggesting that acquiring knowledge about one’s risk or 
diagnosis operates to ensure—or at least work towards—a positive outcome in the future. 
This is seen in another participant biography featured in the Bring Your Brave campaign: 
 Jackie feels empowered by the roadmap she has created to manage her risk, and is 
 hopeful for a bright future for herself and her 4-year-old daughter, Amelia. 
 (CDCBreastCancer, 2016b) 
 
In this excerpt, information illuminates the future for this previvor, thus suggesting that 
the power of knowing more about one’s risk and body reduces concern (but not 
likelihood of getting cancer). Even though the risk for getting breast cancer remains 
stable, the knowledge of this likelihood removes fear of the unknown and replaces it with 
the hope that future actions will be available to fight cancer, thus functioning to assuage 
concerns in both the emotional and psychological realms. The importance of easing one’s 
mind with knowledge acquisition is reiterated by the Beyond the Shock program which 
highlights how agency fosters hope for the future by emphasizing the importance of 




Embarking on this journey requires you to not only be informed, but also to 
realize that you don’t have to face this alone. Family, friends, and other breast 
cancer patients are your shield and safety net, carefully knit together to strengthen 
you. (Beyond the Shock, 2011a) 
 
You will need to make careful decisions and plans regarding your condition, but 
there is no reason to give up on life and relationships. Many women with Stage 4 
cancer discover strength of character and qualities of resilience they never knew 
they had before. Remember to rely on your supportive group of family and 
friends. With their care and support, as well as your personal motivation, you will 
be able invest wholeheartedly in the options at hand, making the most of life for 
you and your loved ones. (Beyond the Shock, 2011d) 
 
As with the Bring Your Brave campaign, these excerpts reinforce the importance of 
patients taking action in the midst of—and sometimes without the support of—the 
medical establishment’s predetermined methods for treating cancer. That is, educating 
oneself about cancer must operate in conjunction with the support systems inherent to 
cancer management in order to maintain the expected optimism encouraged amongst 
breast cancer patients. 
 Relatedly, the emphasis on emotional care and control—both personal and 
from/with others—highlights the individualized nature of fighting cancer. That is, the 
success of treatments and recuperation hinge largely on the support system put in place 
by the patient, rather than the efficacy of the treatment or the proficiency of the medical 
team. For example, the following excerpt from a Beyond the Shock video about the types 
and stages of cancer reinforces the importance of support systems: 
Your responsibility, as discussed in Chapter 4, is to develop a support team, of 
family or friends, that will comfort and encourage you in this time. (Beyond the 
Shock, 2011c) 
 
In this case, the main task for breast cancer patients is to develop ways to handle the 
taken-for-granted treatments that they will take part in, thus reinforcing the idea that 




which emotional control is treated here renders medical decision-making as secondary; 
making emotional choices about support, then, are a key purpose and a primary method 
for patients in managing their diagnoses and treatment plans.   
 Across some of the most prominent and accessible “official” breast cancer 
campaigns and initiatives, the discourse articulates the disease as entirely in the control of 
women who are or might be affected by it; individual agency is paramount, and science 
and medicine are simply resources of which a woman might avail herself. Individual 
agency is understood to encompass both information and physical care, as well as 
emotional support; and it is represented as both an obligation to oneself and to others. 
Notably, this articulation turns on and reinforces a gendered mind-body dualism that 
posits the female body as especially suspect and subject to vigilant surveillance.  
 
Common Discourses 
 Produced concurrently with—yet distinct from—official discourses about breast 
cancer, common discourses about the disease operate within and arise from contexts and 
materialities that are not necessarily accounted for in public health campaigns. The 
common always draws upon dominant/official discourses and unofficial/unacknowledged 
discourses that reflect cultural impulses, sensibilities, and imperatives. As discussed at 
length in Chapter I, even if and as they draw from official discourses, mainstream news 
media in the United States, as privately owned entities, must resonate with their 
audiences, and thus comprise a common discourse, one reflective of resonant cultural 
imperatives and sensibilities while not constituting vernacularity per se. These discourses 
are mobilized in the texts that I have consulted for analysis, specifically coverage of 




Today, Time, and People. Whereas official discourses turn on a presumption, 
valorization, and mobilization of individual agency and control, superior even to science 
and medicine, common discourses, as apparent in mainstream news media, encourage 
collaboration between patients and providers, but ultimately deem it nonviable due to 
medical provider inadequacies. As such, these common discourses posit and privilege an 
individual whose agency is hampered, if not frozen, by medical contradiction and 
controversy, evincing an overarching motif of fatalism.  
 
Bad Medicine 
 Contrary to the intended message and outcome of public health campaigns about 
breast cancer, the medical establishment is drawn into common discourses in ways that 
question the abilities of modern medicine to diagnose and treat breast cancer. This 
suggests a stronger role for the medical establishment than in official discourses—that is, 
implying more of a partnership between the individual agent and medical providers—
such that the failings of the medical establishment are more profound and punctuated in 
common discourses. Whereas official discourses about the disease position the medical 
establishment as secondary to individual agency and functioning at the behest of the 
patient, common discourses explicitly challenge the inner workings and intended 
outcomes of the medical establishment and position it as ultimately working against the 
needs and desires of breast cancer patients. This representation of a dysfunctional 
medical establishment is mobilized via an emphasis on the paradoxical primitiveness of 
medical science, the ineptitude of modern medicine, the potential for/ practices of 
corruption within the medical community, and the threat of new harms caused by breast 




 Primitive science.  In the wake of a decades-long war against cancer that hinges 
largely on advances in modern medicine, the medical establishment is held up as a 
fallible institution that has ultimately been unsuccessful in improving its approaches to 
treating breast cancer. Emphasizing the outmoded and/or unsuccessful nature of many 
diagnostic measures and treatments, the potential for overdiagnosis and overtreatment, 
and the negative outcomes associated with these related phenomena, these common 
discourses construct a motif of primitiveness that both implicates and absolves the 
medical establishment of responsibility for the lack of progress in creating more effective 
measures for dealing with this disease. That is, the status quo is understood as a 
continuance—rather than an evolution—of the antiquated (and often barbaric) treatments 
and imprecise diagnostic measures initially used to detect and treat breast cancer, thus 
further reinforcing the current state of breast cancer fighting measures and normalizing 
the impracticality of expecting/demanding better. The (poor) current state of the art is 
highlighted in an article in The New York Times: 
For decades, the specter of women dying for lack of intervention has made 
aggressive treatment a given. (Hafner, 2015) 
 
Alluding to the embedded nature of aggressive treatments as the standard operating 
procedure (though not necessarily the most successful or desirable), this article 
emphasizes the overall stagnation that shrouds breast cancer treatments, thus reinforcing 
the centrality of antiquated methods to breast cancer treatment. By consistently 
privileging aggressive approaches—despite the problems inherent to them—the medical 
establishment reinforces a reactive stance towards women’s health that is both 
normalized and normalizing, resulting in a reliance on antiquated methods that fails to 




 With aggressive treatment the norm for dealing with a cancer diagnosis, the 
processes of detecting the disease remain similarly entrenched and ineffective. As such, 
inquiries into the inner workings of the body and cancer are often rendered as guesswork 
for those trying to determine how to approach the disease. For example, in an article in 
USA Today, the disease and related screening processes are represented as nebulous and 
antiquated processes, rather than streamlined or even scientifically grounded: 
Cancer screening is like searching for needles in a haystack. The needles are the 
women with breast cancer. The hay is the healthy population. […] Cancer 
screening is a blunt tool. We have to screen everybody to save the few we can. 
The more screening, the more likely that women will have an adverse experience 
– a false positive, an unnecessary biopsy or even unnecessary treatment. (Etzioni 
& Oeffinger, 2015) 
 
Cancer screening practices, in this case, are understood to be both misguided and 
ineffective, serving mainly as hopeful shots in the dark as opposed to sound and proactive 
measures in which the public should partake. When characterized as a “blunt tool” that 
will ultimately save the lives of relatively few patients, these processes more closely 
resemble the erroneous instruments of early efforts at medical treatment rather than the 
results of decades-long research that have come at the expense of thousands of lives and 
millions of dollars.  
 Drawing on the dichotomy of both accepting and challenging the status quo 
alluded to at the beginning of this section, news discourses frequently address the 
perceived barbarism of breast cancer treatments and question the steadfast acceptance of 
these primitive approaches to treating (and ostensibly healing) women’s bodies. The 
treatments that result from questioned detection measures are often framed as 
anachronistic—yet ultimately normalized—such that the perceived outdated ways of 




progressive. Drawing on primitive notions of barbarism and unruliness, multiple articles 
challenge the progress made in breast cancer treatments: 
But what I hope that people realize is that we really don't have good prevention 
for breast cancer. When you have to cut off normal body parts to prevent a 
disease, that's really pretty barbaric when you think about it. (Parker-Pope & 
Belluck, 2013) 
 
Visco says Jolie's story, in spite of her use of genetic testing, illustrates how little 
progress has been made against cancer. “We have invested billions of dollars in 
science and raising awareness, yet we have little more than disfiguring and 
barbaric options to offer women like Ms. Jolie.” (Szabo, 2013b) 
 
Highlighting the seemingly unusual practice of removing healthy body parts in the 
service of maintained or future health, both of these articles suggest that the narrative of 
medical progress—as traditionally signaled by the money spent on research and 
awareness—is misleading and ultimately useless when put in practice. That is, the funds 
spent on exploring alternative prevention measures and treatments are ultimately 
immaterial, and thus allude to the possibility of other influences that support primitive 
methods, despite the financial support available to find more optimal choices (discussed 
more below).  
 Finally, the general aura of ineffectiveness that undergirds primitive science is 
further articulated by the emphasis placed on the frequency of overtreatment and 
overdiagnosis, practices that amplify the harms associated with outmoded medicine. 
Often framed as being either the best possible solution under the circumstances or an ill-
informed reaction, overtreatment and overdiagnosis are discursively constructed as 
existing on the margins of the fight against breast cancer, mobilized out of fear or 
exhaustion rather than utility.  In addressing the recent spike of excessive diagnoses and 




notions of primitiveness as they examine how modern medicine unsuccessfully contends 
with cancer. When discussing high rates of unnecessary treatments, an article in The New 
York Times alludes to the primitive nature of detection measures and the uncertainty 
involved in diagnosing breast cancer: 
“We would all love to avoid diagnosing and treating a breast cancer that doesn't 
need treatment,” Dr. Oeffinger said. “But we don't have the tools.” (Grady, 2015) 
 
While this excerpt speaks to the dearth of effective measures for determining which 
cancers pose the greatest threats, it also mobilizes this notion of primitiveness in distinct 
ways such that it highlights the lack of options available to doctors. By calling into 
question the quality of the available options for treatment, this article suggests that the 
advances in modern medicine have ultimately created a double-bind for patients alike: 
that is, being proactive in learning one’s risk and being diagnosed early are valorized, but 
seemingly pointless since no effective options are available to patients who do acquire 
this information.  
 Relatedly, the primitive nature of medical science extends to standard screening 
and prevention measures, mainly mammography. While a point of contention in the 
medical community, mammograms as a primary means of detecting cancer remain at the 
forefront of discourses about the disease. The attendant shortcomings involved with this 
form of screening—similar to the concerns involved with other tests—result in 
overtreatment and overdiagnosis being constructed as natural by-products of an imperfect 
tool and system. The limited utility of screening procedures in the face of unnecessary 
procedures and potentially ineffective diagnoses is addressed in an article in USA Today: 
Beyond “false positive” results – which can lead women to undergo additional 
tests and painful biopsies – mammograms can lead to “overdiagnosis,” causing 




never become life-threatening. “We're moving to an era where people are 
recognizing the limitations of screening tests,” said physician Nancy Keating, 
who co-wrote an accompanying editorial in JAMA. (Szabo, 2015b) 
 
By highlighting the limitations of the available means of detection, this article 
demonstrates the understanding that the inadequacies and outdated nature of medical 
science are known, but ultimately inevitable. Acknowledging the shortcomings in 
detection and treatment merely serves to highlight the normality of their presence, rather 
than challenge the status quo. As such, while the primitive nature of breast cancer care is 
illuminated, no alternatives currently exist. Similarly, the following excerpt from USA 
Today highlights this approach to overtreatment and overdiagnosis that underscores the 
primitiveness of the primary means of detecting cancer:  
While we believe its [mammography] harms, particularly overdiagnosis, are often 
exaggerated, we acknowledge that mammography is not a simple test. If we want 
to save screening, we have to acknowledge its potential downside. Screening is 
not a magic magnet, even though we can't help wishing it were. (Etzioni & 
Oeffinger, 2015) 
 
Despite challenging the perceived prevalence of overdiagnosis (and ostensibly 
overtreatment), this article ultimately reinforces the taken-for-granted notion that the 
current state of breast cancer detection—while certainly less than ideal—is as good as it 
is going to get (at least for the present). Primitive science, then, is again reaffirmed as the 
norm because of the lack of innovation and effective alternatives; as such, any 
protestations against it are merely whimsical desires that have no basis in reality (that is, 
wanting mammography to be more accurate is equated with magic).  
 Inept medical establishment.  Attendant to the apparent shortcomings in the 
means and ends of modern medicine is skepticism about the efficacy of medical 




is the unsatisfactory nature of the medical establishment’s success in preventing,  
detecting, and treating breast cancer, particularly as it pertains to the contradictions that 
are inherent to these ultimately subjective processes. Despite the aura of objectivity that 
shrouds medical science, these discourses illuminate how confusion amongst both 
patients and providers regarding optimal courses of action is a systemic problem in the 
medical establishment. Highlighting the ineptitude of this establishment is an emphasis 
on revelation, or pulling back the curtain on what medical providers actually can do and 
know about cancer. For example, articles from USA Today highlight the chasm between 
scientific inquiry and the current state of affairs: 
 Scientists don’t even know what causes most breast cancers. (Szabo, 2013c) 
Science often gives us information we do not know what to do with. (Visco, 
2015b) 
 
In these instances, scientists—and by extension, medical practitioners—are presented as 
being in a double-mind of their own making: they have produced a lot of information, but 
generally not the correct or useable information that would assist in the detection, 
prevention, and treatment of breast cancer, and thus must now make sense of both the 
known and unknown. Articles in Time and The New York Times reaffirm the importance 
of being able to mobilize information—and specifically, breast cancer diagnoses—rather 
than just continually discover more: 
“It’s not the ‘finding more’ that we need to work on. It’s what are we going to do 
with the more that we find?” (O’Connor, 2015) 
 
“When we talk about watching and waiting with D.C.I.S. [ductal carcinoma in 
situ], the question is, ‘How do we know it's just D.C.I.S.?’ The answer is that we 
don't.” (Hafner, 2015) 
 




irregularities, yet modern medicine is generally not equipped to handle or act on these  
findings, thus, the achievement of exploring the body has raised more questions than 
provided answers. Additionally, these combined excerpts also work to undermine both 
the means and ends of the medical establishment by calling into question the utility of 
what has been accomplished and what is still being researched, thus suggesting that the 
breast cancer detection/treatment quagmire is essentially an infinite feedback loop of 
unusable information.   
 Drawing on notions of primitive science, these discourses frequently reify the 
ineptitude of modern medicine when discussing physicians—as the users of blunt tools— 
and representing them as the progenitors and purveyors of this confusion and 
ineffectiveness. For example, in an article about former Good Morning America cohost 
Joan Lunden’s breast cancer diagnosis, Lunden highlights the immobility that arises from 
the expert opinions of physicians: 
Despite her having access to top breast cancer experts, “there's such a disparity in 
the advice people give you about which path to take,” she [Lunden] says. “You go 
to three oncologists, and they all tell you to treat it in a different way. That's a 
really scary position to be put in. It can paralyze someone.” (Strohm, 2014) 
 
The negative impact that stems from the lack of agreement about optimal courses of 
actions for breast cancer patients to take undermines the importance of this knowledge. 
That is, the utility of expert opinion is hindered by contradiction such that, once again, 
more knowledge is presented as being the source of—rather than solutions to—problems. 
Disagreement among medical practitioners is further highlighted in USA Today: 
Pathologists disagree more than many realize, particularly about precancerous 
lesions, according to a study in March in the Journal of the American Medical 
Association. (Oldenburg & Puente, 2015) 
 




establishment—and specifically pathologists, in this case—this excerpt suggests that the 
state of medical opinion—as well as the definition of cancer—is inherently determined 
by the fallibility of human subjectivity. As such, even the information that is perceived to 
be understood and useful is ultimately called into question by disagreements among those 
who are in control.  
 This internal uncertainty and inconsistency in the medical establishment extends 
to the best courses of action that physicians can recommend based on their (apparently) 
limited knowledge about the progression of cancer. Concerns over the ability to treat 
cancer effectively imply that the entire system—from detection and diagnosis, to 
treatment and recurrence prevention—is ultimately not operating in service to women, 
but rather at the expense of women. In this case, then, allusions to the harmful, 
ineffective, and temporary nature of many breast cancer treatments suggest that 
shortsightedness is at the helm of these cancer care innovations. For example, an article 
in USA Today highlights how the immediate efforts of the medical establishment are 
reactionary rather than reasonable: 
Breast cancer advocates – tired of seeing women beaten down and burned by 
toxic treatments – are eager for a game-changer. (Szabo, 2013c) 
 
That means those patients could have been subjected to unnecessary procedures, 
such as surgery, chemotherapy and radiation, which could actually do more harm 
than good, given their complications. (Park, 2014) 
 
In these cases, the shortsightedness of physicians is apprehended as being deleterious to 
both women who need treatment and those who do not, as they are treated as one-and-
the-same by physicians who cannot distinguish between the two. Positioning physicians 
as reactive rather than deliberative suggests that they approach patient care as a one-size-




the treatments that encompass this approach. Relatedly, the inability to decipher which 
cancers pose a threat and which do not also plagues discussions about the efficacy of 
physician decision-making: 
Because doctors can’t be certain which breast cancers will prove deadly, they 
typically recommend treating all of them. (Szabo, 2015a)  
 
Some cancers don’t progress, some may even disappear on their own, and others 
may grow so slowly they would not become a problem during the remaining years 
of life. But doctors cannot tell with certainty which cancers are safe to leave 
untreated. (Brody, 2014b) 
 
By evidencing the general lack of knowledge that pervades the medical establishment, 
these articles in USA Today and The New York Times suggest that cancer is frequently 
regarded as generic and standardized, and thus physicians treat most (if not all) cancers in 
the same ways. As this approach aligns with a lack of knowledge and more concern for 
the present (that is, treat now and deal with the consequences later), it represents 
physicians as ultimately operating in the best interest of time, rather than the patients 
themselves.  
 Further enhancing the perspective that doctors are failing to fulfill their 
responsibility to treat patients effectively and with minimal harm is the understanding 
that the information made available to physicians is not actually useable and is at least 
harmful. Alluding to the problems inherent to a mass of unusable information, the 
following examples attend to the obscured role that these tests play in screening and 
treating patients: 
More challenging for doctors trying to guide patients through their choices is the 
fact that many cancer-screening tests, especially nongenetic ones, do not yield 
clear treatment options. (Park, 2013) 
 
In the past, overdiagnosis was thought to apply mainly to ductal carcinoma in situ, 




think that invasive cancers are also being overdiagnosed and overtreated by 
mammography. (Grady, 2014) 
As both of these excerpts demonstrate, the fallibility of physicians as decision makers is 
rendered a primary threat for women, especially those who choose to partake in breast 
cancer screening. In the former example, enhanced detection measures that are available 
to physicians are presented as informative, rather than directive, suggesting that 
physicians produce more information than they can effectively mobilize. Similarly, in the 
latter example, the common detection tool frequently utilized by physicians—
mammography—is presented as an accompaniment to the inadequate performances of 
physicians. That is, the inability to interpret the wealth of information provided by 
screening technologies positions physicians as being paradoxically blinded such that the 
more access they have to the inner workings of a woman’s body, the less they can help it. 
 Finally, the primacy placed on specialized care and personalized medicine is 
articulated as another instance in which the ineptitude of the medical establishment 
hinders patient care through stymied attempts at asserting patient agency. In this context, 
patients are expected to operate in the realm of personalized medicine—a privileged and 
idealized notion of successful medical interventions designed for specific patients that 
hinge on scientific advancements—despite the overall inability of the medical 
establishment to actualize and mobilize such interventions.  The integration of specific, 
individual information from patients that charts risk—garnered through genomic and 
other testing, as well as family histories—is presented as ambiguous, confusing, and even 
controversial. For example, articles in Time and The New York Times attend to the spate 





Thanks to advances in genomic testing and deeper insights into the biology of 
different kinds of breast cancer, doctors are learning that the one-size-fits-all 
approach isn’t  working. They’re also learning that every woman brings with her a 
unique profile of biological risk—as well as a unique appetite for risk. That means 
that while some women require urgent and aggressive treatment, there are many 
who can slow down and take a more sparing approach. (O’Connor, 2015) 
 
“Treatment today is getting much more individualized,” Dr. Hudis said. 
Depending on  the molecular nature of a woman's tumor, postoperative hormonal 
or other drug treatments are routinely prescribed to prevent or delay a recurrence 
of disease. (Brody, 2014a) 
  
Experts say they aren't sure how these conflicting recommendations will affect 
death rates, but they expect continuing advances in treatment. Susan Brown of 
Susan G. Komen Foundation, the breast cancer organization, says there's a trend 
toward more targeted, individualized therapies, and treatments will get only more 
personalized in the future as scientists learn more about the biology of tumors. 
(Ungar, 2015) 
 
Obfuscating the multitude of barriers to system-wide implementation of individualized  
treatment, these articles mollify concerns that women will forever be victims of an 
ineffective system by suggesting that once ineffective treatments will soon be replaced by 
preferable alternatives. While this transition to personalized medicine is presented as 
desirable, this attention to the promises of future interventions ultimately underscores the 
current inability of (many) medical practitioners to incorporate these technologies and 
findings, thus the emphasis on the revelatory departure from a one-size-fits-all approach 
to care.    
 Corrupt establishment.  Underscoring the primitive nature of the means and 
ends of the medical establishment’s approach to treating breast cancer is an implicit 
understanding that these means and ends are extrinsically motivated on the part of 
medical providers. As such, the methods and goals of medical providers and others 
involved with the disease (for example, lobbyists, awareness organizations, insurance 




undergird the decisions made by these entities. A corrupt medical establishment, then, 
reinforces its broader characterization as dysfunctional since it purportedly hinges on 
factors external to patient care and betterment. Corruption is mobilized in these 
discourses through an emphasis on financial gain and influence from external entities.  
 Concerns over financial motives driving decision making about medical care 
center primarily on the cost-cutting and profit-seeking practices commonly associated 
with for-profit organizations, thus representing cancer care as a self-serving business 
rather than a patient-centered venture. Decisions that are called into question by these 
discourses—for example, changing the guidelines for recommended mammograms—are 
routinely imbricated with the possible financial motive that would undergird such 
choices, particularly in the event that the medical establishment is divorced from the 
benevolence that is often culturally tethered to the medical profession. For example, 
when discussing the adjusted recommendations for annual mammograms in the United 
States, The New York Times highlights the financial interests seemingly inherent to this 
decision:  
At the same time, we observe that in a panel that included an economist and 
public  health experts, there was potential for bias the other way – in favor of 
cutting costs over saving lives. (Port, Sonnenblick, & Drossman, 2015) 
By explicitly challenging the presence of figures most likely to have financial interests at 
the forefront of their expert contributions (that is, an economist), this article highlights 
the threats posed by bias (read: systemic corruption) that puts primacy on turning a profit. 
Further drawing on concerns about the possibility of collusion amongst those involved in 
the implementation and practice of breast cancer detection and treatment processes, the 




shorter radiation treatments:   
“How much evidence does the medical community need before it changes 
practice?” says Visco, who notes that doctors may make more money from longer 
treatment courses. “As patient advocates, we don’t want to believe this is 
financially motivated but find it difficult to understand what else could be the 
barrier.” (Szabo, 2014) 
By citing the financial incentive for physicians to ignore evidence of a more convenient 
and less harmful radiation schedule for patients, this article centers concerns about 
corruption within doctors as a product of the system. That is, current practices are well-
entrenched in the medical establishment such that changes on the parts of individual 
doctors would be examples of going rogue, rather than systemic change, thus further 
reifying the understanding that the system as a whole is flawed and operates against the 
best interests of patients. A related—and final—example of financially motivated 
corruption attends to the lack of legitimacy granted to alternate treatments not produced 
by modern pharmaceutical trials. An article about the potential for aspirin to prevent 
breast cancer addresses this invalidation: 
It’s not hard to see why: Clinical trials are typically conducted on drugs 
developed by labs seeking huge profits. No one stands to make money off aspirin, 
which has been a generic drug since the Treaty of Versailles in 1919, and which 
costs less than $6 for a year’s supply. (Holmes & Chen, 2014) 
Noting the limited financial gain to be made from establishing a causal link between 
aspirin and reduced risk of breast cancer, this article reinforces the notion of the system 
as an enterprise motivated by profit rather than patient wellness. Thus, a corrupt medical 
establishment does not inhere solely in the decisions of physicians but rather in the firmly 
embedded normalized and normalizing practices that account for why financial gain 
would be a commonsense response to cancer treatment innovations. 




the credibility and benevolence that are culturally ascribed to the medical establishment 
are further challenged through the presence and perceived influence of entities external to 
patients and providers. Whereas profit motives are understood to be central to the medical 
establishment, the presence of additional voices in the cancer care conversation are 
represented as being just as harmful to patient outcomes. For example, Time attends to 
the influence wielded by nonmedical professionals in the process and practice of 
detection and treatment options: 
MEDICINE IS SLOW TO MOVE, and that’s especially true with breast cancer. 
Doctors are up against not only new data but also an accumulated mass of public 
opinion seeded by policymakers and advocacy groups with strong positions on 
how best to screen for and treat breast cancer. [all caps in original] (O’Connor, 
2015) 
 
By addressing the impact of public opinion—that is, the desires of the population writ 
large—on the decisions of doctors and ultimately the progress of medical innovation, this 
article positions public opinion as ineffectual interference that is fueled by self-serving 
groups. As such, individual doctors receive clemency relative to the medical 
establishment, since the former are represented as beleaguered and downtrodden by the 
process of trying to appease the desires of interested parties, while the latter is portrayed 
as adding to this discomfiture in the form of data. Relatedly, a USA Today article singles 
out breast cancer as distinct from—yet certainly related to—the medical establishment 
since it has become a business outside of the disease itself (for example, pink products as 
disease awareness and support): 
Since my diagnosis, breast cancer has become big business. The popular press 
took on breast cancer as a cause and supplanted science as the main source of 
information. […]. It is only going to get worse. Science often gives us information 






In addition to alluding to the primitiveness of modern medical approaches to breast 
cancer, this excerpt also operates to position the aura around the disease as a for-profit 
enterprise. Capitalizing on this ineptitude (that is, the inability to mobilize the mass of 
data available about the disease), profit-seeking entities are positioned as having primary 
control over how the disease is represented and perceived on the public agenda. The 
medical establishment—as subject to the designs of others—is portrayed as being 
ultimately ineffective in controlling the narrative about breast cancer, often to the 
detriment of medical professionals and patients. Thus, how the medical establishment 
mobilizes information about the disease is rendered negligible since it has ultimately 
enabled this corruption due to its mishandling of data. 
 Threat and creation of harm.  Integral to the notion of bad medicine is the 
impending threat of new and unwarranted harms caused by the shortcomings of the 
medical establishment. In addition to the harms created by those procedures deemed 
necessary for diagnosing and treating preexisting breast cancer (for example, pain and 
disfigurement from mastectomies), the medical establishment is implicated in the 
creation of new and unnecessary harms that result from primitive science and inept 
methods. As such, patients are positioned as victims to a modern-day pharmakon: breast 
cancer treatments operate as both remedy and poison, attending to problems while 
simultaneously creating new ones. The risks inherent to breast cancer treatment, then, 
extend beyond known side effects and cast a specter on the future health of patients, 
especially as this future may be delimited by unknown ramifications of treatment. For 
example, the following excerpts from articles in The New York Times and USA Today 




Women treated with radiation for breast cancer face an increased risk of heart 
attacks and premature death, even 20 years after the end of treatment, a study 
shows. The study is the latest to document the serious long-term health problems 
faced by cancer survivors. Although improved treatments allow more people 
today to survive their disease, these toxic therapies also lead many to suffer 
chronic health problems. (Szabo, 2013a) 
Although doctors try to spare the heart, it still gets some of the dose, especially 
when the left breast is treated. Radiation can damage the linings of blood vessels 
and scar the heart muscle. (Szabo, 2013a) 
In these instances, women’s bodies are treated as collateral damage in the process of 
treating breast cancer, thus placing them in the position of having to accept one risk in 
order to eliminate another. By attending to the tertiary outcomes of cancer treatment—in 
this case, heart problems from radiation therapy—these articles highlight not only the 
ultimate lack of optimal choices for women, but also the ineffective methods for 
administering treatment.  
 New risks also result from the confusion about breast cancer that underscores both 
the lack of knowledge about the disease and the inability of physicians to mobilize what 
is known about it. A primary example of this confusion is the contested position of 
mammography as the mainstay in breast cancer detection and prevention. Combining 
both the dearth of usable information and the contradictions amongst medical providers, 
discourses about mammography highlight the threats inherent to this screening tool. For 
example, the following two excerpts from articles in The New York Times acknowledge 
the short- and long-term problems attributed to this technology: 
The changes reflect increasing evidence that mammography is imperfect, that it is 
less useful in younger women, and that it has serious drawbacks, like false-
positive results that lead to additional testing, including biopsies. (Grady, 2015) 
One of the drawbacks of screening is false positives: over 10 years, a woman 
receiving an annual mammogram has a 61% chance of getting such erroneous 




stage cancers is unnecessary and can have lifelong side effects. (Sifferlin, 2015) 
As these articles suggest, the standardized role of mammography in breast cancer 
screening extends to the practice of routinely overdiagnosing and overtreating women, 
resulting in a tautological system of looking for and finding and/or creating cancer. By 
creating new problems that cannot be adequately handled by the medical establishment, 
breast cancer screening positions women in a consistent state of unease due to the 
omnipresent threats posed by both cancer and the search for it.  
 A final instantiation of new harms posed by breast cancer screening and cancer 
care calls into question the efficacy of prevention and treatment medications. As part of 
the arsenal of cancer treatments, chemotherapy is understood to have side effects for 
patients (for example, hair loss from certain cocktails and nausea from treatment). While 
the immediate side effects are well known, the lesser known and long-term material 
impacts of this treatment are highlighted as being unwarranted harms added onto the 
preexisting concerns for those received chemotherapy. For example, an article in USA 
Today addresses the shortcomings of chemotherapy drugs and the measures patients must 
take to compensate for the damage done to the body in the process of trying to heal it: 
Certain chemotherapy drugs also can cause heart failure […]. Lastly, chemo often 
throws  women into early menopause, which causes many breast cancer survivors 
to gain weight  […]. That puts further stress on the heart. Because cancer 
treatment can damage the heart and blood vessels in so many ways, leading a 
healthy life -- with a good diet, lots of exercise and no smoking – is crucial, Smith 
says. (Szabo, 2013a) 
In this instance, women are not only positioned as being plagued by the alleged cure for 
their malady, but also expected to anticipate and accommodate the new problems 
associated with their treatment. This allusion to the power of patient agency identifies the 




articulating the steps patients can—and should—take to prevent future problems caused 
by chemotherapy highlights the deficit created by breast cancer treatments. In this way, 
women must take action to achieve and maintain baseline, rather than optimal, health just 
to manage their risk of deterioration caused by those measures intended to restore health. 
Similarly, preventative cancer medications are questioned for their utility in preventing 
one cancer while simultaneously increasing the risk of developing another (among other 
issues). Addressing these concerns, an article in The New York Times challenges the 
perceived value of these medications in relation to the threats caused by them:  
Many healthy women, even if they are at increased risk, refuse the drugs, asking 
why they should take pills to lower the odds of a disease they may never get 
anyway, especially when the drugs can have dangerous or unpleasant side effects. 
Besides increasing the risk of blood clots and strokes, the drugs can also cause hot 
flashes and vaginal problems like dryness and pain that can damage a woman's 
sex life. In addition, tamoxifen can lead to cataracts and uterine cancer. (Grady, 
2013) 
Diverging significantly from discussions about chemotherapy drugs—which cause 
problems while treating preexisting cancer—this example attends to the invited trouble 
that patients take on when partaking in prevention measures. By highlighting the 
multitude of new harms that await patients who are proactive in breast cancer prevention, 
this article suggests that women must negotiate the potential harms against the unknown 
benefits from these drugs. That is, the benefits are likely to be unknown—the lack of a 
cancer diagnosis is not proof the medication worked—yet the harms are known, thus 
requiring women to select which threat they prefer. 
The four prongs that undergird the notion of bad medicine—primitiveness, 
ineptitude, corruption, and new harm—result in an overarching motif of fatalism that 




patients. These common discourses challenge the official discourse’s uncomplicated 
valorization of personal agency on the part of patients; despite striving to situate control 
within patients, these common discourses articulate a medical establishment that is 
unable to help and empower patients, and often operates as a hindrance. The role of the 
patient in this situation, then, is expected to be agentic and have the ability to adapt to and 
compensate for ineffective care, but is ultimately thwarted in those efforts by an 
ineffective medical establishment. As such, these discourses illuminate that what patients 
ought to be able to do in regard to their health does not align with what they are able to 
do in practice, thus further reaffirming the fatalistic perspective on the state of modern 
medical approaches to breast cancer.  
 
Trench Warfare  
 
 Emerging in these common discourses is an ancillary discourse that prompts 
women to actively see the medical establishment as oppositional to their interests and to 
take matters into their own hands. Seemingly in response to the four prongs of “bad 
medicine”—primitive tools, physician ineptitude, corruption, and new harm—this 
discourse moves beyond the perception of the medical establishment as a lacking or 
failed partner and describes it as actively oppositional to women’s health and interests, 
but necessary to navigate nonetheless. The helplessness of the patient that the collective 
“bad medicine” discourse arguably prompts still relies upon fatalism, but in a reactive 
“last resort” or “no other option” way. That is, it is mobilized as women being forced to 
take over their health and treatment into their own hands in an attempt to recoup agency 
that is described as obviated in the bad medicine discourse; this is manifest in two ways: 




 Intuition is advanced as the primary touchstone in this ancillary discourse in the 
absence of effective or credible guidance from the medical establishment. Women are 
encouraged to trust their instincts in determining what resources to assess and/or utilize. 
For example, the following excerpts emphasize the importance of instinctual responses to 
a breast cancer diagnosis:  
As with Jolie, Wilson's candor drew praise. “Rita Wilson has become the poster 
child for both second opinions and trusting your own instincts with regards to 
your body…”  (Oldenburg & Puente, 2015) 
 
[Rita Wilson] “For me, this is about telling people, ‘you can get a second opinion 
– your insurance will pay for it, even Obamacare, God bless it, will pay for it,’” 
she said. “It’s so easy to say, ‘I’m just being paranoid,’ but you should trust your 
gut.” (Lyall, 2015) 
  
Though it was the most aggressive surgery option, Robach felt strongly about her 
decision. (Less invasive approaches, including lumpectomy, were also discussed.) 
Her “gut feeling” to undergo the bilateral mastectomy is a decision the mother of 
two is grateful she made every day because a second, undetected malignancy was 
discovered during the operation. (Strohm, 2015) 
 
Robach made the decision to have the most aggressive surgery she could to treat 
her breast cancer: a double mastectomy. “I just had a visceral, immediate gut 
feeling that this is what I wanted to do,” says Robach. (Cotliar, 2013) 
 
Implied in these examples is the presence of bad medicine: first, ineffective medical care  
received by Wilson—thus necessitating second opinions to verify the work of 
physicians—and  second, primitive options for Robach in dealing with her cancer 
diagnosis—hence her double mastectomy being highlighted as the most aggressive 
surgical option available to her. Importantly, these articulations of the medical 
establishment’s shortcomings are assuaged by the healing capacity of women’s intuition 
in so far as it guides them to optimal choices for their situations. Not only are these 
demonstrations of instinct portrayed as authentic and authoritative—that is, Wilson is 




force behind her decision—but they are also represented as the natural response to bad 
medicine because gut reactions and knowing one’s body are the purview of the patient. 
Thus, by operating within an overarching discourse of fatalism that reifies patients as 
victims of both bad medicine and cancer, these excerpts articulate instinct as an avenue to 
better or more satisfactory care.  
 Reactive agency is also described in this discourse as material and operational. 
That is, as clear, specific directives issues by patients to providers—arguably, a 
“muscular” and conventionally agentic complement to the “female intuition” articulated 
as the first line of defense. For example, articles in The New York Times attend to the 
voices of patients in shaping medical decisions and healthcare trends:  
A new generation of women want doctors to take a more aggressive approach, 
and more and more are asking that even healthy breasts be removed to ward off 
cancer before it can strike. (Parker-Pope, 2013) 
 
“Defaulting to patient preference in the face of uncertainty has become the moral 
high ground,” Dr. Rosenbaum wrote. “But it is as much our job to figure out how 
to best help our patients lead healthier lives as it is to honor their preferences.” 
(Brody, 2014b) 
“There's no right or wrong decision, as long as patients are well-informed and 
choose what is best for them,” said Dr. Jennifer K. Litton, a surgical oncologist at 
M.D. Anderson Cancer Center in Houston. “The old days of paternalistic 
medicine are gone.” (Brody, 2014a) 
As indicated in the People article about Robach’s double mastectomy and demonstrated 
here, aggressive self-advocacy about preferred treatments is represented as a response to 
inept or unsatisfactory care, particularly as those shortcomings are mobilized on the part 
of younger patients. This ancillary discourse, as noted, is nonetheless situated in a 
broader common frame of fatalism as regards breast cancer treatment. It mobilizes that 




the helpless, victimized patient of “bad medicine,” as a failed partner, with an 




 This inquiry into the rhetorical construction of medicine and patient agency in 
public health campaigns and news coverage about breast cancer suggests that, while the 
patient and the medical establishment are centrally figured into both of these discourses, 
there are significant differences in how they are ultimately constructed. While both sets 
of discourses valorize patient agency, the primary divergence between these official and 
common discourses about breast cancer resides in the efficacy of the medical 
establishment. Whereas the former takes for granted the effectiveness of physicians and 
medical science in the fight against breast cancer, the latter apprehends the establishment 
as both incompetent and impotent, at best, and downright dangerous, at worst, suggesting 
that the limited power it does have to attend to women’s health is stymied by a multitude 
of shortcomings. Furthermore, official discourses view the medical establishment as 
benevolent, cooperative, and helpful, if secondary, whereas common discourses view it 
as inept primitive, corrupt, and a failed partner. As such, women’s agency is defined and 
qualified by the fatalism created and bolstered by bad medicine, resulting in an 





TO INVISIBILITY AND BEYOND: THE NEBULOUS  
DISCURSIVE NATURE OF BLADDER CANCER 
 
Known as “the invisible cancer,” bladder cancer is situated within a constellation 
of juxtapositions that render this reputation both troubling and surprising: it is one of the 
most common cancers, yet perceived to be the least common by the public (Jensen et al., 
2014); it is the most expensive cancer to treat, yet it is one of the least funded (Lotan et 
al., 2009); and approximately 77,000 new cases will be diagnosed in the United States in 
2016, yet it is one of the most underrepresented cancers in the news and has no dedicated 
public health campaign in the United States (American Cancer Society, 2016; Jensen, 
Moriarty, Hurley, & Stryker, 2010). Considering these factors, the conspicuous absence 
of bladder cancer from the public agenda calls into question what information—if any—
about the disease resonates with the public, as well as how the disease is constructed and 
negotiated by official health organizations and patient advocacy groups.  
In this chapter, I examine how, in the absence of a national-level public health 
campaign, bladder cancer organizations and patient advocacy groups discuss the disease, 
paying particular attention to how preventative, diagnostic, and treatment processes are 
rhetorically constructed. Additionally, I analyze how mainstream news discourses about 
the disease converge and/or diverge with these official dictates about bladder cancer to 




inquiry is located within its potential to see how a largely ignored—yet prevalent and 
threatening—disease is discussed in both health and news spheres, and how these 
articulations of the disease potentially indicate ways to enhance care and improve 
awareness about it in the medical community and the general public. 
 
Official Discourses 
 Like public health campaigns, health organizations and related patient-centered 
online resources provide consumers with prevention, diagnostic, and treatment 
information about prevalent health concerns. Also similar to public health campaigns is 
the fact that this information is rhetorical in nature: it operates in relation to cultural 
perspectives and discourses about how we tend to understand health conditions and those 
affected by them, as well as the potential causes and solutions for them. These resources, 
then, prove to be especially vital when they are about health issues or conditions that—
for whatever reason—fail to garner the funding or attention for an official awareness 
campaign. As such, these official discourses provide an authoritative lens through which 
consumers can learn more about those health concerns that do not occupy a consistent 
position on the public agenda—in this case, bladder cancer.  
 Perhaps not surprisingly, the “invisible cancer” is largely absent from domestic 
online resources about cancer.
3
 Thus, the discourses selected for inclusion here—though 
not associated with any governmental and public initiatives to raise awareness about the 
profile of bladder cancer in the United States—were identified due to their received 
credibility and authority on the subject, as well as their availability. First, the American 
                                                 
 




Cancer Society (ACS) is a leading authority on cancer and thus the ACS website serves 
as a general resource for all cancers. Specific to bladder cancer—and included here for 
study—is the ACS’s detailed bladder cancer guide that consolidates all of the ACS’s 
content about the disease into one document. Second, the Bladder Cancer Advocacy 
Network (BCAN) serves as the only national non-profit advocacy organization in the 
United States about the disease and its website provides information, patient resources, 
and research updates. Finally, the nonprofit American Bladder Cancer Society (ABCS) 
website—started and designed by bladder cancer survivors—features help guides and 
other patient resources designed to improve the communication between patients and 
their providers.  
 These online resources about bladder cancer are important to study because they 
are the official channels through which most (if not all) information pertaining to the 
disease is made available to the public. The limited availability of bladder cancer 
resources and awareness initiatives also renders these websites key texts for study, 
especially since they present a range of resources likely searched for by interested parties: 
scientific perspectives on the disease and research developments, as well as patient-
centered guides and contact information for providers, clinical trials, and the like. When 
analyzed together, these official discourses position bladder cancer as an unknown—and 
even sometimes unknowable—disease that mystifies patients and providers alike. As 
relevant to providers, bladder cancer’s mystique is secured in the official discourse’s 
endorsement of medical teams rather than individual providers, who are concomitantly 
articulated as unable to decipher the condition on their own. It is patients, however, who 




The Unknown and Unknowable Cancer 
 Bladder cancer’s status as essentially invisible across all sectors in the US—for 
example, funding, awareness, news coverage, and the like—is reflected in these online 
resources about the disease, primarily in the articulation of the disease as ambiguous—
precisely, as deceptive and mysterious. Patient agency is encouraged, then, in the context 
of a quest, with no definitive object or end.  
 Deception.  The standard imperatives of health and patient advocacy 
organizations—to highlight, inform, and empower—are mobilized in these discourses in 
ways that position the disease as inherently duplicitous. This deception is frequently 
mobilized via attention to bladder cancer masquerading as other health issues, these 
related health issues presenting bladder cancer symptoms, and an overall sense of 
wellness that obfuscates the presence or threat of the disease.  
 The duplicity that shrouds bladder cancer is underscored by the understanding 
that the disease frequently masquerades as other less severe health issues, and thus often 
goes unnoticed or is dismissed altogether. Symptoms, then, are represented as hiding in 
plain sight due to their ordinary and nonthreatening nature (e.g., lack of pain). For 
example, the following excerpts highlight the masquerading nature of bladder cancer:  
Two features that tend to mask the severity of the gross hematuria and may 
influence patients to postpone seeking immediate medical care are 1) the bleeding 
may be occasional and short-lived; and 2) there is likely to be no pain associated 
with the bleeding. (Bladder Cancer Advocacy Network - BCAN, 2016e) 
 
Bladder cancer symptoms may be identical to those of a bladder infection and the 
two problems may occur together. If symptoms do not disappear after treatment 
with antibiotics, insist upon further evaluation to determine whether bladder 
cancer is present. (Bladder Cancer Advocacy Network - BCAN, 2016g) 
 
Bladder cancer survivors report that they may have had all, some or none of the 




symptoms they can be signs of other conditions. (American Bladder Cancer 
Society, 2016c) 
 
Attending to the commonplace nature of bladder cancer symptoms, the first two 
examples suggest that the disease hides behind issues that fail to incite fear or significant 
concern in those experiencing the symptoms. Specifically, the second example highlights 
how more common health issues are given primacy (e.g., bladder infections) over the 
possibility of bladder cancer, thus rendering the disease as a slim possibility in 
comparison to those issues that are considered to be more likely to occur. Similarly, the 
final example alludes to the multitude of possibilities that exist in regard to bladder 
cancer symptoms such that the masquerade may point patients and physicians in a variety 
of wrong directions. One such direction that is frequently articulated is that which is 
specific to women and indeed considered far more likely than cancer: gynecological 
processes or problems. The following examples reinforce the representation of the 
disease as effectively hiding or evading detection:  
Many women ignore the most basic symptom—blood in the urine—which they 
may associate with menstruation or menopause and delay reporting this symptom 
to their doctors. Even after reporting the problem to their doctors, blood in the 
urine may be initially misdiagnosed as a symptom as post-menopausal bleeding, 
simple cystitis or as a  urinary tract infection. (Bladder Cancer Advocacy Network 
- BCAN, 2016g) 
 
Women often have delayed diagnosis due to bladder cancer being mistaken for 
common gynecological problems. (American Bladder Cancer Society, 2016b) 
 
I never had any signs or symptoms that would have raised a red flag. In hindsight, 
I had a  history of bladder infections, kidney stones, some urgency, and some 
blood in my urine, which I assumed was just menstrual blood. (American Bladder 
Cancer Society, 2016e) 
 
I had been having some symptoms such as pain and dark colored urine for several 
months, but I thought they were connected to menopause. (Bladder Cancer 





By imbricating bladder cancer symptoms with those attendant to menstruation and 
menopause, these examples reaffirm the understanding that the disease not only evades 
notice and investigation, but that it perfectly aligns with those phenomena that women are 
always already primed to expect. As such, these discourses suggest that the disease 
effectively masks itself in ways that render concern about cancer to be misguided at best 
and alarmist at worst (a particularly salient situation for women whose credibility to 
speak up about their health concerns is at stake in these discourses).  
 Inversely, bladder cancer is equally hard to detect and comprehend due to the 
related health problems that mimic the disease and its few symptoms (e.g., blood in the 
urine). Whereas bladder cancer is often understood to be masquerading as other issues, 
other issues are also implicated as portraying themselves to be bladder cancer, such that 
detection measures seem not only challenging but ultimately unnecessary. As the 
following excerpts demonstrate, false alarms can be triggered due to the mimicry of other 
conditions: 
Blood in the urine does not always mean you have bladder cancer. More often it is 
caused  by other things like an infection, benign (non-cancerous) tumors, stones in 
the kidney or bladder, or other benign kidney diseases. But it’s important to have 
it checked by a doctor so the cause can be found. (American Cancer Society, 
2016c) 
 
However, blood in the urine does not necessarily mean a diagnosis of bladder 
cancer. Infections, kidney stones as well as aspirin and other blood-thinning 
medications may cause bleeding. In fact, the overwhelming majority of patients 
who have microscopic hematuria do not have cancer. Irritation when urinating, 
urgency, frequency and a constant need to urinate may be symptoms a bladder 
cancer patient initially experiences. Oftentimes, though, these are merely 
symptoms of a urinary tract infection and antibiotics become the first line of 
treatment. (Bladder Cancer Advocacy Network - BCAN, 2016e) 
 
However only about 1 in 1,000 cases of gross or microscopic hematuria are 
associated with Bladder Cancer many other conditions can cause it. (American 




By highlighting the other possible conditions to which bladder cancer symptoms can be 
attributed, these examples suggest that concern over detecting the disease may be 
exaggerated and potentially unwarranted. Mobilized here, these more common conditions 
serve as a red herring insofar as they distract from the possibility of bladder cancer and 
require unnecessary treatments prior to consideration of cancer as the cause.  
 Finally, bladder cancer is rendered a particularly nefarious and sneaky threat due 
to its ability to infect with few symptoms and/or no sense of dis-ease on the part of 
patients. As such, feelings of wellbeing—indeed another type of masquerade adopted by 
the disease—obscure ill health and undergird the duplicitous and dangerous threat of 
bladder cancer (i.e., a threatening disease that can slip by with little to no materialized 
symptoms). For example, the following excerpts emphasize the lack of disconcerting 
sensations surrounding symptoms: 
People assume they will feel symptoms from cancer, but almost four years later I 
still feel no symptoms at all. (Bladder Cancer Advocacy Network - BCAN, 2016f) 
 
When I took my sample back it looked okay to me but there was blood in it when 
the doctor checked it. I then had an ultrasound, x-ray and cystoscopy. I was not 
concerned by this as I felt fine. (Bladder Cancer Advocacy Network - BCAN, 
2016b) 
 
Not finding cancer on this test [urine cytology] doesn’t always mean you are 
cancer free. (American Cancer Society, 2016d) 
 
Similar to the threats posed by the disease masquerading as other issues or being 
rationalized away by other conditions, these examples highlight how the lack of pain and 
discomfort—as well as the lack of definitive proof about the absence of cancer—make 
the disease that much more difficult to identify and understand. Lacking the signifiers 
traditionally associated with serious health concerns, bladder cancer ultimately deceives 




ambiguous because it fails to align with the expectations of ill health and disease.  
 Mystique.  The mystifying nature of bladder cancer is alluded to in 
representations of the medical establishment and its modus operandi for dealing with the 
disease insofar as the disease is a challenge for physicians. As such, bladder cancer’s 
mystique is mobilized by requiring a high degree of specialization and/or expertise in the 
treating physician, or preferably teams of physicians to try to penetrate the mystery using 
their collective skills.  
 Despite an overall reliance on medical experts and opinion, these discourses 
highlight the mystique of bladder cancer by calling into question the authority and ability 
of nonspecialist individual physicians to handle such an ominous disease. As these are 
common discussions about physicians in these discourses, this construction of physicians 
presents them as lacking the credibility that they are stereotypically imbued with in the 
medical community, especially when it comes to expertise with a mystifying disease like 
bladder cancer. For example, the following excerpts construct regular physicians as 
naturally unqualified to deal with bladder cancer, and thus specialists must be sought out 
by patients: 
Many urologists don’t know enough about bladder cancer. If you want the best 
treatment, find a highly-regarded urologist who specializes in bladder cancer. If 
you can, seek help in a major cancer center where they treat many cases of this 
disease. Choose a urologist you trust and with whom you feel comfortable. Find a 
doctor who will talk to you. (Bladder Cancer Advocacy Network - BCAN, 2016d) 
 
It is important that any type of cystectomy be done by a surgeon with experience 
in treating bladder cancer. (American Cancer Society, 2016a)  
 
 Blood in the urine is not something that can be ignored and should be checked by 
 a urologist who understands bladder cancer and can give you the best care. 
 (Bladder Cancer Advocacy Network - BCAN, 2016f) 
 




physicians to be the exception and under/unqualified physicians to be the rule. This 
construction of the medical community at large portrays it as fundamentally uninformed 
about the disease. As such, the specter of bladder cancer is rendered more sinister and 
mysterious by a medical establishment mostly incapable of understanding it or providing 
effective care. Furthermore, this shift in the representation of the medical establishment 
also places the onus of responsibility on patients to find the “right” physician, thus 
requiring the patient to adopt the role of expert until an official replacement can be 
located, thus further enhancing the daunting nature of the disease.  
 Happening concurrently with the characterization of regular physicians—that is, 
drawn against the skills and training of elite specialists—as inherently under/unqualified 
to handle the mystique of bladder cancer is the representation of them as potentially 
incompetent, as well. Similar to the imperative placed on patients to find experts in the 
treatment of bladder cancer, this construction of physicians relies on the (common) threat 
of—and need to avoid—misdiagnoses to further underscore the inadequacy of modern 
medicine’s approach to dealing with bladder cancer. This theme is demonstrated in the 
following excerpts about misdiagnoses and second opinions:  
Before my diagnosis, following a bout with kidney stones, my local urologist had 
diagnosed me with chronic urinary tract infections. In April, 2008, after voiding a 
huge amount of blood, I called my doctor’s office and a nurse told me that there 
was nothing to worry about because it always looks like there is more blood than 
there actually is, but, I could make another appointment if I wanted. (Bladder 
Cancer Advocacy Network - BCAN, 2016a) 
 
Get 2nd, 3rd and 4th opinions if you are so inclined. Doctors can and do vary 
significantly on the treatments they recommend. (Bladder Cancer Advocacy 
Network - BCAN, 2016c) 
 
It is highly recommended to always get a second opinion from a major center that 
deals with a high volume of bladder cancer. Studies have shown that the 




difference in outcomes. (American Bladder Cancer Society, 2016d) 
 
In keeping with the understanding that the disease is mysterious and often ineffable, 
regular physicians are portrayed as generally not knowledgeable about how to detect or 
treat bladder cancer, and thus these excerpts construct the opinions of these nonelite 
physicians as frequently ineffective, and even potentially flawed and deleterious (hence, 
the normalized nature of receiving multiple opinions on treatment options). As such, the 
complexity and mystery of the disease occur alongside the threats of medical ineptitude 
such that they all reinforce the representation of bladder cancer as a unique and severe 
threat.   
 Aligning with the understanding that bladder cancer is largely invisible in—and 
unknown by—the medical establishment, and thus necessitates specialists to treat, is the 
notion that the preferable way to combat the disease is via a team of medical 
practitioners. Unlike official discourses about breast cancer—which frequently hinge on 
the importance of family and the integration of other support systems to maintain a 
woman’s commitment and responsibilities to her loved ones—these discourses about 
bladder cancer position a team of healthcare providers at the center of the disease (and, 
incidentally, relegate social and emotional support systems mostly to the margins). The 
importance of a medical team, as opposed to a single urologist, underscores the 
complexity and inscrutability of the disease insofar as multiple minds are needed to 
approach it. For example, the following excerpts highlight not only the complexity of a 
team’s composition, but also the impact of a team as a support system:  
Depending on your options, you can have different types of doctors on your 
treatment team. […] You might have many other specialists on your treatment 
team as well, including physician assistants (PAs), nurse practitioners (NPs), 




specialists, and other health professionals. (American Cancer Society, 2016a) 
 
Your cancer care team will be your first source of information and support, but 
there are other resources for help when you need it. Hospital- or clinic-based 
support services are an important part of your care. These might include nursing 
or social work services, financial aid, nutritional advice, rehab, or spiritual help. 
(American Cancer Society, 2016a) 
 
However, the truth is that the time to have a discussion about your sexuality with 
your treatment team is when you are making treatment decisions. (American 
Bladder Cancer Society, 2016a) 
  
As these examples suggest, a bladder cancer diagnosis is a complex enterprise ideally 
requiring specialists to handle the disease, though teams thereof are preferable. 
Importantly, this emphasis on the centrality of providers operates not only to keep it 
within the medical realm (as opposed to the psychosocial realm), but to reinforce the 
magnitude of the disease, as well. By emphasizing the varied specialists in a medical 
team and the integral nature of this team to the success of one’s treatment, these excerpts 
underscore the complexity of the disease and position it as particularly sinister such that it 
necessitates the combined experiences and expertise of these practitioners. Therefore, the 
inadequate ways in which modern medicine approaches bladder cancer underscores the 
mystique of the disease and renders it more cunning and sinister since it necessitates an 
army to address it.  
 Patient agency.  Undergirding the overarching motif of ambiguity in these 
discourses is the valorization of patient agency via an articulation of the patient as a 
seeker of a bladder cancer diagnosis. The importance of patients feeling imbued with a 
sense of control over their health is highlighted by an emphasis on overseeing and 
monitoring the ambiguity of the disease: both the deceptive physical symptoms and the 




individual physicians). This emphasis on agency as information seeking—rather than 
resource identifying—thus reinforces the notion that the disease is largely unknown to the 
medical community and, in some cases, possibly even beyond the comprehension of 
patients. Patient agency, then, is mobilized in these discourses as the ability to navigate 
one’s way through the ambiguity of bladder cancer through data gathering (and 
specifically gathering the “right” data), and mobilizing that information rationally in 
decision making processes.   
 Information seeking, as mobilized here, valorizes individual efforts to research the 
disease and learn details that are specific and relevant to one’s situation and diagnosis. 
For example, the following excerpts address the importance of patients taking the 
initiative to research the disease and conferring with loved ones and healthcare providers 
about confusing information:  
When faced with a diagnosis of bladder cancer, you and those that care about you 
are thrown into a frightening place where knowledge is potentially lifesaving. 
(American Bladder Cancer Society, 2016c) 
 
Bladder cancer is a treatable disease. Learn as much about your diagnosis as you 
can. Look on the internet, search medical libraries, request BCAN’s patient 
handbook. Read the literature yourself. If you find that researching it upsets you, 
let someone close to you do it and bring you the relevant information. (Bladder 
Cancer Advocacy Network - BCAN, 2016c) 
 
The support from my family and friends has helped me in ways I could never 
explain or be able to repay. However, my need for knowledge could not come 
from them. While researching on the internet, I will always be grateful that I 
stumbled across BCAN. (Bladder Cancer Advocacy Network - BCAN, 2016f) 
 
As these examples demonstrate, patient agency—when located within the realm of 
information and research—is positioned as an integral part to a patient’s survival and 
one’s overall journey with cancer. In these cases, data gathering tends to supplant other 




primary action available to patients and as such must be prioritized, particularly since the 
ambiguity of the disease enhances the challenge of knowing how to deal with it.  
Significantly, in contrast to these positive representations of patient agency are 
those articulations of distress that result from such action, thus emphasizing how the 
ambiguity of the disease positions patients as needing both to learn about the disease and 
how to navigate their way out of the distress that results from this knowledge. This 
Catch-22 of securing information and then needing to secure comfort and reassurance 
regarding that information emphasizes the mystique of the disease insofar as learning 
about it ultimately disturbs and disrupts patients. Implied in these discourses is an 
expectation that patients should moderate their information seeking insofar as they should 
not become overwhelmed or tempted to stray from expert opinion. In these cases, the 
potential downsides to patients ostensibly taking control of their diagnosis through 
research are used here to support a limited definition of patient agency that hinges on 
patient irrationality. That is, the perceived emotional distress of learning about bladder 
cancer is presented as the rationale for limiting patient agency and privileging certain 
types of information over others. For example, the following excerpts articulate the 
reasons why limiting patient knowledge can be preferable: 
And to add even more complexity to this emotional storm is the fact that you have 
to learn enough about your diagnosis to make informed decisions. While 
knowledge is power it needs to be the right information that fits your situation and 
is reliable. (American Bladder Cancer Society, 2016f) 
 
Doing blanket research before you understand your personal diagnosis may not 
only leave you with information overload but could cause unneeded worry. Start 
with the basics and once you have your exact diagnosis use that to give direction 
to your research. (American Bladder Cancer Society, 2016f) 
 




information to learn before it becomes a burden. Again referencing the upsetting nature 
of researching bladder cancer, these examples construct information seeking—and patient 
agency as the force behind it—as potentially deleterious to the health of patients. Because 
these discourses delimit patient agency by tethering it to threats of emotional distress and 
the imperative of finding the “right” information, they result in a double bind that 
requires patients to research enough to be proactive, yet not enough to become 
overburdened. This balance—though certainly ideal in theory—is particularly 
challenging in light of the previous directive that knowledge can be lifesaving. By putting 
patients in this bind, these discourses articulate individual agentic action as aimless, thus 
further drawing patient agency against the mystique that surrounds bladder cancer in the 
United States. These articulations of patient agency underscore the mysterious and 
disturbing nature of the disease, and thus concede that agency is an illusion since little 
can be done about it.  
 
Common Discourses 
 Relative to other cancers—for example, breast and skin—little consistent news 
coverage appears about bladder cancer. This dearth of coverage, consistent with the 
disease’s reputation as the “invisible cancer,” underscores the idea of the disease being 
largely unknown both to the medical community and the general population. The 
fragmented discourses about bladder cancer in the popular press reflect how the disease is 
conceived of in the U.S. public imaginary (however limited that might be). Articles in 
mainstream news—specifically those in The New York Times, USA Today and USA 
Today Magazine, Los Angeles Time, Wall Street Journal, Huffington Post, Rolling Stone, 




through which ideas about the disease are mobilized and circulated. Whereas official 
discourses about bladder cancer highlight how the disease is unknown and unknowable to 
all involved parties—patients and providers alike—common discourses about it both 
extend and depart from this notion to posit the disease as entirely unintelligible, without 
shape or character. Accordingly, in the absence of a malevolent and vaguely agentic 
disease, the common discourses seek culpability across two alternate parties: the medical 
establishment/pharmaceutical industry and the patient. 
 
Unintelligibility 
 Cohering with and elaborating on the “official” understanding that bladder cancer 
is inherently unknowable, common discourses about it render the disease as so 
ambiguous that it is entirely unintelligible. Perhaps because of this increased degree of 
ambiguity, the disease is rendered as totally amorphous and nebulous, with no character 
attributes like duplicity or mystique. The ambiguity of bladder cancer is frequently 
mobilized through discussion about the various symptoms or health issues that confound 
accurate diagnoses of the disease. Due to its similarity to other conditions—
symptomatically speaking—the disease is largely unintelligible to both patients and the 
medical community because it lacks signifiers that distinguish it from other health issues, 
or make it easy to identify and understand, and thus this lends a masquerading mystique 
to bladder cancer. The nebulousness that shrouds the disease in mystery is articulated as 
both common and unexpected (i.e., the symptoms are common, but dealing with the 
disease and the ramifications of a misdiagnosis are unexpected). An example of the 
former is featured in Huffington Post: 




can now get an on-line UTI diagnosis and prescription to treat without a doctor) 
or bladder inflammation, blood in the urine, difficulty or pain when urinating or 
unexplained swelling in the lower extremities. (Collins, 2015) 
 
As this article indicates, the common nature of bladder cancer symptoms—so ordinary, in 
some cases, that they do not require doctor’s appointments to diagnose—position the 
disease as unusual relative to the other standard health issues that could be responsible for 
these symptoms. Relatedly, as hallmarks of other health concerns, these symptoms are 
often invoked in discussion about misdirection and misdiagnosis, issues that bespeak the 
unknown and ambiguous nature of bladder cancer due to their prevalence and severe 
consequences. Thus, the ambiguity of bladder cancer is apparent in these discourses at 
both the symptomatic and diagnostic stages. For example, the following excerpts 
highlight the masquerading nature of the disease:  
Quivers had no idea she was sick until 10 days earlier, when she had rushed to the 
doctor with an alarming symptom: She suddenly found herself unable to urinate. 
The problem, she learned, was a cancerous mass pressing on her bladder. During 
the surgery, doctors were initially pessimistic as they discovered how far the 
cancer had spread. (Hiatt, 2013) 
 
My mother's end, nearly 20 years later, was because of bladder cancer, 
misdiagnosed for more than a year as a urinary infection. When the pain was too 
much, and the correct  diagnosis finally made, it was too late. She was gone in less 
than four months. Proper testing combined with an accurate diagnosis might have 
saved her. (Dupont, 2014) 
 
“In many cases, there are significant delays in diagnosing bladder cancer, 
especially in women,” Hardie said. Doctors and patients alike tend to dismiss the 
symptoms, thinking they're dealing with postmenopausal bleeding or a common 
urinary tract infection. “I was treated for urinary tract infections for a year” before 
anyone suspected cancer, she said. (Peres, 2016a) 
 
As these examples indicate, the ambiguity of the disease often centers on misdiagnosis, 
resulting in physicians failing to recognize the disease. Whereas the article from Rolling 




health complications, the Boston Globe and Chicago Tribune articles underscore the 
confounding implications of the disease which direct attention to other—more 
common—health issues (e.g., urinary tract infections). As such, the disease is constructed 
as beyond comprehension for both those experiencing it and those trying to detect and 
treat it.  
Unintelligibility is also mobilized through emphases on both the lack of 
knowledge about the disease and the lack of innovation in treatments for it. Despite its 
prevalence and severity, the disease is constructed here as one that lacks definitive and 
consistent answers in the medical establishment, thus underscoring the notion that little is 
understood about the disease beyond its prevalence and severity. The following excerpts 
bespeak both this contradictory nature and dearth of answers:   
Q: I have T1 bladder cancer and am being treated with BCG [Bacillus Calmette-
Guerin] immunotherapy. I dye my hair dark brown every four weeks, as I have 
been for 20 years. I heard that hair dye is linked to bladder cancer. Should I stop 
using color?  
A: Your question is surprisingly difficult to answer. For decades, epidemiologists 
have been debating whether hair dye increases the risk of cancer. The problem is 
that studies often are contradictory. (Graedon, 2016) 
 
“It is well known that bladder cancer tumors have certain molecular alterations, 
but the problem is that there has been little data regarding which patients should 
get additional  therapy, especially if there is no radiologic or pathologic evidence 
that the cancer has spread beyond the bladder,” explains Lotan of Texas' Simmons 
Cancer Center. (Lotan, 2014) 
 
If hyperthermia is shown to help treat bladder cancer, “it's another option, and 
with the range of chemotherapy and novel agents it may be a much better option,” 
Dr. Kelly said. “Taken together, the studies tell us that hyperthermia is effective 
in bladder cancer, and further work will help establish which patients benefit 
most.” (Wang, 2015) 
 
Attending to both the causes of and treatments for bladder cancer, these examples suggest 




ambiguity. Exacerbating this struggle is the long term inscrutability of the disease, which 
bars clarity from emerging despite critical distance, the passing of time, and severity of 
condition. With little evidence or knowledge to guide or inform one’s cancer battle, then, 
the medical establishment—and by extension patients—are presented here as figuratively 
having their hands tied when trying to understand and handle the disease.  
 Similarly, the general lack of medical research and innovation is highlighted in 
discussion about the (few) new treatments being explored. In these cases, minimal 
research—and uncertain subsequent approval and distribution of treatments—perpetuate 
the unknown nature of the disease by emphasizing its status as an ignored disease. For 
example, the following excerpts emphasize the rarity of innovation regarding bladder 
cancer: 
 And just last month, data from Roche’s advanced bladder cancer study lit up the 
 international medical community, pointing toward what could be the first major 
 breakthrough in over 30 years for this dangerous cancer. (Smith, 2014) 
 
Roche's Genentech unit, which developed the drug, atezolizumab, said it plans to 
discuss the results with health authorities in an effort to bring it to market as soon 
as possible. If approved by regulators, it could become the first of a new wave of 
cancer  immunotherapies to be cleared to treat bladder cancer, and the first new 
treatment for the disease in the U.S. since 1998. (Loftus, 2015b) 
A new class of drugs that retrain the body's immune system to attack cancer cells 
is bringing hope to people with bladder cancer, a disease for which no new 
medications have been developed in three decades. (Peres, 2016b) 
Whereas the previous section articulated the disease as shrouded in ambiguity and 
uncertainty, these excerpts underscore the unintelligibility of the disease by constructing 
it as a puzzle that has long lacked solutions, thus resulting in a dire decades-long dearth 
of innovation. Highlighting the impact of innovation on the medical community and 




enigmatic disease. In this context, then, those dealing with the disease are positioned as 
blindly dealing with a disease that defies form or definition.  
Corruption 
 In the wake of ambiguity about the disease and in light of the high threat it poses, 
these common discourses move the disease beyond mysterious to unintelligible, and as 
such it is divested of character. Accordingly (and perhaps inevitably), other targets move 
into the sightline, with the obvious one being the medical establishment/pharmaceutical 
industry. Naturally aligning with the lack of knowledge and innovation on the part of the 
medical establishment is an underlying notion that corruption undergirds the detection 
and treatment of the disease in the United States. In the absence of information about the 
disease, then, the medical establishment and pharmaceutical industry become suspect 
through the perception of perpetuating and exploiting the unknown and unknowable 
nature of bladder cancer by conning patients, ignoring the disease, and/or abandoning 
research that fails to turn a profit. The limited attention paid to this disease by the medical 
establishment—per these discourses—largely hinges on the befuddling nature of the 
disease (as discussed above) and the ways in which medical practices can turn a profit 
based on the general lack of knowledge about it. For example, articles in The Wall Street 
Journal highlight the ways in which patients have been exploited by physician choices 
regarding treatment:  
The results suggest that robotic surgery may be no safer than open surgery, 
despite being more expensive, Dr. Bochner said. A 2010 study in the Journal of 
Urology found robotic bladder removal procedures cost an average of $16,250, or 
11.2% more than the average  cost of $14,610 for open surgery. (Walker, 2014) 
 
The pricey bladder-cancer test, known as FISH [fluorescent in situ hybridization], 
has been part of that program. Urologists at 21st Century Oncology ordered it 




2010. “There was in the background, I suppose, a financial component” to the 
urologists' propensity to order the test, he says. (Carreyrou & Adamy, 2014) 
In a letter to a friend, the manager of a Florida urology practice worried in 2010 
that her company would attract federal scrutiny for its frequent use of an 
expensive bladder-cancer test.  The manager's concern involved a program at 21st 
Century Oncology Holdings Inc.—a national chain of cancer practices—that 
gives its urologists a financial incentive to order the test from a central in-house 
lab. A federal law since the 1990s has prohibited “self-referral,” in which doctors 
can profit from Medicare-reimbursed procedures they order. But 21st Century 
Oncology and many physician groups around the country have found ways to do 
it anyway, exploiting an exception to the law in ways its writers didn’t anticipate. 
(Carreyrou & Adamy, 2014) 
 
As these excerpts suggest, physicians routinely utilize both unnecessary surgeries and 
tests to suit their financial interests, rather than provide quality care to patients (or even 
match standard operating procedure regarding diagnosis and treatment, in these cases). 
Whereas, as described above, lack of physician knowledge contributes significantly to the 
ambiguity of the disease, these excerpts position their ignorance differently, as 
disingenuous, nefarious, and avaricious. Patients, then, face a double-bind of dealing with 
either uninformed or greedy physicians, neither of which is prepared to provide optimal 
care (nor willing to, in the latter case). Thus, these discourses posit that the corruption 
that plagues the medical establishment hinges on physicians skirting both the law and the 
knowledge boundaries of patients who do not know to demand  
some surgeries over others. 
 Similarly, the lack of treatment development—as elaborated on in the previous 
section—is rearticulated here via discussion of the stalled production of drug treatments 
(including the limited selection currently available). Hinging on financial 
considerations—that is, drug development failing to be financially solvent and/or 
promising—the corruption of the pharmaceutical industry is constructed here as 




excerpts highlight the role (or lack thereof) of financial incentive in studying the disease 
and developing treatments: 
BCG, a liquid delivered into a patient's bladder, is expensive to manufacture 
because it is derived from live bacteria. Yet because the therapy is 25 years old 
and no longer  protected by patent, it fetches only about $145 a vial, compared 
with about $2,700 for a vial of Avastin, a newer, patented drug for other forms of 
cancer that hasn't had shortage issues. BCG's low price, coupled with the 
complexity and cost of manufacturing, has  made the drug unattractive for many 
companies to produce, says Erin Fox, director of the drug information service at 
the University of Utah. […] “This totally took me by surprise,” she [a patient] 
says. “It was the very first time I had to think about the drug companies as  failing 
the people that they're supposed to be there for.” (Loftus, 2015a) 
Although bladder cancer is the fifth most common malignancy in the U.S., it 
comes  in 11th in terms of research funding, according to the Bladder Cancer 
Advocacy Network.  “For many years, bladder cancer was ignored,” said Dr. 
Gary Steinberg, director of urologic oncology at University of Chicago Medicine. 
“The pharmaceutical industry was not interested.” (Peres, 2016a) 
In a small study, Roche's drug, known as MPDL3280A, shrank tumors in 43 
percent of a subset of patients with advanced bladder cancer. The company might 
now make bladder cancer the priority for its first approval rather than lung cancer, 
Daniel O'Day, head of Roche's pharmaceutical business, said in an interview here. 
[…] Companies are exploring whether a PD-L1 test can be used to determine 
which patients should get the drugs. That would be important because the drugs 
are expected to cost at least $100,000 a year. (Pollack, 2014a) 
In these cases, the pharmaceutical industry is similarly aligned with the medical 
establishment insofar as decisions regarding patient care are profit-driven. In keeping 
with the invisible nature of bladder cancer, these discourses underscore the understanding 
that the disease is mostly unknown, and thus the dearth of research is presented here as 
naturally resting on financial considerations (as opposed to the severity and prevalence of 
the disease). Patients, then, are positioned as needing to adapt to the financial interests 







 Imbricated with the unintelligibility of bladder cancer and concern about the  
corruption that seemingly stalls medical innovation is an emphasis on patient morality, 
and thus patients are targeted and held responsible for their disease. Centering patient 
accountability as the norm, these discourses mobilize blame to articulate not only the 
poor choices that exacerbated one’s propensity for bladder cancer, but also to identify the 
proper way to be a bladder cancer patient (i.e., one who takes responsibility for one’s 
diagnosis). The following excerpts—perhaps not surprisingly—center on smoking as 
both a primary cause of bladder cancer, but also a habit frequently espoused by bladder 
cancer patients, and thus highlight how patients must be held accountable for their 
diagnoses: 
More than half of bladder cancers in the U.S. are the result of smoking, and 90 
percent of smokers with the disease are aware of the connection, according to a 
new study. […] “Bladder cancer patients smoking at diagnosis appear to accept 
that their own  smoking caused their cancer, positioning them for a more 
motivated (and more likely successful) attempt at quitting,” Bassett said. (Doyle, 
2014) 
 
Survivors of lung or bladder cancer, which are often caused by cigarette smoking, 
were the most likely to still be smokers. (Salahi, 2014) 
 
Emphasizing that cancer patients are knowledgeable about the causal link between 
smoking and bladder cancer, these discourses position the locus of responsibility entirely 
within the patients. In these cases, patients are expected not only to take responsibility for 
their diagnosis, but also make amends for it, as well (i.e., by attempting to quit). Since 
these discourses cannot lock into particular behaviors and actions due to the 
unintelligibility of bladder cancer, they articulate equally universally “bad” habits at the 




and generic nature of bladder cancer and smoking.  
 Also occurring within this construction of patient morality is an emphasis on the 
retroactive and proactive steps patients could and should take. In keeping with the above 
emphasis on what patients knew/know about their diagnoses, these discourses highlight 
what patients did/can do about their diagnoses. For example, the following excerpts detail 
the ways in which cancer patients are interrogated and prompted to perform 
accountability: 
I remember my mom saying that one of the many difficulties in her time living 
with cancer was having people try to figure out what she could have done 
differently. You know, to prevent a giant tumor from growing in her bladder and 
eventually crushing her organs. “Did you drink too much?” “Did you stand near a 
microwave?” “Did you not eat solely organic vegetables grown in a garden no 
further than 10 miles from your home?” She felt like she was constantly 
defending her life choices (which, might I add, included going to bed at 8:30 p.m. 
most nights, running seven miles every morning, and only drinking a glass or two 
of wine on the weekends). (Leyko, 2015) 
  
Phelps' brushes with cancer now have him coaching up in a different way. He is 
trying to alert men about the importance of getting annual physicals that include 
prostate and  bladder screenings. When Phelps turned 60, he made a point of 
going regularly to his  doctor. Now he goes twice a year, and he thinks it might 
have saved his life. “If I went for a physical last October and something kicks in 
November, and I wait until next October to see the doctor again, I could have had 
some serious issues here,” Phelps said. “Men need to stop being macho. Make 
yourself a priority and get yourself checked.”(Sherman, 2013) 
 
By emphasizing the expectation for patients to be fully accountable for their cancer 
diagnoses (both in the midst of cancer and during recovery), these excerpts highlight how 
the disease exists in popular discourses primarily within the realm of individual 
responsibility and morality. That is, patients are interrogated for what they have done 
wrong (e.g., eating nonorganic foods) and implored not to make more errors in the future 
(e.g., wait too long to get a physical), thus suggesting a commensurability between 




individual agentic efforts, while empowering in theory, is imbued with both blame and 
shame, and calls into question both the decision-making capabilities of patients and the 
righteousness of their diagnosis (i.e., whether it was “deserved” or not). Inherent to this 
representation of patients is the common practice of blaming the patient (Gulyn & 
Youssef, 2010). New to this practice, however, is the idea that the prescribed actions are 
as diffuse, vague, and ambiguous as the disease itself. Relatedly, while the perceived 
corruption on the part of the medical establishment/pharmaceutical industry—the other 
half of the two-sided coin of blame—may or may not be actually occurring in practice, 
scholars have noted that whenever patients are held responsible/blamed for their own 
condition, attention is deflected away from the role of structural and institutional factors 
and agents relevant to a given health condition (Crawford, 1980).  
 
Summary 
 Inquiry into the rhetorical construction of bladder cancer confirms but also gives a 
bit of shape to the overall invisibility of the disease on the U.S. public agenda. In 
discourses disseminated by health organization websites and mainstream news coverage, 
the disease is represented as mostly unknown and unknowable, though this is mobilized 
in different ways. Official discourse characterizes the disease as ambiguous insofar as it 
is duplicitous and mysterious, while common discourse articulates it as completely 
unintelligible. While these characterizations may seem interchangeable, they feature 
distinct differences: the official discourse lends some shape to bladder cancer, whereas 
the disease is incomprehensible in the common discourse, defying any delineation—even 
ambiguous. These differences in disease characterization have distinctive implications for 




medical teams underscores the ambiguity of bladder cancer, and patients are drawn as 
seekers of information about the disease. In the latter discourse, the absence of form, 
shape, or definition of the disease, the medical establishment/pharmaceutical industry and 
patient, respectively, are rendered suspect. This suggests a casting about for agency, a 
rhetorical move that aligns with the ideology of individualism that permeates the U.S. 
healthcare system’s approach to health and disease management (Crawford, 1980). By 
attempting to identify, locate, and/or remove responsibility for the disease, these 
discourses suggest that comprehension of the disease potentially resides in the 
articulation of action and accountability (i.e., what can be done about the disease and who 
is positioned to partake in these actions). Conspicuously absent from this levying of 
responsibility for bladder cancer are the structural/institutional agents that are 
traditionally associated and tasked with public health. This notable departure operates as 
a form of denial, suggesting that authoritative bodies take their cues from—rather than 
instruct—other definable agents (in this case, patients).
  
 CHAPTER IV 
 
 
SUSPICIOUS MINDS, SHAMED BODIES: MORALITIES AND  
RESPONSIBILITIES IN SKIN CANCER DISCOURSE 
 
 As one of the most common cancer types, and one of the most obvious, skin 
cancer is uniquely situated as figuratively and literally visible in the U.S. public 
imaginary (Jensen et al., 2014). This figurative visibility manifests in a variety of official 
initiatives to raise awareness about the disease and news coverage about both the disease 
and related issues (e.g., tanning bed legislation) such that the disease parallels breast 
cancer awareness and is the inverse of bladder cancer’s invisible nature, despite 
melanoma rates being commensurate with bladder cancer rates (National Cancer 
Institute, n.d.-a). Tensions inherent to the disease—for example, the disease is comprised 
of both banal types that occur with such great frequency that they are not counted by 
cancer registries (i.e., basal cell and squamous cell carcinomas) and one of the most 
deadly forms of cancer that can strike anywhere on or in the body (i.e., melanoma)—
render it an important site of inquiry to examine how medical organizations and news 
coverage, as official and common discourses, respectively, rhetorically construct the 
disease and ways for handling its prevalence and severity (Skin Cancer Statistics, 2015).  
 In this chapter, then, I analyze how a selection of national health campaigns and 




involved with its detection, prevention, and treatment. Specifically, this dual approach 
attends to how the ideas circulated in public health and awareness campaigns 
arepotentially taken up, mobilized, and negotiated in popular news discourse in order to 
illuminate if, where, and how these ideas featured in official and common sources 
converge and/or diverge. Exploring the potential differences and similarities between 
how prominent voices in public discourses about skin cancer construct the disease has 
implications for patient care, public understanding about the disease, and the construction 
of future campaigns. 
 
Official Discourses 
 Generally constructed to inform the public about—and potentially ameliorate the 
effects of—a worrying health condition or issue, public health campaigns instruct 
consumers in the processes of detection, prevention, and treatment. This centering of not 
just knowledge acquisition, but also behavior change—that is, what patients can do about 
the health condition/issue—is a particularly interesting area for rhetorical inquiry. How 
patients are constructed and instructed to change inevitably reflects, reinforces, 
challenges, and/or creates cultural perspectives about the disease, those affected by it, and 
the causes of and treatments for it. As such, official discourses about skin cancer have the 
potential to shape public understanding about the disease and those involved with it, 
including the medical establishment, regulatory agencies, and patients.   
 Similar to the multitude of initiatives employed to raise awareness about breast 
cancer, skin cancer is at the center of a variety of government and health organization 
campaigns. Those selected here for critical interrogation were included because of their 




Foundation features two self-detection awareness programs—#GetNaked (#GN) and 
Check Me Out! (CMO!)—that instruct consumers in the proper procedures for examining 
their own bodies for skin abnormalities. Second, The Skin Cancer Foundation advocates 
for the benefits and processes of abstaining from sun exposure for aesthetic purposes 
(e.g., tanning) via the Go With Your Own Glow (GWYOG) campaign. Finally, The 
National Council on Skin Cancer Prevention instructs in sun-safety measures, especially 
for families partaking in outdoor activities, via their annual Don’t Fry Day  
(DFD) program (which—not coincidentally—coincides with Memorial Day).  
 These campaigns and programs warrant study due to their authorial status, 
credibility, prevalence, and longevity. Reflecting a variety of perspectives on how to 
manage the disease, these discourses represent the official dictums for how to be sun safe 
and proactive in detection, resulting in a sample of programs endorsed by governmental 
agencies (e.g., Don’t Fry Day) and constructed by leading skin cancer authorities (e.g., 
#GetNaked). When analyzed together, these discourses portray the disease as one that is 
the specific responsibility of each individual patient insofar as patients are identified as 
appropriate diagnosticians of the condition, as well as held accountable for the use of 
preventative measures, or lack thereof. The “privatized” nature of managing the disease is 
further demonstrated in the ways in which patient responsibility is mobilized, mainly as 
matters of morality and authenticity. 
 
Privatized Skin Cancer 
 These campaigns construct skin cancer and processes for dealing with it through 
the valorization of patient agency in classically neoliberal fashion such that managing the 




accountability. By placing patients at the center of the skin cancer conundrum, these 
official discourses articulate individual agentic action as preferable—even superior—to 
medical intervention. Therefore, physicians and the medical establishment are positioned 
as resources, if relevant at all.  
 Patient as expert.  Central to the construction of skin cancer as privatized is the 
assumption that patients—rather than physicians—are superior detectors of abnormalities 
and experts on the body. Whereas doctors know skin cancer generally, patients know 
their own skin specifically, and thus are configured here as the authorities on what 
constitutes a threat to their optimal health. Since deviation from the norm is the crux of 
this threat, patients are presented as responsible for creating and understanding their own 
norm, distinct from that which may be dictated by any authority on skin cancer, as 
demonstrated by the following excerpts:   
#GetNaked and check your skin for new or changing spots. You know what your 
 “normal” is. (Melanoma Research Foundation, 2017a)  
 
Pay attention to your skin and know what is normal for YOU. Bring any mole or 
lesion that is new or changing to the attention of your dermatologist right away. 
(Understand Melanoma, 2014) 
 
 Most melanomas are spotted by patients so know your skin well. [original bold] 
 (Melanoma Research Foundation, 2013a) 
 
As these examples suggest, patients must obviously be the experts on their own bodies 
due to the variation of what constitutes “normal.” Because the imperative to know one’s 
own “normal” can be a life-or-death situation, the imperative to know one’s self—rather 
than specific medical advice—is of utmost importance. Related to this presumption of 
patient expertise is the labor that is expected to go into achieving this level of self-




extensive labor on the part of patients, and the routinized tasks required to monitor and 
maintain this norm are naturalized and rendered necessarily distinct from medical 
involvement or intervention, thus further undergirding the notion of patients as superior 
to the medical establishment. For example, the following excerpts emphasize the 
expectation for regular monitoring of the body: 
Since you are more likely than your doctor to notice a funny-looking spot or a 
change in your skin, #GetNaked and make monthly skin checks part of your 
routine. [original bold] (Melanoma Research Foundation, 2017c) 
 
Research shows that patients, not doctors, are most likely to spot melanoma. The 
Melanoma Research Foundation encourages you to thoroughly check your skin 
each month for moles that are new, changing or different than other spots on your 
body.(Melanoma Research Foundation, 2013b) 
 
The best way to detect skin cancer early is to examine your skin regularly and 
recognize changes in moles and skin growths. (National Council on Skin Cancer 
Prevention, 2016a) 
 
By highlighting the individual effort that must be taken by patients to identify threats to 
the body, these excerpts reaffirm the superiority of patient expertise over physician 
knowledge, as well as suggest that patients must be continuously suspicious of their 
bodies and any changes that potentially occur. The labor necessitated by knowing one’s 
own skin confers a sense of medical authority on patients such that they employ expertise 
in deciding if, when, and why physicians must be contacted.  
 Also occurring within this construction of patient superiority is the articulation of 
physicians as supplementary—rather than primary—to skin care and monitoring. By 
privileging the individual agentic efforts required and expected of patients, these 
campaigns position the medical establishment as secondary to the patient’s first line of 
defense against skin cancer and thus expect patients to shoulder the responsibility for skin 




physicians. For example, the following excerpts allude to medical intervention insofar as 
it occurs only after patients have labored over their health and utilized their expertise to 
determine the presence of abnormalities: 
Increase your chances of catching melanoma early by carefully examining your 
skin once a month and visiting a dermatologist once a year. (Melanoma Research 
Foundation, 2017b) 
 
Routinely examine your whole body for changes in your skin and report concerns 
to a parent or healthcare provider. (National Council on Skin Cancer Prevention, 
2016b) 
 
#GetNaked is the MRF’s early detection campaign designed to raise awareness 
about melanoma and the importance of being proactive—instead of reactive—
about your health. (Melanoma Research Foundation, 2013b) 
 
#Dermatologists agree sun protection is best method of preventing premature 
aging, #skincancer http://ow.ly/102Br0 #DontFryDay. (National Council on Skin 
Cancer Prevention, 2016) 
 
Whereas several of the previous examples have largely obscured the role of the medical 
establishment in the processes of skin cancer detection, these excerpts identify physicians 
as being necessary only when deemed appropriate by patients, thus reinforcing the notion 
that patients have the proficiency to both identify causes for concern and the ideal time to 
request provider assistance. As such, these campaigns indicate that the medical 
establishment—though necessary in isolated moments in a patient’s life—is generally 
supplemental to patient expertise. In this way, patient action and prevention are the only 
viable solutions to the threat of skin cancer, and thus patients are presented as being in 
control of their lives and health while simultaneously selecting moments for 
supplemental physician intervention. That is, by explicitly referring to and implicitly 
referencing the physician-approval granted to preventative measures, these excerpts 




cancer and primarily supplemental in nature.  
 
Virtues of Patient Responsibility  
 In keeping with the construction of skin cancer as privatized and positioned in the 
personal sphere, patient responsibility for the prevention and detection of skin cancer is 
rhetorically mobilized in these discourses as matters of morality and authenticity. That is, 
partaking in/failing to adhere to sun safe practices are constructed as issues central to 
one’s character and demonstration of genuine concern for self and others. As such, the 
threats posed by skin cancer extend beyond one’s health to include one’s character.   
 A matter of morality.  The articulation of personal responsibility as a moral issue 
tethers one’s character to one’s decision-making processes regarding sun-safety 
measures. This attention to acting in an ethical manner centers largely on the actions 
taken in regard to caring for children, thus further adding to the responsibility imbued in 
the individual actions of consumers. For example, the following excerpts from the Don’t 
Fry Day campaign emphasize the ethical imperatives in both maintaining proper sun 
safety measures and applying/modeling those same measures to and for one’s offspring: 
In the same way we teach kids to wear bike helmets, we can also teach them to 
wear wide-brimmed hats. (Melanoma Research Foundation, 2016) 
 
You wouldn’t let your child do this [a picture of a child smoking]…so why would 
you let them do this. [a picture of a sunburned child in a swimming pool] (Don’t 
Fry Day, 2016a) 
 
1 in 5 children will grow up to get skin cancer. Don’t let your child be the ONE. 
[original caps] (Don’t Fry Day, 2016b) 
 
As these excerpts suggest, the failure of parents to exercise good judgment about sun  
safety is tantamount to negligence at best and abuse at worst. By equating good parenting 




responsibility with skin cancer prevention such that being a good person means being a 
good steward of one’s skin and subsequently instilling the same sun-safe values in the 
next generation.  
 Relatedly, the practices of skin cancer detection and prevention are rhetorically 
mobilized here as an obligation that people must take responsibility for out of love for the 
self and others. Similar to the notion of sun damage hiding one’s true beauty and health, 
the following excerpts elaborate on this idea to conclude that unsafe sun habits are a form 
of self-abuse and negligence as a loved one. For example, the following excerpts 
highlight the importance of sun safe practices for the self and others:  
As many patients and survivors have recounted, their melanoma was found by a 
friend or partner who happened to notice something different – and urged them to 
see a dermatologist. (Understand Melanoma, 2014) 
 
Catching melanoma early could save a life. Be an MVP. Check out the ones you 
love. (Cure Melanoma, 2011) 
 
 Friends don’t let friends get skin cancer. Don’t tan. Don’t burn. This May 27,  
#DontFryDay http://ow.ly/102Br0. (National Council on Skin Cancer Prevention, 
2016c) 
 
Whereas previous attention has been paid to the moral imperative of sun safety, these 
discourses articulate the relational imperative of maintaining one’s health such that 
protecting the skin protects one’s life and loved ones. Alluding again to the idea of unsafe 
sun habits equating with abuse, these excerpts undergird the notion that a person must 
engage in active prevention and detection so as to maintain health and the well-being of 
friends and family.  
 Another articulation of morality similarly invokes the importance of scrupulous 
decision making such that safe sun and tanning habits are presented as the mea culpa for 




one’s ways, but also modifying harmful behaviors, these discourses tether personal 
responsibility to educated decision making. For example, the Go With Your Own Glow 
campaign highlights the importance of managing one’s past mistakes:  
“I didn't think it could happen to me,” she said. “I had read about skin cancer. I 
heard about the risks of tanning in sunbeds, but I thought it was sort of a myth.” 
Luckily, the melanoma had not spread, and today, Donnar uses sunscreen, wears 
protective clothes, and avoids UV tanning. (Skin Cancer Foundation, 2016d) 
 
Karissa Martin, Miss Ohio 2008, was 14 when she had a precancerous mole 
removed – possibly the result of a serious sunburn on her scalp a decade before. 
Martin speaks  regularly at schools about the dangers of the sun, and appears on 
behalf of the American Cancer Society at events throughout Ohio. (Skin Cancer 
Foundation, 2016b) 
 
In these cases, the proverbial “seeing the light” is triggered by faulty judgment on the part 
of the cancer victim—either indoor tanning or unsafe sun habits—such that modifying 
behavior is positioned as a necessary reparation for these mistakes. By detailing the 
extent of compensating behaviors undertaken by the cancer victims, these excerpts 
feature of a conversion motif—reliant upon witnessing and testimony to convince the 
“unsaved” to convert—that mobilizes morality as an antidote to the potential for the 
cancer comeuppance brought on by poor decision making and thus further entrench 
morality in skin cancer discourse.  
 A matter of authenticity.  Attendant to the threats to one’s moral character is the 
construction of skin safe practices as being the mark of an authentic person, or one who is 
self-actualized and comfortable in one’s own skin. With much emphasis placed on 
tanning and the social cachet culturally ascribed to tanned skin, these discourses construct 
vanity as a threat to authenticity and position vanity as a central cause of skin cancer. In 
this way, then, embracing one’s natural—authentic—skin hue is a solution to unsafe skin 




from self-avowedly antitanning campaigns, Go With Your Own Glow and Don’t Fry 
Day, emphasize the link between covering one’s skin and maintaining one’s beauty: 
When you’re out in the sun be sure to protect your skin. Shade, sunscreen, and a 
cover-up can go a long way to helping your natural beauty shine through. (Skin 
Cancer Foundation, 2016c) 
 
Let your inner glow, glow. Get out of the sun. Grab some shade. There’s nothing 
sexier than healthy skin. (Skin Cancer Foundation, 2016c) 
 
Burning and blistering your skin is like smoking packs of cigarettes or excessive 
boozing. It's negative and gnarly and self-destructive. You must love yourself, 
which includes loving your epidermis. [original italics] (Doonan, 2009) 
 
The natural color of your skin is beautiful. Keep it that way #protectyourskin 
every day http://ow.ly/102Br0 #dontfryday. (National Council on Skin Cancer 
Prevention, 2016c) 
 
 There is nothing pretty about #skincancer. #protectyourskin every day  
http://ow.ly/102Br0 #dontfryday. (National Council on Skin Cancer Prevention, 
2016c) 
 
Love your skin: give it a good cover-up on #DontFryDay & every day. 
http://ow.ly/102Br0 #protectyourskin. (National Council on Skin Cancer 
Prevention, 2016b) 
 
By suggesting that unsafe sun habits not only endanger one’s true self, but ultimately 
hide one’s authentic self behind damaged and diseased skin, these discourses render 
tanning and other questionable practices as hindrances to being a genuine, confident 
person. In this way, tanned skin is rhetorically constructed as a mask that conceals and 
threatens one’s subjectivity such that self-worth is—not surprisingly—tethered to 
aesthetics and appearance. Relatedly, the importance of one’s authenticity as a person is 
underscored by the holistic—not just aesthetic—benefits that abstaining from tanning 
yields. That is, people who embrace their natural hue are constructed as inherently 
vibrant and freed from the shackles of vanity, and thus poised to lead authentic and 





According to makeup artist Dick Page, who created the look at designer Michael 
Kors’s  show [that of pale runway models], the look “is less about bronze this 
time, more about energy.” (Skin Cancer Foundation, 2016a) 
 
 Tanning as a life priority is over. (Skin Cancer Foundation, 2008) 
 
Finally, to put it simply, what hurts your health hurts your looks. Smoking, 
pollution sleep deprivation, poor nutrition, unprotected sun exposure, and high 
stress all put your appearance at risk. They take a toll on the way you look and 
feel. So, take care of your health and spirit, every day, because healthy skin is a 
beautiful thing. (Skin Cancer  Foundation, 2016d) 
 
While the previous examples emphasized physical appearance, these excerpts suggest 
that skin safe practices are part of a holistic approach to healthy, successful, and authentic 
living.  As the first excerpt indicates, a model’s pale complexion is rendered vibrant by 
focusing more on (seemingly internal) energy and charisma rather than an artificial glow. 
Since energy is constructed here as diametrically opposed to a bronzed appearance, 
natural vibrancy is also understood as being hindered by tans, both fake and real. 
Similarly, prioritizing healthy life choices is constructed as a natural path to healthy skin 
in the latter two excerpts such that authenticity arises from preferable alternatives to 
tanning and overall actions understood to be healthful (e.g., not smoking). Therefore, 
authenticity not only comes from the decision not to tan, but also from the decision to 
engage in alternate self-honoring behaviors.  
 
Common Discourses  
 The proliferation of skin cancer information from authoritative voices—via 
official discourses like public health campaigns—is concurrent with popular discourses 
about the disease in mainstream news coverage. These popular discourses can be 




engage resonant cultural sensibilities that shape how audiences understand and respond to 
skin cancers. Popular press news articles about skin cancer—specifically those in The 
New York Times, USA Today, Time, People, Health, and Men’s Health—align with and 
underscore the privatized sensibilities of individual responsibility apparent in the official 
discourses, albeit in slightly different ways. The prevalence of privatization is mobilized 
here via suspicion of regulatory bodies; consumer shaming; and vanity, deployed in 
paradoxical ways. 
 
Suspicion of Regulatory Bodies 
 In official discourses about skin cancer, patients and physicians are articulated as 
complementary agents, if patients are vested with greater authority. Seemingly 
uncontested by the medical establishment, this relationship relies on patients both to 
know their own bodies and recognize the necessary time to request medical intervention. 
Conversely, common discourses construct an adversarial relationship that is grounded in 
a suspicion of physicians specifically and regulatory bodies generally. Undergirded by 
emphases on conflicts of interest, overcharging, and overtreatment, this suspicion throws 
into doubt the need for medical intervention at all, and positions patients as being 
potential victims of the whims and devices of authorities.  
 Prevalent in these discourses is a general sense of distrust directed at those 
regulatory authorities that dictate how one should prevent and treat skin cancer: namely, 
the medical establishment and private industry. While the roles of these experts and 
authorities are mostly obscured regarding involvement with patients (and their journeys 
with skin cancer), they are frequently implicated as involved in financial gain (often at 




prevention, detection, and treatment—is rendered suspect by frequent references to the 
questionable intentions and actions of physicians. That is, physicians are portrayed, first, 
as being particularly susceptible to mercurial changes in diagnostic and treatment 
procedures such that new technologies are adopted with little or no obvious advantages to 
patients; and second, as prioritizing profits over outcomes. Additionally, allusions to 
corporate corruption likewise challenge the veracity of claims about optimal sunscreen 
use such that one of the first lines of defense for patients—that is, sunscreen—is rendered 
suspect. For example, the following excerpts allude to the questionable behaviors of 
physicians: 
For decades, dermatologists have used their eyes, along with a magnifier called a 
dermatoscope, to try to distinguish abnormal but benign lesions from potential 
melanoma in order to avoid unneeded biopsies. Some dermatologists argue that 
these low-tech tools are still the most useful and worry that their colleagues are 
falling for expensive, cool-looking gadgets that may simply offer extraneous, and 
perhaps incorrect, data. “This technology should still be considered to be in the 
developmental stage,” said Dr. Roberta Lucas […]. “We are better off when the 
system supports doctors who are thorough and unhurried; who examine and listen 
carefully and who empower patients to practice good surveillance and sun 
protection.” (Singer, 2013) 
“It helps me see what I cannot see with my eye,” Dr. Day said [regarding new 
technology for finding melanoma]. “I have great comfort that I am not missing a 
melanoma.” (Dr. Day has been a paid device investigator and speaker for Mela 
Sciences; she appears in promotional videos on the MelaFind Web site). (Singer, 
2013) 
And even within the same Boston-area market, the price of removing a common 
type of skin cancer can vary by hundreds of dollars depending on the hospital. 
(Ungar & O’Donnell, 2015) 
While it [Mohs surgery, a new type of skin cancer treat] offers clear advantages in 
certain cases, it is more expensive than simply cutting or freezing off a lesion.  
[…] Use of the surgery has skyrocketed in the United States – over 400 percent in 
a little over a decade – to the point that last summer Medicare put it at the top of 
its “potentially misvalued” list of overused or overpriced procedures. Even the 
American Academy of Dermatology agrees that the surgery is sometimes used 




As these excerpts suggest, the pricing for services rendered and the use of some 
technologies and procedures over others are largely depicted as unjustified by the medical 
community and even questioned by the federal government and other regulatory bodies. 
As such, physicians—although occasionally portrayed as victims of the system in ways 
similar to patients—are represented as advocating for (and participating in) collusion, 
often at the expense of optimal care for patients. This questioning of physicians’ integrity 
tarnishes the benevolent reputation traditionally attributed to them and foments suspicion 
of the medical establishment in general. Relatedly, in addition to being portrayed as 
easily influenced by financial gain and technological advancements, the medical 
establishment is also tethered to Wall Street in these discourses such that scientific 
innovation is imbricated with profit margins: 
But the treatments will not be inexpensive. Merck said Thursday that the drug, 
known  generically as pembrolizumab, would cost about $12,500 a month, or 
about $150,000 a year. […] Some Wall Street analysts have said that collectively 
cancer immunotherapy drugs could achieve annual sales of tens of billions of 
dollars. (Pollack, 2014b) 
Investors and Wall Street analysts began poring over the abstracts late on 
Wednesday, looking for information that could affect the stocks of 
pharmaceutical companies.  (Pollack, 2015) 
Together, the drugs slowed or temporarily stopped tumor progression in 60 
percent of patients, versus 11 percent of those who received only Yervoy, in a 
pivotal study of 140 previously untreated patients with melanoma, the deadliest 
type of skin cancer. But with  a wholesale price of $141,000 to $256,000, even 
insured patients may not be able to afford their portion of the bill. Bristol-Myers 
shares rose 86 cents to close at $60.03. (Associated Press, 2015) 
The consistent inclusion of stock and pharmaceutical prices in discussions about cancer 
treatment advancements suggests that the medical establishment is in tune with the 
financial needs and considerations of investors rather than patients. With profits 




establishment and scientific innovation as being susceptible to and governed by the 
demands of shareholders.  
 Skin cancer prevention is also an arena in which corruption and self-interest on 
the part of medicine and science are intimated. These excerpts suggest that financial gain 
is usually central to awareness-raising and information dissemination such that examples 
to the contrary must be noted: 
Take endorsements and seals of approval with a grain of salt. The Skin Cancer 
Foundation gives a “seal of recommendation” to sunscreens, but only if their 
manufacturer has donated $10,000 to become a member of the organization. 
(Rabin, 2013) 
The sunscreen study was paid for by the National Health and Medical Research 
Council of Australia. No sunscreen makers contributed. (Kolata, 2013) 
Dr. Wang, who is a spokesman for the Skin Cancer Foundation, which gets 
funding from sunscreen manufacturers, tells his patients to apply sunscreen as if 
they were adding a second coat of paint to a house. (Saint Louis, 2014) 
 
These characterizations cast further doubt on those authorities that dictate how best to 
avoid sun damage (and subsequently cancer). As alluded to here, the relationship between 
expert advice and directives for sun safety is articulated as grounded in financial 
considerations, resulting in a representation of authority figures as willfully participating 
in corporate corruption and deliberately hoodwinking consumers and patients.  
 
Consumer Shaming 
 In both official and common discourses about skin cancer, patient character is 
located as the impetus for responsibility, although in the former, character is tethered to 
morality, and in the latter, character is relative to intelligence and common sense. 
Significantly, these discourses diverge in their construction of at-fault parties: official 




sources more directly characterize the reader/audience as suspect: they anticipate 
irresponsibility on the part of the audience. This distinction also appears to be related to a 
conceptualization of the audience as consumers in the common discourses, as opposed to 
patients in the official discourses. Consumers, then, are the targets of shaming for their 
decisions and skepticism about their intelligence (a fate not shared by the patient 
articulated in these discourses). Additionally, official discourses intimate collusion 
between authorities and the patient, but the common constructs a contentious relationship 
between experts and the audience that is based in suspicion (as noted above) and vexation 
(i.e., authorities assume patients are going to make poor decisions).   
 By representing consumers as necessarily at fault for their potential or actual 
diagnoses, these discourses center understanding about the disease within the (flawed) 
actions of people and suggest that they must take actions to redress the harmful behaviors 
that led to their skin damage or cancer diagnoses. The motif of consumer shaming, then, 
hinges largely on the relationship between poor decision-making and individual 
responsibility. The first articulation of shaming discussed here is mobilized through an 
emphasis on consumer ignorance or defiance of sunscreen directions, thus positioning 
consumers as lacking the necessary intelligence and/or rationality to be sun safe. For 
example, the following excerpts identify the lack of knowledge as the central issue in 
skin cancer prevention via sunscreen and other related precautions: 
By law, sunscreens can no longer claim to be sweatproof or waterproof – the truth 
is, you do sweat them off. And don't rush the spritz process. Yes, it's supposed to 
be quick, but you still need to be thorough. (Whitmore, 2014) 
Wear your sunscreen, seek the shade, wear protective clothing and never, ever go 
to a tanning salon. Despite decades of repetition, many of us fail to follow that 
skin-saving advice – and a new study shows that's true even for people who have 




Will the new labels help consumers better protect their skin from damage? They 
will, skin health experts say – if consumers take the time to read the fine print and 
then choose and use the products wisely. (Painter, 2013b) 
Some experts blame inappropriate use of sunscreen, saying that people do not 
apply enough lotion (a golfball-size dollop) or do not reapply it every two hours 
as instructed. […] It’s not clear that sunscreens with higher SPFs actually are 
more effective, and consumers may not apply them as frequently. (Rabin, 2013) 
The main reason to reapply a broad-spectrum sunscreen every two hours isn’t that 
it breaks down; most of today’s sunscreens are stable in sunlight. Rather, 
reapplication is crucial because most people don’t apply enough sunscreen in the 
first place. (Saint Louis, 2014) 
As these examples suggest, consumers (and patients, to a lesser extent)—even those 
trying to be sun safe—fail to follow or attend to instructions for the proper application of 
sunscreen and other safety measures, and as such authoritative bodies are positioned as 
having to (re)educate and/or account for the poor decisions of the masses. In this way, 
consumers are held accountable for every iteration of unsafe sun behaviors—for example, 
failing to apply sunscreen correctly, requiring frequent reapplication of sunscreen 
because of initial failure, and reading/following directions—that lead to sun damage, and 
thus they are positioned as both the problem and the solution, responsible for the damage 
but also expected to make material changes in their lives to prevent skin cancer (a 
marginally optimistic outlook that does not feature elsewhere in these discourses).  
 Consumers are similarly shamed for potentially not exhibiting common sense, a 
sentiment that here seems equated with compliance with those known behaviors that 
experts encourage—and often assume—from patients and consumers. The failure to 
follow directions or partake in sun-safe measures is utilized here as a foundation to 
assume that consumers have ostensibly learned their lesson and are ready/able to act in 




examples apprehend consumers as cognizant of their past failures and/or as ready to 
make amends for them: 
If you have used tanning beds in the past (you're not doing it anymore, right?), 
experts advise that you tell your dermatologist to include that information in your 
skin cancer history. (Gwinn & Mazziotta, 2015) 
You won't read “wear broad-spectrum spf 30 daily!” here, because by now, 
you know you should. [original bold] (Whitmore, 2014) 
“Sun protection is a total package” and includes shade, broad-brimmed hats and 
“common sense,” says Henry Lim, chief of dermatology at Henry Ford Hospital 
in Detroit.  (Painter, 2013b) 
“Too many people think that sunscreen is just to protect them from a sunburn,” 
says Brooke Jackson, MD. “They wear it at the beach but not every day.” Truth 
is, your skin is vulnerable all year round. (Gwinn & Mazziotta, 2015) 
By highlighting language that assumes consumer knowledge of (and even compliance 
with) proper sun and tanning safety measures, these discourses take on a paternalistic 
view of people insofar as they must be cajoled into behaving correctly, or verbally 
reprimanded if compliance is not attained. Unlike the previous examples—which assume 
an incompetent consumer/patient—these excerpts apprehend a consumer who can take 
direction but still ultimately comes up short, and ultimately needs guidance and 
prompting from authoritative figures.  
 Paired with this emphasis on consumer failure is an expectation for individual 
agentic action to prevent and/or combat the dangers of sun exposure and skin cancer. 
This mobilization of shaming, while contradictory with the initial portrayal of consumers 
(and some patients) as incompetent, is rendered coherent in light of these discourse’s 
emphasis on paternalism. That is, because some people are considered malleable and able 
to take direction, these discourses position consumers as able to take action as long as 




The report does not tell us all to live in caves. “Enjoy the great outdoors,” 
Lushniak says, “but take steps to protect your skin.” (Painter, 2014) 
 
People who diligently use sunscreen every day can slow or even prevent for a 
time the development of wrinkles and sagging skin, a new study found. (Kolata, 
2013) 
If you get color, you are going to damage your skin on some level. In the old 
days, sometimes they’d ask me [actor Hugh Jackman] to get tan for a role, but 
now I spray-tan if I need it. (People, 2015) 
Ask your partner to examine the skin on your back. “I don’t recommend checking 
more frequently than monthly, because you’re less likely to notice changes when 
you look at something every day,” Dr. Perlis says. […] Take photos of moles, 
spots, or patches, and  then compare them to what you see next month. (Fowler, 
2014) 
 
Because we look at our skin in the mirror every day, we are the first line of 
defense against this disease. […] So it’s crucial to regularly look at your own 
skin, and to speak up if you spot something suspicious on someone else’s. (Gwinn 
& Mazziotta, 2015) 
 
Not limited to  just proper sunscreen application measures but also inclusive of self-
examinations, early detection, and prevention of skin damage, these discourses indicate 
that individual agency and actions—while possible—are delimited by expert opinion, 
though curiously absent of any authoritative oversight. This absence—though somewhat 
amended via pleas to report any suspicious abnormalities to dermatologists—further 
undergirds the privatized nature of skin cancer insofar as consumers are expected to act 
simultaneously within the guidelines established by authorities, yet mostly outside of the 
control and assistance of these regulatory bodies. In addition to this, said bodies are not 
flatteringly depicted in this discourse in any case, resulting in a portrayal of apathetic and 
controlling authorities.  
 Similarly, these discourses address those messages that may dissuade people from 




Seemingly in anticipation of consumers—yet again—failing to act appropriately and—
yet again—needing supervision and direction, the following excerpts clarify studies that, 
respectively, suggest that skin protection is primarily necessary earlier in life, and that 
skin cancer is often the result of genetic chance rather than poor safety habits (two 
findings that could, arguably, confuse a person into thinking sun safe measures are not 
needed): 
“This doesn’t mean that you’re off the hook if you’re careful early in life,” Dr. 
Qureshi added, since too much sun exposure at any age is linked to an increased 
risk of other forms of skin cancer. (O’Connor, 2014) 
The element of chance does not, however, mean you should stop wearing 
sunscreen or take up smoking. “My biggest fear is that people will do nothing. 
The opposite is true,”  says Tomasetti, who stresses that while we may not be able 
to prevent all tumors, we can  focus on early detection and taking advantage of 
lifesaving treatments like chemotherapy and radiation, among other things. “We 
need to do everything we did before, but we want to do it even more than before.” 
(Park, 2015) 
As these excerpts suggest—and align with previous articulations of the consumer—
authorities turn a wary eye to consumers such that poor decision-making is assumed to be 
their default mode. Whereas consumers are occasionally assumed to be agentic in their 
health decisions in these discourses generally, these examples specifically underscore the 
general misgivings about the population’s competence as a whole. As such, concerns 
about noncompliance with recommended behaviors situate consumers as being 
continually in need of prodding to make good decisions.  
 
Double-Edged Vanity 
 References to vanity and its association with skin appearance and modification 
permeate official and common discourses, with both emphasizing how vain behaviors—




cancer. Abstention from these behaviors, however, takes different tacks in these 
discourses such that official dictums encourage the abandonment of this type of vanity so 
as not to hinder one’s authentic self (including natural skin hue), while common voices 
suggest that bolstering people’s sense of vanity will enhance compliance with sun safe 
behaviors. In this way, the common constructs vanity as a pharmakon, both the cause of 
skin cancer and the most compelling impetus for skin cancer prevention. The former 
articulation of vanity centers on the reasons for unsafe sun/tanning measures such that 
skin cancer victims are understood as wanting to maintain a certain lifestyle or aesthetic, 
particularly those visual signifiers associated with being outdoors and living an active life 
(e.g., have a tanned appearance from vacationing and/or outdoor activities). For example,  
 I used to think if I didn’t come back with a little bit of color, it’s not a real 
 holiday. (People, 2015) 
But she adds that she has interviewed melanoma survivors who have let down 
their guard. “Survivors have told me that it is very important for them to maintain 
a normal outdoor lifestyle.” You can do that but “be smart about it,” says Ali 
Hendi, a dermatologist in Chevy Chase, Md. (Painter, 2013a) 
There's no way to square skin-cancer statistics in the United States – more than 
3.5 million cases diagnosed yearly and almost 10,000 deaths – with the number of 
Americans showing off their tans. They aren’t all getting body paint. They’ve 
been lectured about sunscreen and shade and hats. But vanity trumps sanity, and 
melanoma rides its coattails. (Bruni, 2014) 
Some experts say combating the problem is a matter of raising awareness about 
the dangers of tanning. But many women said in interviews that they were aware 
of health risks but cared more about how they looked now. (Tavernise, 2015) 
Madison, 21, a student at the University of Rhode Island, said tanning made her 
feel “more confident and more comfortable when I walk around.” “Sometimes it 
makes me feel thinner,” she continued. “It has all these weird effects that just 
make me feel better about myself.” (Tavernise, 2015) 
In these cases, the emphasis on vanity as a danger to one’s health results in a tension over 




highly problematic and evidence of insecurity, whereas accepting oneself is the 
optimal—and intelligent—choice. Moreover, embracing one’s natural appearance is 
presented as the disposition and choice of an emotionally healthy person. Thus, partaking 
in “bad vanity,” or that which results in altering one’s natural appearance, is challenged 
as both physically and emotionally unsound.  
 Concomitant with this articulation of vanity as a source of cancer is the 
mobilization of vanity as a potential solution, or at least a primary prevention tactic. 
Identifying the seemingly futile nature of appealing to the rational sensibilities of 
consumers, these discourses construct logical decision-making and pleas thereto as a 
strategy that must be made to reflect and align with the vain desires and choices of 
consumers. In this way, reasoning with the public is portrayed as a lost cause and thus 
vanity must be utilized in order to gain the attention of—and hopefully compliance 
from—the public. For example, the following excerpts highlight vanity as the common 
language, so to speak, shared by consumers and authorities:   
“Maybe sheer vanity will encourage young people to be proactive and use their 
sunscreen, because the cancer fear doesn't seem to be getting through to them,” 
says Deborah Sarnoff, a dermatologist in New York City and a senior vice 
president at the Skin Cancer Foundation, a non-profit group that receives funding 
from sunscreen makers. (Painter, 2013c) 
 
I'm heartened to see the idea that to be sexy and beautiful you have to be tan is 
gone. People like Nicole Kidman have done a great job. She was made fun of 
when she was a kid in Australia because she stayed in the shade. No one is 
making fun of her now. (People, 2015)  
  
Much like the articulation of vanity as unreasonable suggests that consumers must be 
implicated as responsible for their fates, these excerpts suggest that consumers will 
ultimately be responsible for their health via attention to trends and appearance-saving 




damage aids in a person remaining attractive longer than a person who is reckless about 
sun damage. Appealing to cultural notions of antiaging sentiments that permeate U.S. 
popular and lived culture, these discourses align with the idea that consumers (and 
subsequently patients) must be prodded into acting appropriately. Thus, consumers—
much like patients—are constructed here as requiring oversight and coaxing to make 
optimal choices for their health.  
 In this discourse, sun-safe clothing represents an industry response to this deferral 
of vanity. Positioning this industry as that which will ultimately keep people out of 
harm’s way (rather than superfluous and vain), these discourses identify the fear of aging 
as both an additional threat to and type of vanity, thus rationalizing the need for this 
interest in sun-safe clothing. Speaking specifically to the assumption that sun-safe 
outerwear is not attractive, the following examples rely on the presumption that 
appearance takes primacy over health, and therefore new developments in outerwear 
allow consumers to be both vain and healthy, as well as beat the aging effects from early 
life sun damage: 
But there’s a way to rationalize these prices [for rash guard surf-gear that doubles 
as sun protection]: just take into account how much a small tube of good 
sunscreen costs and multiply by the number of days between Memorial Day and 
Labor Day. (Zissu, 2013) 
Say “sun-protective clothing,” and the imagination drifts to outfits that look like 
hazmat suits, safari attire or possibly a burqa. But in the last few years, sun-
shielding apparel has become more flattering and fashionable, reshaping the 
market and potentially improving public health. “For a long time, I felt there was 
a need for this,” said Alexandra Kotur, the alabaster-skinned creative director at 
Town & Country […] “I burn easily and had been dressing like a crazy person on 
the beach.” […] “There was just no clothing out there that was protective and 
pretty.” While cancer is a concern of many of her customers, she said, vanity is 
what's really driving sales, particularly among women in their 20s and 30s. “Once 
they start to see signs of aging – the wrinkling and spots – they really want to 




In addition to highlighting the temporality of sun safety, these excerpts appeal to the 
importance of acting sensibly in the face of guaranteed skin damage if spending 
prolonged time in the sun. By emphasizing both the ways in which sun-safe clothing 
compensate for other safety precautions (i.e., purchasing sunscreen) and the ways that 
sun-safe clothing have traditionally be constructed (i.e., as unattractive), these excerpts 
align vanity with commonsense decision-making such that consumers are positioned as 
unreasonable for not participating in these types of vanity. Furthermore, insecurity is only 
associated with early age vanity, suggesting that younger consumers are both targeted 
with sun safety discourses and appeals to the deferral of vanity. As such, consumerism—
via vanity—is sanctioned as a necessary step in accomplishing one’s sun safety 
precautions and forestalling the negative effects of sun exposure, a rhetorical move that 
underscores both the temporal and competitive notions that reside at the intersection of 
health and vanity in skin cancer discourses. Finally, this general approach to consumers 
constitutes a “fight fire with fire” approach which mobilizes the very disdain that 
underwrites the general apprehension of consumers throughout these common discourses.  
 
Summary 
 Inquiry into the rhetorical construction of skin cancer in competing U.S. 
discourses is necessary for identifying fissures and intersections in how the disease is 
discussed, negotiated, and understood across contexts. These official and common 
discourses highlight tensions over the roles of the medical establishment and patient 
agency in the fight against the disease. Whereas public health campaigns emphasize the 
importance of individual agentic efforts in prevention and diagnostic procedures—often 




physicians as adversarial toward patients and their optimal health, thus undermining the 
medical establishment’s credibility and integrity. Appealing to patient’s individuality, 
official discourses apprehend patients as experts on their own bodies and construct the 
maintenance of the natural or authentic body as a moral imperative. Conversely, 
consumers are identified and shamed for their failings to practice sun safety amidst a 
surge of interest in sun-safe clothing. Significantly, common discourses about skin cancer 
are unique—relative to those about breast and bladder cancers—in their distinction 
between consumers and patients, with the former being held responsible for their skin 
damage and increased potential for cancer diagnoses and the latter granted clemency in 
the face of suffering at the hands of a corrupt medical establishment. In this way, patients 






PROGNOSIS: CONTRIBUTIONS AND IMPLICATIONS OF  
DISCURSIVE CANCER PRACTICES 
 
 Despite decades of awareness, research, and even a federal war against it, cancer 
is projected to be the leading cause of death in the United States by the year 2020 (if 
present conditions and trends remain stable) (Weir et al., 2016). This imminent increase 
in prevalence indicates the continued importance of attending to how cancer is covered 
and constructed in public health campaigns and mainstream news coverage, both official 
and common, especially since the latter frequently shapes public perceptions about the 
disease (Jensen et al., 2010, 2014) and the former educates populations about the disease 
(Campaigns, 2016). As such, rhetorical inquiry into respective discourses about these 
prevalent cancers is warranted to reveal how ideas about detection, prevention, and 
treatment circulate in the public imaginary. Attending to the nuances of these discourses 
is useful for potentially assisting health care providers in utilizing emergent 
understandings of optimal engagement, treatment, and care of cancer patients. In the 
preceding chapters, I attended to these discourses as relevant respectively to breast, 
bladder, and skin cancer to assess how official and common discourses in each case 
diverged and converged in meaningful ways. My analysis surfaced three primary 
rhetorical motifs that characterize not only cancer itself, but also patients and the medical 




then engage the emergent motifs that cut across all of them.  
 
Breast Cancer 
 In this chapter, I analyzed how public health campaigns funded by the Centers for 
Disease Control and the National Breast Cancer Foundation rhetorically constructed the 
disease and the respective roles of patients, physicians, and support teams in treatment 
processes, resulting in the centering of patients as responsible and accountable parties 
who are implicitly bolstered by the obscured medical establishment. In order to determine 
if/how these same ideas were drawn into common discourses circulating across the 
country, I analyzed 3 years’ worth of mainstream news coverage, including The New 
York Times, USA Today, Time, and People. Contrasting with the official discourses about 
the disease, these articles centered the medical establishment as a harmful and corrupt 
apparatus that operates as a threat to the well-being and futures of patients.  
 
Bladder Cancer 
 In this chapter, I analyzed how online health resources about bladder cancer from 
the American Cancer Society, Bladder Cancer Advocacy Network, and American 
Bladder Cancer Society rhetorically constructed the disease as inherently unknown and 
unknowable such that both patients and individual physicians are rendered essentially 
powerless when faced with it. Additionally, I analyzed 3 years’ worth of mainstream 
news coverage, including The New York Times, USA Today and USA Today Magazine, 
Los Angeles Time, Wall Street Journal, Huffington Post, Rolling Stone, Chicago Tribune, 
The Washington Post, and Boston Globe, in order to determine if and how these same 




discussion and apparent understanding about the disease, the common discourse suggests 
that the disease is not only unknown/unknowable, but rather is entirely unintelligible, 
without shape or character. Furthermore, the patient helpfulness identified in official 
discourses is carried over within this framework and is extended to characterize health 
providers as bumbling and dangerous, and unfit to address and deal with the disease.  
 
Skin Cancer 
 In this chapter, I analyzed how public health campaigns funded by the Melanoma 
Research Foundation, The Skin Cancer Foundation, and The National Council on Skin 
Cancer Prevention constructed the disease, patients, and methods of detection and 
prevention. Taken together, these official discourses portray the disease as a privatized 
and individual issue that must be dealt with at the directive of patient expertise and for 
the sake of maintaining the moral character of patients. Likewise, I analyzed 3 years’ 
worth of mainstream news coverage—The New York Times, USA Today, Time, People, 
Health, and Men’s Health—in order to ascertain how, if at all, these ideas about the 
disease and patient responsibility would be taken up in the common. Similar to official 
discourses, the common constructed the disease as privatized, but primarily mobilized in 
these discourses through an emphasis on consumer shaming and suspicion of regulatory 
bodies.   
 
Rhetorical Motifs 
 The discourse surrounding each respective cancer turned on particularized 
characterizations of the cancer at hand, patients, and the medical establishment, but it is 




articulate characterizations of cancer, patients as implicated parties, and the medical 
establishment’s role therein.  
 
Cancer Characterizations 
Despite the multitude of ways in which both official and common discourses 
discuss cancer, two primary characterizations permeate these discourses and provide the 
lenses for understanding the disease as either malevolent or ambiguous.  
 Malevolent.  Drawing on the natural fear that cancer instills, these discourses 
frequently articulate cancer’s malevolent qualities such that the disease is not treated as a 
static entity, but rather an active agent which operates outside the realm of intelligibility 
for patients and providers alike. This mobilization of agency on the part of cancer tends 
to take the form of deception and confusion, thus underscoring the threatening nature of a 
disease which, in these cases, defies logic and expectation. For example, the duplicitous 
nature of cancer is born from its ability to masquerade as other maladies or be dismissed 
because of its similarity to other health issues. Hiding behind the symptoms of common 
processes (e.g., menopause or menstruation) or health issues (e.g., bladder infections), 
cancer not only deceives, but also misdirects and propels both physicians and patients on 
fruitless quests for answers. This confusion, then, reaffirms the malevolent nature of 
cancer by obfuscating inquiry into symptoms as potentially indicative of cancer, and thus 
resulting in the understanding that cancer manipulates medical knowledge and sabotages 
medical intervention. Finally, the threat posed by cancer is sometimes understood 
through religious language and allusions. For example, skin cancer is suggested as a 
substitution for a vengeful god insofar as those who smite it will be struck down by the 




ways of sun safety must make amends for their past transgressions.  
Ambiguous.  In these discourses, cancer is inherently ambiguous and hard to 
define, identify, and understand. It is framed as a threat to health due to its nebulous and 
diffuse nature despite decades of research and seemingly countless dollars, resulting in 
relatively little understanding about what causes it, what prevents it, and what best treats 
it. The futility of powerful, expensive, and persistent interventions renders cancer 
rhetorically as even more ambiguous and perhaps forever unknowable. The nebulous 
nature of the disease is commonly apprehended as uncertainty about what causes it. For 
example, recommendations and/or questioning about healthful eating and similarly banal 
habits are speculated as potential causes or solutions for cancer, thus suggesting that 
patient control over their bodies must be wielded to partake in preventative, if 
unsubstantiated, behaviors. Additionally, the genetic makeup of a cancer diagnosis 
underscores this ambiguity by highlighting how genetic predisposition for one cancer 
may result in another un/related cancer, or no cancer at all, while no predisposition or 
family history has the potential to convince people they are not susceptible to certain 
cancers (when, in fact, they very much are). As such, understanding about genetic 
mutations and predispositions is articulated in the discourse in such a way as to heighten 
the confusion about cancer rather than assuage it. Finally, cancer often fails to align with 
traditional notions of ill health and disease such that certain cancers can mimic common 
health phenomena and confound practitioners, resulting in an imperative for patients to 







Patients as Autonomous/Responsible  
 A central motif on which all of these discourses hinge is the understanding that 
patients are responsible—either in whole or in part—for their cancer diagnoses, and as 
such they must be treated as autonomous individuals in their quests to regain optimal 
health and moral character. This emphasis on patient responsibility and accountability—
as noted below—is mobilized through functional and moral imperatives, both of which 
obscure the systemic and structural factors that likely impact a patient’s ability to take 
responsibility for and action regarding their diagnosis. These articulations of individual 
responsibility contribute to current understanding of how neoliberal sensibilities that 
privilege individual agency and responsibility are deployed in these discourses.  
 Functionally/logistically.  As these discourses suggest, the task of learning about, 
understanding, and addressing cancer is always already the patient’s responsibility, and 
thus entreaties to engage in extensive research about the disease operate both to 
foreground the patient and background the medical establishment. This emphasis on the 
functional and logistical responsibilities of patients is frequently invoked in discussion 
about the need for patients to learn the right information about their disease, as well as 
the right amount of that information, with little to no direction on how to accomplish 
either feat. Expecting patients intuitively to know how much information is “enough” 
reinforces the notion that patients must naturally be left alone to learn about cancer 
because the individual nature of the disease is matched by the individual preferences of 
those dealing with it. A related double-bind exists for female patients who are expected to 
account for and manage their bodies due to their unruly nature and confounding 




discourses such that it is rendered suspect and in need of active medical and self-
surveillance. Because a woman’s body is a site of struggle for meaning in a medical 
context, female patients are assigned the additional task of compensating for and making 
sense of this struggle on an individual level for the benefit of the system. 
 The individualized nature of cancer is further underscored in articulations of 
patient responsibility for diagnoses. As elaborated on below, patients are regularly held 
responsible for their cancer diagnoses, with emphases placed on poor decision making, 
ignorance, obstinacy, and/or apathy, all of which center the patient as accountable to 
medical experts, and more severely, responsible for their ill health. A somewhat 
contradictory articulation of the patient coexists with this understanding of the patient as 
responsible for her/his diagnosis, and that construction suggests that the patient is an 
expert on her/his own body, and thus they must instruct the medical establishment on 
what is normal, appropriate, and needed. Since patients understand and define what is 
normal, they are portrayed as superior to the medical establishment which must then 
operate at the behest of this expertise on the part of patients. 
 Morally.  In keeping with the understanding that patients are autonomous agents 
in the fight against cancer, these discourses also construct a complex of moral 
imperatives that call into question a patient’s moral character during all stages of the 
journey with cancer, including hypothesized actions that led to diagnosis, actions taken to 
prevent it, and actions taken to maintain one’s health post-cancer. These imperatives 
construct the patient as not only responsible, but also inherently accountable to others 
such that preventing and treating cancer are done at the behest of—and for the sake of—




duty insofar as patients must take care of and monitor/scrutinize the body for changes and 
problems—as well as research, understand, and comply with the nuances of one’s 
diagnosis—so as to maintain one’s ability to care for others. This moral responsibility 
becomes particularly salient in regard to breast cancer patients who have families, and 
caregivers who fail to teach and model proper sun safety measures in front of children. 
By centering the family in the cancer journey—as well as highlighting the female 
imperative of putting others before the self—these discourses indicate that surviving is a 
responsibility one has to others, rather than a personal goal or victory. As such, being a 
moral person and patient means being accountable to the needs and habits of the family. 
Lastly, the responsibility assigned to and expected of patients is also mobilized as a 
reverential and religious duty. As discussed above, cancer is understood as a malevolent 
and vengeful disease, and thus patients are constructed as either the unwashed masses or 
converts, with the former partaking in careless behaviors (e.g., tanning) and the latter 
declaring a mea culpa for their recklessness. These religious undertones—firmly situated 
in ecclesiastical notions of right and wrong—position the patient as the recipient of 
righteous punishment for past wrongdoings, and thus naturally tasked with making 
amends (e.g., performing self-exams or wearing sunscreen).  
 
Conflicted Role of Medical Establishment 
 In conflict with the reputation of expertise and benevolence traditionally ascribed 
to medical practitioners is the construction of the medical establishment in these 
discourses. Despite fleeting acknowledgement of expertise and ability, the persistent 
representations of physicians and other authorities cast them as being of limited 





 Limited utility/effectiveness.  Aligning with and reinforcing the motif of patient  
autonomy/responsibility that is pervasive across discourses, the role of the medical 
establishment is largely understood to operate in the background, and thus serve 
primarily as a resource waiting for patients to seek out. The consistent centering of 
patient experiences and expertise marginalizes the medical establishment and questions 
the efficacy of the expertise and abilities embedded therein, resulting in the 
understanding that physicians serve as supplementary support rather than a first line of 
defense. Even more prominent than the construction of a silent and plastic medical 
establishment is the notion that it is rife with problems such that everything about it—
including individual physicians, technologies, and standard operating procedures—puts 
patients at risk of harm. In this way, patients must not only contend with the threats of 
cancer, treatment, and side effects, but they must also gird themselves against the threats 
posed by incompetence, lack of knowledge and qualifications, and the tenets of bad 
medicine. Thus, the visibility of the medical establishment in these discourses serves to 
question it and its potential for effectively and efficiently treating cancer patients. For 
example, the complexity of cancer can render individual physicians powerless, and thus 
necessitate teams of experts to handle it (although this expertise often comes with its own 
threats of patient exploitation for the sake of monetary gain, as discussed below). 
Additionally, the treatments and diagnostic procedures proposed and utilized by the 
medical establishment are often represented as ineffective at best and barbaric at worst, 
resulting in the implication that—at least in some cases—patients would have been better 




 Suspect.  Attendant to the portrayals of expert incompetence and ineffectiveness 
in these discourses is the underlying concern that regulatory bodies are corrupt, and thus 
require circumspection on the part of the patients. Often articulated as indictments of 
financial gain over patient outcomes, this motif primarily hinges on the understanding 
that physicians and health-based organizations operate at the behest of financial 
considerations or those with financial interests. For example, controversies around the 
necessity of tests for different cancer types and the motives behind awareness raising call 
into question those who stand to benefit from the funds raised in both cases. Similarly, 
the proposed ways for preventing cancer are also questioned for the potential vested 
interests that exist in health-based organizations. For example, the suggested use of 
sunscreen is questioned for its veracity in light of the fact that the suggestions are written 
and promoted by those who stand to benefit from rapid consumption and replacement of 
the product (i.e., sunscreen companies contribute funds to skin cancer foundations).  
 Related to the limited effectiveness of physicians is the notion that physicians 
tend to have a fundamental lack of knowledge about cancer, and thus they adopt a 
reactive approach for dealing with it that requires standardized ways of treating all 
patients. In addition to being swayed by profit margins, physicians are also understood to 
be inherently mercurial and susceptible to changes in treatments and diagnostic 
procedures, regardless of the usefulness of the changes to patients or the soundness of the 
scientific research behind these procedures. Finally, the medical establishment is cast as 
suspect through the ways in which it is perceived to exploit patients and prey upon their 
desperation for answers and solutions. Extensive attention is paid in these discourses to 




of understanding on the part of the patients. With little agency or technical expertise to 
question or challenge physician recommendations, patients are constructed as having a 
dearth of options and ultimately vulnerable to the suggestions of designated experts. As 
such, physicians are portrayed as requiring unnecessary tests and treatments in order to 
maximize profits and boost their own status among those utilizing emergent technologies, 
all at the literal and figurative expense of cancer patients. 
 
Convergences and Divergences   
 The above motifs that construct cancer, patients, and the medical establishment in 
distinct ways were apparent across cancers and across both official and common 
discourses. However, there were notable variations, per respective cancers, between these 
discourses. Regarding breast cancer, official discourses construct cancer as an ever-
present risk for women, assume patients are in control and understand their moral 
imperatives to regain health, and portray the medical establishment as secondary and at 
the will of the patient. The common, however, assumes that breast cancer is puzzling and 
largely not understood by practitioners, situates patients as always already harmed by the 
practices and inefficiencies of physicians, and highlights the extensive modalities of bad 
medicine that permeate the medical establishment. Similarly, official discourses about 
bladder cancer construct cancer as deceitful, patients as expected to take (limited) action 
against the disease, and physicians as ultimately insufficient to deal with it; conversely, 
the common portrays cancer as unintelligible, patients as morally culpable for their 
diagnosis, and the medical establishment as inherently suspect. Finally, official 
discourses about skin cancer construct cancer as righteous comeuppance for bad 




assistants to patients; the common draws on similar ideas to position cancer as the result 
of poor decision making, patients as irresponsible, and the medical establishment as 
corrupt.  
 These convergences and divergences suggest that, broadly, cancer is represented 
as a challenge sourced by issues external to the medical establishment (e.g., the female 
body is more prone to breast cancer) in official discourses, whereas it is confusing at best 
and unintelligible at worst in common discourses. Patients, likewise, are centered as 
responsible for their diagnoses and overall health in official discourses, whereas they are 
assumed to be victims of external agents, at best, or their own poor decision making, at 
worst, in the common. Finally, official discourses frame the medical establishment as 
well intentioned and often helpful, whereas the common question providers’ 
effectiveness at best and trustworthiness at worst. While people affected by cancer—
either through diagnosis or the diagnoses of family/friends—are likely to consult both 
kinds of discourses in the process of learning about/dealing with treatment, prevention, 
and recovery, and thus it is warranted to discuss practical implications, it is also 
important to acknowledge that there may be competing and even conflicting 
understandings that patients and the populace at large are engaging.  
 
Contributions 
 Analysis of the rhetorical articulations of breast, bladder, and skin cancer across 
official and common discourses suggests two primary theoretical contributions. First, this 
study contributes to health communication literature to the extent that it adds to critical 
inquiries in health communication. Specifically, it parses established knowledge about 




establishment entities, particularly noting that individual responsibility is mobilized 
differently across cancers with significantly different implications. While extensive 
critical health communication literature has established the problematic individual 
responsibility model of health communication, no one has as yet unpacked what this 
means and how it is mobilized. The current study, however, does just that by assessing 
the ways in which responsibility is mobilized and identities are constructed in relation to 
cancer. Alternatingly tethering morality, authenticity, accountability, and culpability to 
the choices of patients, these competing discourses construct dramatically different 
imperatives for patients that are dependent upon cancer type. As such, the mobilization of 
individual responsibility—though consistently invoked across these discourses and 
cancers—fails to provide a consonant view of patients and instead places mercurial 
expectations on them. Likewise, it is similarly significant how the medical establishment 
is seen as oppositional or inept in regard to certain cancers, particularly as some cancers 
are more closely associated with private industry and profit-driven ventures, and/or 
medical interventions that prove to be advantageous for the medical establishment as 
opposed to the patient. This oppositional view of the medical establishment is contrary to 
the well-established narrative of the benevolent—and often heroic—provider that 
permeates popular discourses about health and medicine.   
 Relatedly, identities were apprehended in distinct ways across these discourses 
and cancers, particularly as they relate to fulfilling the aforementioned imperatives of 
responsibility and accountability. Illuminating on their own terms, these findings are also 
valuable in that they lend definition and nuance to extant literature that has established 




responsibility (Crawford, 1980; Dutta, 2010; Lupton, 2015). Said responsibility, this 
study reveals, is not “one size fits all,” as the type of responsibility varied across the 
discourses under review. Moreover, individual responsibility—however articulated—is 
correlated in many cases with particular identity markers, as well. Gender, for example, 
was revealed to play a role as relevant to women’s particular moral obligations to others 
as well as higher demand for vigilance in regard to their (as articulated) relatively more 
suspect bodies. Age was found to intersect with gender such that the construction of 
younger people’s—and particularly younger women’s—role in avoiding cancer hinged 
on expectations of irresponsibility and even immaturity. A final example of identity being 
brought to the fore in these discourses was demonstrated in the configuration of 
education and/or media literacy as central to handling one’s cancer diagnoses. In many 
cases, patients were assumed to have achieved a level of education or media literacy that 
would enable them effectively and efficiently to seek out the appropriate information in 
the right amounts at the opportune times (all of which assume access, awareness, and 
knowledge, and which underscore the patient’s role in learning about cancer generally 
and their diagnosis specifically).  
 Second, the significant differences in official discourses and common discourses 
in each case confirm that mainstream news, if historically appropriately characterized as 
official discourse in the past, cannot be said to categorically occupy that status any longer 
(at least not by default). This is primarily so because mainstream news now seems to be 
reflective of and responsive to broader cultural imperatives and responsibilities that are 
not reflected in the same way as official discourses (i.e., those institutional and 




control/create public space). This reconceptualization of what constitutes the “official” is 
undergirded by cultural and technological shifts in media outlets and formats, and 
concomitant widespread adoption of practices of engagement on the part of publics with 
mainstream media outlets, all of which have resulted in a mediascape, inclusive of 
mainstream media, that is no longer consonant with official discourse as historically and 
conventionally imagined. Additionally, while it is perhaps not justifiable to codify 
mainstream media as a variant of vernacularity, it is justifiable—per recent scholarship 
furnished by both media scholars (e.g., Bruns, 2006, 2008) as well as critical rhetoricians 
(e.g., Howard, 2008)—to trouble or at least complicate and nuance that original binary. 
To that end, this project hypothesized and has borne out that there is a viable “third way,” 
or category, of “common” discourse: a classification original to Howard (2008), but one 
that, contrary to his argument at the time, I find significant, distinctive, and germane. 
This “middle ground” discourse provides an added dimension to our thinking about 
discursive (re)productions, articulations, circulations, and negotiations of meaning and 
power. Indeed, the fact that my analyses surfaced substantial and distinctive variances 
between official and these common discourses supports this claim. Redefining the 
common to include mainstream cultural discourses acknowledges that clear distinctions 
between media producers and consumers have been irreparably blurred, and that the elite 
role of producer once occupied by mainstream news has—in many ways—collapsed into 
media production more generally (a shift no doubt enabled by the rapid proliferation of 
digital media). While the democratizing function of digital and social media is not under 
examination here, the dynamic synergy between traditional media (e.g., The New York 




between the two in digital spaces. That is, mainstream news stories are 
shared/liked/pinned/et cetera frequently in social media to the extent that sites like 
Twitter have made adjustments to their user interface in order to accommodate the 
addition of links, and news sites now inevitably include comments sections and tools to 
share stories seamlessly via multiple social media platforms. This synergy, then, 
challenges the notion that the common only resides in ostensibly secluded (and 
assumedly oppressed) communities, and instead suggests that vernacularity can exist in 
spaces where the fluidity of power is both apparent and possible, and inherently drawn 
against those discourses that establish the status quo and that are far more fixed than 
news sources or social media accounts (i.e., institutional/structural discourses).  
 
Implications 
 Even though health providers are likely to know (and toe) the “party line” (i.e., 
ideas featured within official discourses) about how the medical establishment and its 
personnel function within the milieu of cancer care, the disjunctures relevant to common 
discourses are poised to be instructive for them. In all likelihood, patients/those affected 
are going to consult both official and common discourses, however, so the following 
implications assume as much. Thus, identifying those ideas about cancer that gained 
traction in the public imaginary via common discourses indicated four suggestions for 
potentially improving patient-provider communication and the construction of future 
public health campaigns. These implications, if abstract in nature, draw on the prevalent 
emphasis placed on patients in these discourses in order to illuminate potential fissures in 
the current standards of cancer care, primarily the management of expectations, removal 




constructions of physicians.  
 
Management of Expectations 
 As these collective discourses suggest, patient agency and information-seeking 
habits are central to fighting cancer and engaging with the medical establishment 
effectively and efficiently. However, these expectations are often constructed via double 
binds that constrain patients in accomplishing the very actions advocated. Therefore, 
patients could potentially be benefited by clear directives of physician expectations, as 
well as contextualization of those directives (e.g., bladder cancer patients are implored to 
learn about their disease, but that information is often rendered useless by lack of 
knowledge about the disease throughout the medical establishment). Clarifying what 
patients are expected to do and what those efforts are understood/expected to accomplish 
could potentially reduce uncertainty about the processes of pursuing and receiving cancer 
care for patients and administering it for physicians.  
 
Removal of Moral Imperatives  
 Prevalent across these discourses is an emphasis on patient (and consumer) 
morality and the ascribed moral pitfalls that are perceived or understood to generate 
cancer diagnoses (e.g., smoking, not wearing sunscreen, not eating organic foods, etc.). 
By centering blame on patients (and consumers, to a lesser extent), these discourses 
invoke notions of guilt over poor decisions (i.e., a patient did a bad thing), and often 
escalate into shaming patients (i.e., a patient is a bad person). Since guilt appeals without 
shame are more effective and less prone to resulting in boomerang effects (i.e., patients 




2013), those constructing cancer care messages could potentially benefit from removing 
shame-based guilt appeals from campaigns and patient interactions in order to avoid 
boomerang and other negative reactions (e.g., anger). Additionally, providers might also 
consider attempting to inoculate patients against those messages that contain problematic 
information (e.g., misperceptions about cancer, and that which suggests patients can 
control their cancer and whether or not they get it), and debunk this information  
directly and explicitly (even preemptively).  
 
Facilitation of Trust 
 Whereas official organizations and health advocacy websites generally assume 
competence and honesty on the part of practitioners, dissent apparent in the common 
discourse about the rectitude of the medical establishment suggests that physicians could 
benefit from an emphasis on the facilitation of trust so as to assuage concerns about 
various forms of corruption (e.g., overtreatment, unnecessary testing, collusion, etc.). 
Because much of common discourse about cancer turns on extensive suspicion of 
regulatory bodies and authorities, analysis suggests that patients could potentially benefit 
from enhanced transparency about the procedures for determining necessary tests, 
associated costs, and vested interests in related technology in order to eliminate—at least 
in part—potential concerns about the character and intentions of providers.  
 
Physicians as Partners  
 Conspicuously absent across these collective discourses is the idea of medical 
practitioners as partners (which is perhaps not surprising in light of the aforementioned 




to the foreground as incompetent or relegated to the background as silent assistants 
working at the behest of patients, physicians fail to earn parity with each other or even 
their patients in these discourses insofar as they are positioned as only strong in numbers 
and/or inferior to patient expertise. As such, added emphasis on the symbiotic 
relationship between patients and providers could potentially enhance public health 
campaigns, especially those campaigns that are seeking to enhance patient efficacy and 
agency through knowledge acquisition and medical expertise.  
 
Limitations and Future Directions 
 This inquiry is limited by key constraints on scope and context, and indicates 
ways to attend to these limitations in future research. First, the narrow scope of these 
three cancers occludes discussion of other prevalent—and, in some cases, more 
prevalent—cancers (e.g., prostate and lung). These specific types of cancer under study 
here are also often demarcated by gender, indicating that messages about them will 
potentially feature patterns consistent with normative gender roles and expectations in the 
US (e.g., breast cancer campaigns focusing on a woman’s role in the family), thus 
limiting those messages constructed for a broader array of patients. Second, the specific 
3-year time frame (2013-2015) chosen for this project is far from comprehensive, nor 
does it account for time-sensitive coverage of scientific breakthroughs about these 
cancers that happened before and after 2015. Finally, the discourses analyzed here are 
comprised solely of mainstream domestic venues only, thus limiting other perspectives 
(e.g., patient-created discourses) and international discourses.  
 Taking these limitations—as well as the findings of this inquiry—into account, I 




rhetorical constructions of other particularized discourses of health, illness, and medicine 
is warranted in order to ascertain how other prevalent health issues are taken up in 
common discourse. Second, a comparative cultural study of rhetorical constructions of 
health, illness, and medicine would be valuable in order to illuminate key rhetorical 
motifs in official discourse, particularly as they may or may not be consonant with the 
progression from individual responsibility to shame and blame that is endemic to U.S. 
discourses. This type of study could potentially reveal how notions of individual 
responsibility are constructed and taken up in varying discourses, and pay particular 
attention to how they potentially transmogrify from official to common discourse. Third, 
a comparative historical study of coverage of these same cancers from approximately 30 
years ago would provide a theoretical contribution to the study of cancer discourses. Such 
a study should interrogate the potential variances between official discourse and what I 
am identifying as a viable “common” discourse now in order to establisher whether there 
has always been a difference between the two, or whether there was little difference 
between official discourse and mainstream news venues back in the day (thus suggesting 
that the official/vernacular binary was more sustainable and defensible then as opposed to 
now). Fourth, a study of vernacular discourses as originally conceptualized would be 
interesting in order to note how lay discourses articulate these cancers, particularly in 
regard to rhetorical motifs, identity, and related factors identified in the current study. 
Attending to how vernacular discourses do or do not vary from common discourses—and 
in which ways—would further clarify and refine emergent conceptualizations of 
discourse relevant to power in a contemporary context. Such a study would benefit from 




making sense of these cancers. Through the inclusion of tweets, Instagram posts, shared 
links, hashtags, and similar social media fare, a study could determine how those who 
likely lack any expertise on the subject of cancer are making sense of it and engaging 
with other users on the same subject (thus also providing a sense of community that is 
central to original theorizing about the vernacular). Finally, a praxis-oriented future 
direction would be to create and mobilize a health campaign and/or practice that 
consciously attends to and engages common discourse could illuminate optimal ways in 
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